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Humans express 15 different inward-rectifying potassium (Kir) channels that play a variety of 
roles in epithelial transport, nerve conduction, and muscle contraction. Polymorphisms in Kir 
channels underlie numerous genetic diseases. In order to investigate the function and regulation 
of Kir channels, researchers have long recognized the potential of expressing them in strains of 
Saccharomyces cerevisiae (Bakers’ yeast) engineered for sensitivity to growth in a low 
potassium medium. These studies capitalize on the wide variety of genetic and biochemical tools 
available in yeast, namely the ease of transforming large quantities of cells with recombinant 
DNA and the availability of comprehensive mutant libraries for high-throughput screening. Due 
to the longstanding popularity of yeast as model eukaryotes, the mechanisms underlying cellular 
phenomena are relatively well-documented and are also conserved in multicellular organisms. In 
this document, I will first review the history and diversity of techniques for studying potassium 
channels in potassium-sensitized yeast. Next, I will describe the results of a genetic screen to 
identify the key regulatory factors for a particular Kir channel: the renal outer medullary 
potassium (ROMK) channel. ROMK, also known as Kir1.1, is the major route for potassium 
secretion into the pro-urine and plays an indispensable role in regulating serum potassium. 
However, the cellular machinery that regulates ROMK trafficking has not been fully defined. I 
used a synthetic genetic array to identify nonessential genes that reduce the plasma membrane 
pool of ROMK in potassium uptake-deficient yeast. Through this screen, I identified several 
members of the endosomal complexes required for transport (ESCRT) and the class-C core 
vacuole/endosome tethering (CORVET) complexes. Moreover, silencing of ESCRT and 
CORVET components increased ROMK levels at the plasma membrane in a mammalian cell 
line, therefore establishing that post-endocytic sorting influences the cell-surface density of 
ROMK and modulates its activity. Finally, I will briefly delineate potential future studies in yeast 
with ROMK and other Kir channels and will describe several investigations into various aspects 
of Kir channel biology to which I have contributed through collaboration. 
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University of Pittsburgh, 2018
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1.0  INTRODUCTION 
In this section, I will describe the rationale, history, and future potential for using budding yeast 
to investigate potassium channels. This first section is adapted from a review article currently in 
revision at the journal Genetics. I will then describe how my dissertation research contributes to 
this legacy. 
1.1 INVESTIGATING POTASSIUM CHANNELS IN YEAST 
1.1.1 Potassium channel classes, activities, and structures 
Potassium channels are ubiquitous in eukaryotes and prokaryotes and are the most diverse type 
of cation channel due to early evolutionary divergence (Loukin et al., 2005). The most salient 
feature of potassium channels is their ability to discriminate K+ from smaller cations such as Na+ 
(MacKinnon, 2003). All potassium channels have four-fold symmetry around their central pore 
(MacKinnon, 1991). This is typically accomplished upon tetramerization of identical or 
homologous subunits, although some channels are dimers or monomers in which two or four 
pore-forming domains are fused in tandem. The paradigmatic feature of all potassium channels is 
the eight amino acid potassium selectivity motif, TXXTXG(Y/F)G. The alignment of the peptide 
backbone carbonyls of the selectivity motif mimic the hydration shell of a potassium (K+) ion, 
thus favorably dehydrating K+ ions while excluding ions with smaller van der Waals radii, such 
as Na+ or Li+ (Doyle et al., 1998; Roux and MacKinnon, 1999).  
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Potassium channels are broadly classified based on the number of transmembrane 
domains (TMD): 6-TMD voltage-gated (Kv) channels and 2-TMD inward-rectifying (Kir) 
channels (Miller, 2000).  
In voltage-gated channels—also known as Shaker-type channels after the first such 
channel identified in Drosophila melanogaster (Tempel et al., 1987)—the selectivity filter is 
situated between TMD5 and TMD6. In addition, TMD4 is distinguished by highly conserved 
arginine or lysine residues at every third or fourth position along the transmembrane helix, which 
are essential for sensing transmembrane voltage and channel opening upon membrane 
depolarization (Figure 1). Calcium-gated potassium channels (KCa) are also 6-TMD-containing 
channels and have diverged from Kv channels, though some (notably “big current” or “BK” 
channels) retain voltage sensitivity. As their name implies, they are activated upon binding 
intracellular Ca2+ through various mechanisms (Vergara et al., 1998; Ghatta et al., 2006). 
Inward-rectifying channels have a simpler structure of two TMDs flanking the selectivity 
filter (Hibino et al., 2010) (Figure 1). They are presumably the basal clade of potassium channels 
with widely distributed homologues in both prokaryotes and eukaryotes (Loukin et al., 2005). 
Their bias for inward over outward currents (in apparent violation of the Nernst equation) occurs 
via transient block by intercellular divalent cations, such as Mg2+ and polyamines (Lu and 
MacKinnon, 1994). However, in mammalian physiological settings, Kir channels rarely 
encounter sufficient voltage to allow potassium influx and are usually efflux channels. The 
classical mammalian Kir channels (Kir2.x) are constitutively active—i.e. they have a high open 
probability (Po) and are regulated primarily by the amount of protein at the cell surface—while 
other classes have a low Po until activated by G-proteins (e.g., Kir3.x) or intracellular nucleotides 
(e.g., KATP or Kir6.x) (Hibino et al., 2010).  
Mammalian cells also express tandem pore domain channels, or K2P channels, which 
appear to be the product of a gene fusion event (Figure 1). K2P channels are responsible for very 
small “leak” currents that are voltage insensitive and non-rectifying. However, K2P channels can 
still be gated by a variety of stimuli, such as membrane stretching or deformation, heat, and pH 
(Enyedi and Czirják, 2010).  
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Figure 1: Topological and structural features of major potassium channel clades (A) 
Cartoon representation of the transmembrane topology and key functional features of several 
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subclasses of potassium channel monomers mentioned in this section. Note the universally 
conserved pore domain containing two TMDs, a pore (P) helix, and a selectivity filter. (B) 
Representative structures of mammalian Shaker (Kv1.2), a 6-TMD channel, and (C) bacterial 
KcsA, a 2-TMD channel, shown looking down the pore from the extracellular side (left images) 
and parallel to the membrane (right images). Both structures are homotetramers with individual 
polypeptides rendered in different colors. The Shaker structure is derived from PDB ID: 2A79 
(Long et al., 2005), and the KcsA structure is derived from PDB ID: 2WLM (Clarke et al., 
2010). All images were rendered in PyMol (v. 1.8.6). 
 
 
 
 
Based on their activities, regulation, and distribution, potassium channels mediate a broad 
range of biological processes. For example, in humans they are involved in nerve conduction 
(Mathie and Veale, 2009), cardiac contraction (Sanguinetti and Tristani-Firouzi, 2006), hearing 
(Wangemann, 2006), maintenance of blood pressure (Wang et al., 2010), immune responses 
(Cahalan et al., 2001), and numerous other processes beyond the scope of this review. Moreover, 
polymorphisms in human potassium channels have been linked to dozens of genetic disorders 
affecting the nervous system, heart, kidneys, endocrine glands, and immune cells (see (Kim, 
2014) for an extensive review of channelopathies). Unfortunately, investigating potassium 
channel activity, modulation, and biogenesis is often labor-intensive, especially in mammalian 
cells. The development of a rapid, genetically tractable model in which these studies can be 
conducted has significantly aided our understanding of potassium channel physiology. 
1.1.2 Potassium channels and potassium homeostasis in S. cerevisiae 
The budding yeast Saccharomyces cerevisiae presents several properties that make it an 
attractive system in which to probe the function of potassium channels. First, genetic 
transformations are famously facile in S. cerevisiae as compared to other commonly-studied 
organisms. Second, strain libraries have been developed in which every gene in the yeast genome 
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has been deleted, can be conditionally deactivated, or is present at reduced copy. Third, these 
unicellular eukaryotes can be propagated on either solid or in liquid growth medium, so yeast 
numbers are eminently scalable and the organism is amenable to high-throughput manipulations. 
Fourth, lab strains can be transitioned between the haploid and diploid state, allowing for genetic 
recombination and analyses of recessive and dominant phenotypes. Fifth, the resting membrane 
potential in S. cerevisiae is believed to be high relative to mammalian cells (see below), thus 
driving inward cation currents. Finally, despite nearly a billion years of evolutionary separation 
from humans, the vast majority of subcellular processes that animate yeast are conserved. 
Therefore, insights from yeast research are often analogous to the cell biology of multicellular 
eukaryotes.  
Plasma membrane alkali metal transport in S. cerevisiae is adapted to efficiently import 
potassium and exclude sodium from the cytosol (for a detailed review, see (Ariño et al., 2010)) 
(Figure 2). In brief, the electromotive force for potassium influx is generated by the electrogenic 
plasma membrane proton ATPase Pma1. Transmembrane potential in yeasts is believed to be 
quite high due to the activity of this proton transporter, but is notoriously difficult to measure 
directly with electrophysiological methods due to the high rigidity of the yeast cell wall (Vacata 
et al., 1981; Volkov, 2015). Pma1 is the most abundant plasma membrane protein in yeast and 
consumes ~20% of cellular ATP (Morsomme et al., 2000).  
The Pma1-dependent transmembrane potential provides the electromotive force for 
potassium uptake through two high-efficiency channels, Trk1 and Trk2 (Figure 2). Trk1 was 
identified as the primary avenue for potassium influx (Gaber et al., 1988; Ko and Gaber, 1991) 
and its structure is quite distinct from mammalian potassium channels. Most prominently, the 
pore-forming unit is a single polypeptide consisting of four 2-TMD units, which together form a 
fourfold symmetric pore. Under most growth conditions, Trk1 is responsible for nearly all 
potassium influx, but it is not essential. Yeast lacking TRK1 (trk1Δ) have slightly increased 
potassium requirements that nevertheless fall within the bounds of ordinary laboratory growth 
medium. These yeast survive due to the presence of Trk2, which is a Trk1 paralogue with a 
lower affinity for potassium and far lower expression in wild-type yeast. In contrast, doubly 
mutated trk1Δ trk2Δ yeast have a drastically increased requirement for potassium 
supplementation in growth medium, usually ~100 mM. That these yeast are able to survive at all 
speaks to the presence of a very low-affinity potassium uptake system, termed “non-specific 
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cation channel 1” (Nsc1) (Bihler et al., 1998). The gene encoding this putative channel is as yet 
unidentified, and in fact may not even exist because potassium may leak into trk1Δ trk2Δ cells 
through various nutrient transporters. Indeed, mutations in hexose or amino acid transporters are 
a common cause of phenotypic reversion in trk1Δ trk2Δ yeast (Ko et al., 1993; Wright et al., 
1997; Liang et al., 1998). This can be prevented by propagating trk1Δ trk2Δ cells on high 
potassium medium up until the time that key experiments are conducted (section 1.1.6). 
Nevertheless, trk1Δ trk2Δ cells are hyperpolarized and are sensitive to low pH (Ko and Gaber, 
1991), to alkali metals other than potassium (Bertl et al., 2003), and to a variety of toxic cations 
such as hygromycin B (Madrid et al., 1998). 
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Figure 2: Schematic of plasma membrane proton and alkali metal channels and 
transporters in S. cerevisiae. Native yeast channels and transporters mentioned in this text are 
shown here with representative ion currents. This figure has been adapted and simplified from 
previously published work (Ariño et al., 2010). Select phenotypes of the potassium channel and 
transporter deletion strains mentioned in the text are shown to the right (Bañuelos et al., 1998; 
Bertl et al., 2003). 
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In addition to the Trk channels, S. cerevisiae express a voltage-gated outward-rectifying 
potassium channel, Tok1. Like Kv channels in animals, Tok1 opens upon membrane 
depolarization. However, Tok1 is neither essential nor does deletion of TOK1 make trk1Δ trk2Δ 
yeast more sensitive to growth on low potassium medium; however, compared to trk1Δ trk2Δ 
yeast, the triple mutant strain exhibits increased tolerance to high cesium (Bertl et al., 2003). In 
addition, whereas mammals lack Trk1 or Trk2 homologues, Tok1 is homologous to the 
vertebrate two-pore K2P channels (Wolfe and Pearce, 2006). Therefore, select studies have 
utilized the trk1Δ trk2Δ tok1Δ potassium sensitive strain (section 1.1.7). 
While potassium influx in yeast involves gradient-dependent passive transport through 
the Trk1 and Trk2 channels, potassium efflux under conditions of excess cytosolic potassium 
requires active transport. Yeast have two primary systems to expel excess alkali metals into the 
extracellular environment: the ENA (exitus natru) uniporters and the Nha1 Na+/H+ antiporter 
(Figure 2). Although they primarily transport sodium, these systems are also able to export 
excess potassium (Bañuelos et al., 1998). ENA uniporters are encoded as tandem repeats at a 
single locus on chromosome IV with high (~97%) conservation. The number of ENA isoforms 
varies among laboratory strains, with W3031-A having four copies and S288C having five. This 
may partially explain the observation that these two common laboratory workhorses differ in 
their tolerance to sodium and other cations (Petrezselyova et al., 2010). Deletion of the ENA 
cluster renders yeast sensitive to both sodium and lithium. ENA expression is typically low but is 
strongly induced upon exposure to high sodium or lithium via the action of the osmoresponsive 
transcription factor Hog1 (Märquez and Serrano, 1996). In contrast, Nha1 is constitutively 
expressed at low levels and seems to play a housekeeping role in regulating intracellular 
potassium under low pH and in expelling the small quantities of Na+ that enter through other 
transporters, such as the Na+/PO43- symporter Pho89 (Persson et al., 1998). Both Nha1 and Ena1 
promote growth in high K+ medium, and a strain lacking both the ENA cluster (ena1-4Δ) and 
NHA1 fail to propagate on high concentrations of potassium or any other alkali metal (Bañuelos 
et al., 1998; Kinclová et al., 2001). 
Yeast are also capable of sequestering alkali metals in organelles, particularly the 
vacuole. Vnx1 is a vacuole-localized antiporter that can exchange vacuolar protons for cytosolic 
sodium or potassium (Cagnac et al., 2007). Vnx1 likely plays an important role in detoxifying 
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the cytosol upon sodium stress as vnx1Δ yeast are sensitive to high sodium (Cagnac et al., 2007) 
and the genomes of halotolerant fungi such as Hortaea werneckii contain multiple paralogues of 
VNX1 (Plemenitaš et al., 2016). While concentrating potassium in the vacuole can contribute to 
cellular turgor and help to balance the negative charge of vacuolar polyphosphate (Klionsky et 
al., 1990), it is unclear whether the vacuole can function as a “strategic reserve” upon acute 
potassium starvation. 
1.1.3 Discoveries with trk1Δ trk2Δ yeast 
In the following subsections, I survey the many uses of trk1Δ trk2Δ yeast and then discuss 
several studies that have significantly aided our understanding of potassium channel function, 
regulation, biogenesis, and pharmacology. For the sake of brevity, I limit discussion to seminal 
studies, and the most recent findings. For further information, I direct the reader to the studies 
outlined in Table 1, which provides a more comprehensive list of discoveries in which 
exogenous potassium channels expressed in trk1Δ trk2Δ yeast played a key role. 
 
Table 1: Select studies utilizing expression of an exogenous channel or transporter in 
trk1Δtrk2Δ, trk1Δtrk2Δtok1, or ena1-4Δnha1Δ yeast 
 
 
Channel Primary Method Full Citation 
K2P2.1 Drug Screen (Bagriantsev et al., 2013) 
Kir2.1 Drug Screen (Zaks-Makhina et al., 2004) 
Kir2.1 Drug Screen (Zaks-Makhina et al., 2009) 
Kir3.2 (GIRK2) Drug Screen (Kawada et al., 2016) 
Akt1 Expression (Sentenac et al., 1992) 
AKT2 Expression (Cao et al., 1995) 
HIV-1 Vpu Expression (Herrero et al., 2013) 
Hkt1 Expression (Schachtman and Schroeder, 1994) 
Kat1 Expression (Anderson et al., 1992) 
Kat1 Expression (Schachtman et al., 1992) 
Kir2.1 Expression (Hasenbrink et al., 2005) 
Kir2.1 (IRK1) Expression (Tang et al., 1995) 
Kir6.1/6.2 Expression (Graves and Tinker, 2000) 
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Table 1 (continued) 
Kv11.1 (hERG) Expression (Schwarzer et al., 2008) 
ORK1 Expression (Goldstein et al., 1996) 
RhAG (not a Kchannel) Expression (André et al., 2000) 
SKD1,2 
(Transporters) 
Expression (Perier et al., 1994) 
TcCat Expression (Jimenez and Docampo, 2012) 
AKT1 Random Mutagenesis (Ros et al., 1999) 
Hak5 Random Mutagenesis (Alemán et al., 2014) 
HvHAK Random Mutagenesis (Mangano et al., 2008) 
Kat1 Random Mutagenesis (Nakamura and Gaber, 2009) 
Kat1 Random Mutagenesis (Nakamura et al., 1997) 
Kat1 Random Mutagenesis (Lai et al., 2005) 
KcsA Random Mutagenesis (Paynter et al., 2008) 
Kir1.1 (ROMK) Random Mutagenesis (Paynter et al., 2010) 
Kir2.1 Random Mutagenesis (Cho et al., 2000) 
Kir2.1 Random Mutagenesis (Minor et al., 1999) 
Kir3.2 (GIRK2) Random Mutagenesis (Yi et al., 2001) 
Ksv Random Mutagenesis (Chatelain et al., 2009) 
TRVP4 Random Mutagenesis (Loukin et al., 2010) 
Kcv Synthetic Biology (Cosentino et al., 2015) 
Kir1.1 (ROMK) Synthetic Genetic Array (Mackie et al., 2018) 
Kir2.1 Synthetic Genetic Array (Kolb et al., 2014) 
Kir2.1 Trafficking assays (Grishin et al., 2006) 
Kir2.1 
KCNK3 
KCNK9 
Trafficking assays (Bernstein et al., 2013) 
Kir3.2 (GIRK2) Trafficking screening (Bagriantsev et al., 2014) 
Kir6.1 Trafficking assays (Zerangue et al., 1999) 
Ksv Trafficking assays (Balss et al., 2008) 
Kir1.1 (ROMK) Trafficking assays (O’Donnell et al., 2017b) 
Kir2.1 Trafficking screening (Shikano et al., 2005) 
 
1.1.4 Identification of uncharacterized potassium channels from cDNA libraries 
The Gaber lab first noted the potential of exogenous potassium channels to substitute for the 
endogenous potassium uptake system in yeast (Ko and Gaber, 1991; Nakamura and Gaber, 
1998), and numerous studies over the past two decades have exploited this phenotypic assay to 
identify novel classes of potassium channels from various organisms. By transforming cDNA 
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libraries into trk1Δ trk2Δ yeast and identifying clones that enable growth on low potassium 
media, researchers have identified new potassium channels rapidly and with minimal bias. This 
technique offers several advantages over traditional screens for new channels. In this case, cRNA 
libraries are injected into Xenopus laevis oocytes and then ion current is measured. This process 
must be reiterated several times with subdivided RNA pools. This labor-intensive protocol led to 
the identification of many potassium channels (see for example (Ho et al., 1993)). In contrast, 
the yeast selection scheme is cheaper, there is no need for electrophysiology “rigs”, and the 
isolation of positive clones does not require sequential subdivision of RNA pools and the 
isolation and amplification of unique clones because transformed yeast only express single 
clones. This technique has provided a particular boon for identifying potassium channels and 
transporters from the plant kingdom.  
Potassium is a key macronutrient for plants that is absorbed from the soil through the root 
system and concentrated in cells to maintain cellular turgor. Because plants lack contractile 
tissues, potassium fluxes underpin various tropisms that allow them to respond to environmental 
stimuli (Dreyer and Uozumi, 2011). The first plant potassium channel, KAT1, was identified by 
coopting the trk1Δ trk2Δ growth phenotype on low potassium (Anderson et al., 1992; 
Schachtman et al., 1992). KAT1 is a Shaker-type voltage-gated channel with inward-rectifying 
properties, is highly expressed in guard cells, and its activation in response to hyperpolarization 
causes the stoma to swell and open. Dozens of subsequent studies have since identified 
previously unknown potassium channels and transporters in both model and crop plants, 
including AKT1, a strongly inward-rectifying potassium uptake channel in root hairs (Sentenac 
et al., 1992; Hirsch et al., 1998), as well as HKT, which was the first plant high-affinity 
potassium transporter identified (Schachtman and Schroeder, 1994) (see Table 1). Potassium 
transporters are functionally and morphologically distinct from potassium channels and as such 
fall outside the scope of this review, but they have also been extensively studied in yeast (see 
(Rodríguez-Navarro and Rubio, 2006) for review). 
One limitation of this system bears mention. Full length Kv channels from animals are 
unable to rescue the growth of trk1Δ trk2Δ yeast on low potassium. This phenomenon arises due 
to the fact that mammalian Kv channels fail to open in the hyperpolarizing potential across the 
yeast membrane; in contrast, plant Kv channels open under these conditions, which is why 
KAT1 and other related channels could be isolated in yeast (Table 1). However, the Kv channel 
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rat ether-à-go-go Related Gene-1 (rEAG1) was able to restore growth in trk1Δ trk2Δ cells if the 
N-terminal 190 amino acids (i.e. the entire cytosolic N-terminal domain) were removed 
(Schwarzer et al., 2008). This result, while potentially opening many doors for studying 
mammalian Kv channels in yeast, is puzzling as the N-terminal PAS domain of hERG, the 
human homologue of rEAG1, is necessary for channel activity in native systems (Gianulis and 
Trudeau, 2011). Fortunately, many mammalian Kir channels function in trk1Δ trk2Δ and ena1-4Δ 
nha1Δ yeast: Of the 11 known human Kir channels, 10 have been successfully expressed and are 
active in trk1Δ trk2Δ cells (D’Avanzo et al., 2010). The first of these—and to date the most 
extensively studied—is the cardiac inward-rectifier Kir2.1, which was originally called IRK1 
(Tang et al., 1995) (see below). 
New potassium channels can currently be predicted by in silico recognition of core 
features based on DNA sequence analysis. Nonetheless, trk1Δ trk2Δ yeast remain a valuable tool 
to validate the function of putative potassium channels detected in the ever-expanding collection 
of sequenced genomes. This approach is particularly useful for exotic potassium channels that 
lack the canonical potassium selectivity motif. Many of these non-canonical channels have been 
found in the genomes of viruses or intracellular parasites, such as Trypanosoma cruzi (Jimenez 
and Docampo, 2012). 
Viroporins are small transmembrane proteins encoded in viral genomes that insert into 
the host cell plasma membrane, increase cell permeability, and play important roles in virion 
maturation and budding (Nieva et al., 2012). Because they are exposed to the extracellular 
environment, viroporins are also attractive therapeutic targets. Expression of viroporins from 
various viral taxa in trk1Δ trk2Δ yeast established that these proteins function as potassium 
channels. Notable viroporins studied in this system include Paramecium bursaria Chorella 
virus-1 Kcv (Greiner et al., 2011), human immunodeficiency virus-1 protein U (Vpu) (Herrero et 
al., 2013), and porcine epidemic diarrhea virus ORF3 (Wang et al., 2012a). Vpu lacks a 
canonical potassium selectivity motif, has a pentameric (rather than a tetrameric) pore structure, 
and only weakly selects potassium over other small monovalent cations, such as sodium and 
ammonium (Kukol and Arkin, 1999). In contrast, a potassium selectivity filter was predicted in 
Kcv based on its presence in a viral genome (Plugge et al., 2000), even though Kcv is the 
smallest canonical potassium channel identified (each subunit is only 94 amino acids) and 
completely lacks a cytosolic C-terminal domain (Figure 1A) (Gazzarrini et al., 2003).  
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1.1.5 Structure-function relationships via mutagenesis and genetic selection 
Random mutagenesis has long been used as a rapid and nonbiased method to identify critical 
residues, motifs, and domains in ion channels. The approach may target specific regions, in 
which degenerate primer sets scramble a small segment of the coding sequence, or the entire 
coding sequence or a sizable portion thereof through error-prone PCR. Yeast are an ideal system 
for these studies as transformed yeast only uptake single clones, from which mutations can be 
quickly isolated and identified. In addition, homologous recombination can be used to join 
multiple linear DNA fragments, one of which can contain a mutagenized insert (created, for 
example, by PCR) and one that contains the expression plasmid, via direct transformation into 
recipient yeast strains (Weir and Keeney, 2014).  
Targeted mutagenesis studies of KAT1 focused on the selectivity filter. The conserved 
“YG” site in the canonical selectivity filter TXXTXGYG was mutated to 400 possible 
combinations using a degenerate primer set (Nakamura et al., 1997). While some conservative 
mutations of the tyrosine produced nominally functional channels with impaired selectivity (i.e., 
growth on low potassium in the absence of sodium), only the most conservative YGFG 
mutation resulted in a fully selective channel that allowed growth of trk1Δ trk2Δ yeast on low 
potassium media in the presence of high sodium. When the residues flanking the selectivity 
motif were instead mutated, multiple mutations increased Na+ exclusion, as evidenced by 
increased growth on low potassium as well as high sodium. Curiously, the mutations in the 
flanking region which led to increased Na+ exclusion also allowed the transport of large toxic 
cations such as Cs+ and triethylammonium (TEA) that normally block the channel. These data 
suggest that the entire pore region has evolved under dual selective pressure to exclude both 
larger and smaller cations than K+ (Nakamura and Gaber, 2009). 
While residues conferring selectivity are confined to a small but highly-conserved region 
in potassium channels, residues that regulate gating are often more broadly distributed. Jan and 
colleagues performed mutagenesis to determine the importance of the voltage-sensing TMD4 
helix in relation to the pore forming domain in TMD5 in KAT1. Mutations in TMD5 that 
conferred a mild loss-of-function phenotype were isolated, and then random mutagenesis of 
TMD4 uncovered second-site suppressors, thus providing evidence of the close proximity of 
TMD4 and TMD5 particularly when the channel is in the open state (Lai et al., 2005). Similar 
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studies from the same lab focused on identifying the gating mechanisms of mammalian Kir 
channels. Specifically, TMD1 and TMD2 in Kir2.1 were randomly mutagenized, and based on 
the relative tolerance of strains containing the mutated residues, the authors hypothesized that the 
TMDs of mammalian Kir channels were more tightly associated than in bacterial Kcs channels 
based on structural work (Doyle et al., 1998; Minor et al., 1999).  
Of the mammalian Kir channels, Kir2.1 is the most amenable to studies in trk1Δ trk2Δ 
yeast as it is highly expressed, traffics efficiently to the plasma membrane, and its open 
probability (Po) is high (Minor et al., 1999). In contrast, the G-protein-activated inward-
rectifying potassium channel-2 (GIRK2, a.k.a. Kir3.2) has a much lower Po (~0.01). A random 
mutagenesis screen of the entire GIRK2 coding sequence identified five residues in the pore 
domain that are necessary for gating, and substitution at any of these positions increased the Po 
independently of G-protein stimulation. The authors also identified a specific valine in TMD2 
that plays a critical role during channel opening (Yi et al., 2001).  
1.1.6 Studies on potassium channel trafficking in the yeast model 
The whole cell potassium conductance, which determines the potassium current for a given 
driving force, is the product of the single channel conductance, the open probability and the total 
number of channels at the surface membrane. Therefore, cells must tightly control the plasma 
membrane residence of ion channels by regulating synthesis, intramembrane trafficking, and 
degradation.  
Like all classes of transmembrane proteins, potassium channels interface with the 
intramembrane trafficking machinery through specific amino acid motifs (Griffith, 2001). Most 
of these trafficking signals are short linear motifs, similar to “canonical” signals shared by a wide 
variety of membrane proteins, but they can also be found at the interface between two subunits 
(Ma et al., 2011; Li et al., 2016). ER-retention motifs are short linear motifs found on the 
cytosolic face of transmembrane proteins and promote retrograde transport from the Golgi 
apparatus to the endoplasmic reticulum (ER), thereby preventing cargo proteins from reaching 
the cell surface. One such motif is the di-arginine “RXR” motif that interacts directly with the 
coatamer (COPI) (Zuzarte et al., 2009; Okamoto and Shikano, 2011) and becomes occluded as 
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the channel folds and assembles (Zerangue et al., 1999). RXR was first characterized in Kir6.2 
and is present is many mammalian Kir channels. Channels that lack this motif, such as Kir2.1, are 
robustly trafficked to the plasma membrane in both yeast and mammalian cells (Grishin et al., 
2006). To identify novel ER exit/forward trafficking motifs that may override RXR, Shikano and 
colleagues fused a random peptide library to Kir2.1-RXR and screened for increased channel 
activity in trk1Δ trk2Δ yeast. As a result of this analysis, the authors identified the “SWTY” 
motif as a 14-3-3 protein interactor (Shikano et al., 2005). 14-3-3 proteins bind to phospho-
serine/threonine motifs to regulate myriad processes (Muslin et al., 1996; Kumar, 2017). In both 
yeast and multicellular eukaryotes, the -2 threonine of the “SWTY” motif must be 
phosphorylated to bind 14-3-3 proteins, and this phenomenon was demonstrated using both 
model substrates as well as naturally occurring proteins with SWTY-like sequences (Shikano et 
al., 2005). In a similar study, novel modulators of GIRK2 (Kir3.2) were identified by fusing 
either a peptide library that contained random 15 amino acid motifs flanked by a well-folded 
domain from Staphylococcus aureus protein Z, or a randomly mutagenized version of protein Z 
itself to either N- or C-terminus of GIRK2. This multi-pronged approach made for a more 
comprehensive screen by preventing bias against poorly folding peptides that are nonetheless 
strong positive regulators of GIRK2. As a result of this study, the authors identified a peptide 
that augments GIRK2 current by increasing plasma membrane residence (Bagriantsev et al., 
2014). 
In contrast to the identification of embedded sequences that regulate potassium channel 
trafficking, genetic screens in yeast have also identified extragenic regulators of trafficking. This 
was accomplished through the use of synthetic genetic array (SGA) strategies (Tong and Boone, 
2006) in which a genome-wide analysis can be performed to identify genes that when deleted 
alter the growth of potassium channel-expressing trk1Δ trk2Δ yeast on low potassium media 
(Figure 3). Based on the strength of the phenotype, the candidates can also be ranked.  
The first instance in which an SGA was performed in yeast expressing a potassium 
channel used a targeted library of deletion strains lacking components associated with the early 
secretory pathway. The library was used to query yeast expressing a constitutively active GIRK 
variant (Kir3.2S177W) that increases Na+ influx (Yi et al., 2001). As a result of this phenotype, 
yeast growth was slowed on high sodium media. Therefore, isolated strains with increased 
growth on high sodium were hypothesized to lack a factor that promotes Kir3.2S117W biosynthesis 
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and forward trafficking. The genes identified in this analysis were primarily involved in 
sphingolipid biosynthesis, which may facilitate channel opening at the plasma membrane 
(Epshtein et al., 2009), and COPII vesicle cargo packing of GPI-anchored proteins, which may 
indirectly impact ER protein export. These data indicate a preeminent role of these pathways in 
Kir channel biogenesis and function (Haass et al., 2007).  
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Figure 3: Synthetic Genetic Array (SGA) technology to screen for potassium channel 
regulators (1) The “Magic Marker” yeast strain, which contains the can1Δ marker for dominant 
selection against diploid cells and HIS3 under the control of the STE2 promoter to select for 
MATa haploids, is additionally deleted for trk1Δ and trk2Δ. This is strain is then transformed 
with a potassium channel (“K-Chnl”) and mated to the yeast deletion library (“xxxΔ”). (2) Yeast 
colonies are transferred to selective media to propagate diploids, then onto low nitrogen media to 
induce sporulation. (3) Sporulated yeast are grown on a series of selective media to isolate MATa 
haploid progeny harboring trk1Δ trk2Δ and the library hypomorph. All growth media in steps 1-3 
should be supplemented with 100 mM K+ to prevent intergenic suppression of potassium 
sensitivity. (4). Triple mutant (“trk1Δ trk2Δ xxxΔ”) yeast are transferred to high and low 
potassium media and growth is assessed. See also Section 2.2.2. 
 
 
 
 
Subsequent studies from the Brodsky lab have applied SGA to identify regulators of 
potassium channels with the entire non-essential gene library, which contains >5,000 gene 
knock-out strains. For this analysis, Dr. Alexander Kolb deleted TRK1 and TRK2 in the “magic-
marker” SGA query strain (Tong and Boone, 2006), which resulted in slow growth on low 
potassium media. The strain was then transformed with a plasmid encoding Kir2.1 and mated to 
each strain in the deletion collection. Yeast displaying increased growth on low potassium media 
were hypothesized to lack negative regulators of Kir2.1. The result of this screen led to the 
isolation of yeast lacking genes encoding factors involved in vacuolar protein sorting (VPS) and 
several subunits of the endosomal complexes required for trafficking (ESCRT) (Kolb et al., 
2014). These data suggested that Kir2.1, while primarily being targeted for destruction by the ER 
associated degradation (ERAD) pathway (see Section 1.2.2), is also routed to the vacuole for 
degradation; therefore, slowed vacuole-dependent degradation liberated additional Kir2.1 
channels at the plasma membrane, which facilitated growth on low potassium media. Consistent 
with this hypothesis, inhibition of the ESCRT pathway via knock-down strategies in human cells 
increased the steady-state pool of Kir2.1. A second use of a yeast SGA to uncover regulators of 
potassium channel trafficking and stability is outlined in Chapter 2. 
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1.1.7 Pharmacological studies of potassium channels in yeast 
As a large and functionally multifaceted class of proteins, potassium channels represent a 
wellspring of potential targets for new additions to the pharmacopoeia (Kaczorowski et al., 2008; 
Wulff et al., 2009). Drugs that regulate potassium channels have proved efficacious in clinical 
settings. For example, rosiglitazone, which stimulates insulin release from pancreatic β-cells 
through inhibition of KATP (Kir6.1), has been used to treat diabetes and hypertension (Yu et al., 
2012), while retigabine, a potentiator of Kv7.2/Kv7.3 channels, has shown promise as an anti-
epileptic (Ihara et al., 2016). Conversely, the human ether-à-go-go related gene (hERG or 
Kv11.1) is a common nemesis of drug trials as it is inhibited by many structurally and 
functionally unrelated compounds due to its unusually promiscuous extracellular pore domain 
(Priest et al., 2008). As hERG is critical for repolarization of the myocardium (i.e. the Q-T 
wave), hERG inhibition can lead to cardiac arrhythmia and sudden cardiac death. Therefore, 
there is an unmet need for drugs that target potassium channels that have been heretofore 
refractory to medicinal chemistry or that exhibit fewer side effects. To these ends, potassium 
channel pharmacology lends itself naturally to the trk1Δ trk2Δ system as molecules can be added 
directly to growth media to interact with the plasma membrane pool of potassium channels. As 
many of these compounds interact with the extracellular face of the channel pore, their efficacy 
is unlikely to be affected by S. cerevisiae’s well-known arsenal of multi-drug resistance ABC 
transporters.  
In pioneering work, a library of >10,000 synthetic compounds was screened for their 
ability to inhibit Kir2.1-mediated rescue of trk1Δ trk2Δ yeast as determined by the optical density 
of cultures in low potassium medium. From a list of preliminary hits, compounds were excluded 
that inhibited other potassium channels, such as GIRK2 or KAT1. Ultimately, a synthetic 
compound was found that blocked the ion conducting pore in Kir2.1 and protected against 
potassium efflux-mediated caspase activation and apoptosis in primary cultured neurons (Zaks-
Makhina et al., 2004). A follow-up study using a natural products library identified gambogic 
acid as a potent and long-lasting inhibitor of Kir2.1 that alters the interaction of the channel with 
the membrane microenvironment (Zaks-Makhina et al., 2009). These screening techniques were 
then modified to find regulators of the mechano- and thermosensitive K2P channel TREK-1 
(K2P2.1). K2P channels are of broad interest in medicine due to their roles in pain, protection from 
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ischemia, migraine, and depression. By screening a library of >100,000 compounds in trk1Δ 
trk2Δ yeast that expressed TREK-1 and were grown in a variety of K+ concentrations, one 
compound was identified that activates TREK-1 and its close relatives, but not more distantly 
related K2P channels or other classes of potassium channels (Bagriantsev et al., 2013).  
In another successful application of this technology, the KCNJ6 gene was used. KCNJ6, 
which encodes GIRK2 (Kir3.2), is located on chromosome 21 in humans, and its duplication in 
trisomy-21 (Down syndrome) has been linked to cognitive impairment (Rachidi and Lopes, 
2007). In a screen of >2000 compounds in GIRK-expressing trk1Δ trk2Δ tok1Δ yeast, proflavine 
and several derivatives were identified as voltage-dependent blockers of GIRK2 (Kawada et al., 
2016). It should be noted that the use of trk1Δ trk2Δ tok1Δ rather than trk1Δ trk2Δ allowed the 
authors to employ Cs+ as a positive control for GIRK2 channel blockage. In each of the other 
drug screens a more pleiotropic positive control for cell death was used, such as SDS. In 
contrast, Cs+ specifically targets the exogenously expressed potassium channels in trk1Δ trk2Δ 
tok1Δ yeast.  
 
1.1.8 Synthetic biology and the future of potassium channel research in yeast 
Potassium channels and other ion channels are critical to maintain homeostasis and allow for 
information transduction and stimuli response on much shorter timescales than any other 
biological process (Isacoff et al., 2013). Due to their ion conducting properties and selectivity, 
potassium channels have attracted significant attention amongst synthetic biologists, who have 
endeavored to engineer novel gating mechanisms in potassium channels. Screens for 
neofunctionalized channels in yeast allow synthetic biologists to benefit from many of the same 
high-throughput molecular evolution techniques described thus far. For example, voltage 
sensitivity can be engineered into the Kcv channel upon fusion with a Kv-like voltage sensing 
domain from a phosphatase (Arrigoni et al., 2013). More recently, a blue light activatable 
potassium channel was created by fusing the light-sensitive LOV2 module from an Avena sativa 
phototropin to the N-terminus of Kcv. Error-prone PCR mutagenesis was then used to identify 
clones that rescue growth of trk1Δ trk2Δ yeast on low potassium when activated by blue light. 
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The researchers then expressed this new potassium channel, termed blue light induced potassium 
channel-1 (BLINK1) in zebrafish embryos and found that their escape response reflex in 
response to touch was fully and reversibly inhibited upon exposure to blue light (Cosentino et 
al., 2015). This study represents the first instance of an optogenetically controlled potassium 
channel and will enable the creation of transgenic animals expressing these photo-activatable 
potassium channels in specific neurons.  
In the future, we envision continued use of the yeast screen for therapeutics, as many 
channel modulators lack desired specificity. Drugs are also needed for many other potassium 
channels, particularly those whose function increases the severity of various cancers (Huang and 
Jan, 2014). Moreover, we envision screens for modulators of mutated potassium channels for 
which treatments are currently lacking. For example, the expression of Bartter Syndrome mutant 
forms of ROMK, which are trapped in the early secretory pathway and degraded by ERAD 
(O’Donnell et al., 2017a) (section 1.2.2), might respond to small molecule protein folding 
correctors. In fact, corrector molecules have proved to be efficacious treatments for other 
disease-causing mutated ion channels targeted for ERAD, such as CFTR (Van Goor et al., 2011).  
A small molecule screen might uncover pharmacological chaperones which promote the folding 
of mutant ROMK and allow it to escape ERAD and other forms of protein quality control. 
In sum, recent studies from multiple laboratories, spanning a wide breadth of disciplines, 
have demonstrated the continuing utility of a technique originally developed a quarter century 
ago. From the earliest identification of novel potassium channels before the genomic era to 
frontiers in molecular medicine and biotechnology, yeast screens have contributed significantly 
to our understanding of potassium channel biology. To date, a scan of the potassium channel 
literature demonstrates that most investigations have focused on a small group of channels—
KAT1, Kir2.1, GIRK—which are either isolated from highly studied model organisms or are 
intimately linked to human biology. However, this list barely scratches the surface of this diverse 
and ubiquitous class of biomolecules. In the upcoming decades, yeast-based assays will 
undoubtedly continue to serve in the vanguard of potassium channel science. 
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1.2 RATIONALE FOR STUDYING ROMK IN YEAST 
The bulk of my research career at the University of Pittsburgh has been dedicated to elucidating 
the mechanisms involved in the cellular regulation of the renal outer medullary potassium 
(ROMK) channel (Kir1.1). While many ion channels are believed to be partially regulated by 
protein quality control in both normal and diseases states, several biological and pragmatic 
considerations make ROMK an attractive system in which to answer these questions. Firstly, 
ROMK’s physiological role of managing potassium concentrations in the extracellular fluid 
requires robust and rapid regulation, yet ROMK gating does not appear to be regulated since the 
channel has a constitutively high Po (Choe et al., 1999). In turn, transcriptional control is likely 
too slow to respond to the sudden spikes in extracellular potassium experienced upon consuming 
a high potassium meal. These considerations suggest the involvement of various post-
translational avenues of regulation, but the exact mechanisms are still an area of active 
investigation. Secondly, polymorphisms in ROMK leading to a loss-of-function phenotype and 
cause an autosomal recessive condition known as Bartter Syndrome Type II. Furthermore, 
several of the disease-causing mutations lead to ROMK retention in the ER, hinting at the 
primacy of ER quality control in regulating the channel (Fallen et al., 2009). Finally, ROMK is a 
mammalian Kir channel, making it highly amenable to functional studies in yeast for the reasons 
enumerated in the preceding section. At its inception, my project built on the experimental 
designs and genetic toolkit constructed by a previous graduate student in the Brodsky lab, Dr. 
Alexander Kolb, to assay negative regulators of Kir2.1 (Section 1.1.6) (Kolb et al., 2014). As 
ROMK and Kir2.1 are 42% identical, I reasoned that I could adapt these methods to study 
ROMK regulation in the yeast model. 
1.2.1 The renal outer medullary potassium (ROMK) channel 
While potassium is the most abundant cation in the human body, comprising about 0.4% of our 
total mass (Frausto da Silva and Williams, 2001), it is primarily sequestered intracellularly with 
extracellular concentrations maintained at ~4.5 mM in healthy individuals. It has long been 
understood that one of the primary functions of the mammalian kidney is to excrete excess 
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potassium following a high potassium meal. Accordingly, hyperkalemia is a major contributor to 
mortality and morbidity among individuals with chronic kidney disease (Einhorn et al., 2009; 
Rodan, 2016). 
ROMK was the first Kir gene identified in mammals (Ho et al., 1993) and is primarily 
expressed in two distinct distal segments of the nephron: the thick ascending limb (TAL) of the 
Loop of Henle and the cortical collecting duct (CCD). It is expressed as two nearly identical 
major isoforms via alternative splicing of the KCNJ1 locus; ROMK1 has 19 more amino acids at 
its N-terminus than ROMK2. Although the functional consequences of alternative splicing are 
unclear, the two isoforms are expressed in different nephron segments and as such have 
divergent physiological roles (Figure 4). ROMK2 is constitutively expressed in the TAL, where 
it plays an important role in sodium balance and urinary concentration. In this segment, ROMK2 
allows potassium to cycle so that sodium can be efficiently reabsorbed by the 
sodium/potassium/chloride cotransporter (NKCC2) (Welling and Ho, 2009). In contrast, 
ROMK1 is expressed more distally in the nephron in the CCD where it provides a means to 
secrete excess extracellular potassium into the pro-urine in response to changes in dietary intake. 
Accordingly, ROMK1 expression and activity in the CCD respond to a variety of regulatory 
stimuli (reviewed in Section 3.1.1) while ROMK2 expression and activity are maintained at a 
constant level.  
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Figure 4: Major electrolyte channels and transporters in two segments of the distal 
nephron Polarized renal epithelium in the TAL and CCD is shown with cartoon representations 
of the primary ion channels and transporters mentioned in the text. The apical (Ap) surface faces 
the tubular lumen while the basolateral (BL) surface faces the extracellular fluid. All illustrations 
are taken from Servier Medical Art (https://creativecommons.org/licenses/by/3.0/legalcode). 
 
 
 
ROMK is not essential, though ROMK-/- mice exhibit polyuria, natriuresis, and kaliuresis 
(Lu et al., 2002). Potassium efflux from the distal nephron can also occur via BK channels. BK 
(KCa1.1) is expressed throughout the nephron and is upregulated in response to elevated 
aldosterone (Rieg et al., 2007). BK currents are activated by increased tubular flow, which 
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explains why ROMK-/- mice exhibit kaliuresis. Although BK and ROMK are capable of 
compensating for each other when one channel is blocked or defective, it is believed that both 
contribute to potassium efflux in healthy kidneys (Rieg et al., 2007).  
As one of the most consequential cation channels in the renal epithelium, ROMK 
mediates two functions—constitutive reabsorption of sodium and selective excretion of 
potassium—critical to the survival of land animals (Rossier et al., 2015). While potassium is 
abundant in many plant-based foods, over 90% of ingested potassium must be excreted in order 
to prevent fatal hyperkalemia (Rodan, 2016). Conversely, sodium is usually limiting in terrestrial 
environments, thus our kidneys have evolved to conserve sodium. Hypertensive patients have 
long been counselled to curb their sodium intake, however a study of over 100,000 individuals in 
18 countries found that blood pressure is most strongly correlated not with gross sodium intake 
but rather with the ratio of sodium to potassium in the diet (Mente et al., 2014).  
As mentioned in Section 1.1.1, mutations in potassium channels give rise to a range of 
human diseases, and ROMK is no exception. As of this writing, over 50 loss-of-function 
mutations in ROMK—distributed evenly throughout the primary sequence—have been linked to 
the autosomal recessive disease Type II Bartter syndrome. The Bartter syndromes are a group of 
diseases caused by mutations in various components of the sodium reabsorption system in the 
distal nephron (Fremont and Chan, 2012), in which ROMK2 plays a critical role (see above). In 
addition to hyponatremia, Type II Bartter Syndrome is also characterized by potassium 
misregulation due to the central role of ROMK1 in mediating potassium efflux. Type II Bartter 
syndrome typically presents prenatally as polyhydramnios and can be diagnosed in neonates as 
polyuria, hypercalciuria, and hyperkalemia (Simon et al., 1996a; Bhat et al., 2012; Fremont and 
Chan, 2012). The initial acute hyperkalemia progresses to chronic hypokalemia due to the 
compensatory effects of flow-activated BK channels. Type II Bartter syndrome patients typically 
experience growth and developmental defects due to the pleiotropic effects of chronic electrolyte 
imbalance. Assuming that a competent diagnosis is made early in life, some of these symptoms 
may be alleviated with dietary potassium supplementation and non-steroidal anti-inflammatory 
(NSAID) drugs; however hypercalciuria leads to nephrocalcinosis in many patients which 
invariably leads to renal failure (Puricelli et al., 2010). Very few Type II Bartter syndrome 
patients survive past adolescence due to persistent hypotension and eventual renal failure (Shaer, 
2001). 
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Type II Bartter syndrome is an exceptionally rare disease, estimated at roughly 1:106 
births, but since Bartter-associated polyhydramnios often leads to premature birth and 
subsequent infant mortality, the real number of cases is probably higher. An analysis of the 
sequenced genomes from the third cohort of the Framingham Heart Study (FHS) shows that 
known Bartter polymorphisms have a prevalence of 1:670 (all heterozygous) and correlate with 
reduced blood pressure that nonetheless falls well within the optimum range for healthy 
individuals (Ji et al., 2008). Similar findings were reported for NKCC2 and the sodium chloride 
cotransporter (NCC): the targets, respectively, of the diuretics furosemide and thiazides. It is 
hypothesized that as this cohort ages, carriers of Bartter mutations will experience reduced 
mortality and morbidity due to hypertension-related conditions such as congestive heart failure 
and stroke.  
The vital role of ROMK in regulating sodium reabsorption and therefore blood pressure, 
makes it an attractive target for novel antihypertensive therapeutics. Such drugs would 
theoretically not cause potassium-wasting as an off-target effect as is seen with furosemide and 
thiazides. Dr. Jerod Denton’s research group at Vanderbilt University has identified novel 
ROMK channel blockers—VU590 and VU591—that appear to act by direct occlusion of the 
channel pore (Bhave et al., 2011; Kharade et al., 2017). A group at Merck Pharmaceuticals has 
also reported on a ROMK inhibitor that is structurally unrelated to the VU compounds, but 
seems to interact with the same residues in ROMK. As predicted, this compound induces 
potassium-sparing diuresis in a rat model (Tang et al., 2016). 
 Overall, ROMK is central to our understanding of two diseases: one of which is 
devastating to newborn children and yet rare enough that many pediatricians will never see a 
case, and the other is the largest current burden on global health as measured by total disability-
adjusted life-years (DALYs) lost (Murray and Lopez, 2013). In addition to its medical relevance, 
ROMK presented an attractive study system for studies in yeast since several lines of evidence 
suggested that cellular protein quality control pathways are employed to regulate ROMK in both 
normal and disease states. 
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1.2.2 Disease-causing ROMK mutants are delivered to the ERAD pathway 
A study in Xenopus laevis oocytes and HEK293 cells examined 20 Type II Bartter Syndrome-
causing mutations and found that 14 mutations (i.e. ~75%) abrogate channel export from the ER 
rather than directly affecting channel conductance (Peters et al., 2003). In collaboration with Dr. 
Brighid O’Donnell, I hypothesized that many of these mutations compromise ROMK folding or 
tetramerization, which would trap the channels in the ER and target them for ERAD. Yeast and 
multicellular eukaryotes utilize ERAD to recognize and degrade misfolded proteins in both the 
ER lumen and the ER membrane (Vembar and Brodsky, 2008). As the ER lumen lacks a major 
degradative protease, the AAA+ ATPase Cdc48/p97 retrotranslocates substrates to the cytosol 
for degradation in the proteasome (Ye et al., 2001; Jarosch et al., 2002; Rabinovich et al., 2002; 
Bodnar and Rapoport, 2017). Mutations in proteins that enter the secretory pathway, including 
several classes of ion channels, have been linked to several genetic diseases, many of which arise 
from protein misfolding and targeting for ERAD (Guerriero and Brodsky, 2012).  
We chose to focus on four mutations which had been shown to cause ER-retention in the 
C-terminal β-sandwich immunoglobulin-like domain (IgLD) (Fallen et al., 2009; Fang et al., 
2010). In addition, we hypothesized that mutations in the IgLD would be more likely to cause 
misfolding and subsequent ERAD. As the IgLD is the only β-sheet rich domain in ROMK, it 
likely represents a kinetic barrier to polypeptide folding (Fallen et al., 2009; Beerten et al., 
2012). Mutations in cytosolic β-rich domains such as IgLDs are particularly deleterious for 
protein folding (De Angelis et al., 2002; Randles et al., 2006; Metzger and Michaelis, 2009), and 
my colleague in the Brodsky Lab, Dr. G. Michael Preston, has recently shown that destabilizing 
mutations in a β-rich domain of a model ERAD substrate increase its aggregation propensity 
(Preston et al., 2018)   
Working initially in the yeast model, Dr. Brighid O’Donnell and I found that four Bartter 
Syndrome mutations in the ROMK IgLD cause loss of function in trk1Δ trk2Δ yeast and that this 
phenotype was correlated with increased ERAD of the mutant proteins. We recapitulated 
increased ERAD of ROMK IgLD mutants in HEK 293 cells, thus establishing Bartter Syndrome 
Type II as an ERAD-linked channelopathy (O’Donnell et al., 2017b). Through this study, and in 
agreement with prior studies from Dr. Paul Welling’s group (Schwalbe et al., 1998; Ortega et al., 
2000), we noted that wild-type ROMK is not appreciably degraded by ERAD in mammalian 
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cells. Therefore, it follows that the wild-type channel most likely relies instead on post-ER 
quality control for regulation and quality control. 
1.2.3 Protein quality control in the secretory pathway 
To understand the mechanisms of post-ER quality control, it is helpful to briefly summarize how 
eukaryotic cells traffic proteins from one organelle to another. The secretory and endocytic 
pathway quality control steps are visually represented in Figure 5. 
The composition of the eukaryotic plasma membrane is controlled by the compensatory 
actions of the secretory and endocytic pathways. The genetic components of the secretory 
pathway were first identified using yeast forward genetics (Novick et al., 1980) and have been 
elucidated in great mechanistic detail in subsequent decades (see (Schekman, 2010) for historical 
perspective). In brief, nascent polypeptides enter the secretory pathway through the ER 
translocon (Deshaies and Schekman, 1987; Stirling et al., 1992). Those that are correctly folded, 
assembled, and modified are exported from the ER to the Golgi apparatus in COPII-coated 
vesicles (Zanetti et al., 2012) and eventually unite to form a cis-Golgi cisterna. Secretory 
proteins receive further modifications as Golgi cisternae mature, eventually becoming 
concentrated and encapsulated into uncoated secretory vesicles in the trans-Golgi network 
(TGN) (Matsuura-Tokita et al., 2006; Glick and Luini, 2011). These secretory vesicles then bud 
from the TGN and fuse with the plasma membrane. Coated vesicles also bud from the TGN and 
are transported to endosomes, allowing delivery of endosome or lysosome/vacuole resident 
proteins from the Golgi (Kienzle and von Blume, 2014). Note that this description represents a 
generalized portrayal of the secretory pathway, and drastic variations exist among different 
organisms and cell types. For example, neuronal dendrites are capable of routing secretory cargo 
through recycling endosomes, circumventing the Golgi altogether (Jensen et al., 2014; Bowen et 
al., 2017). 
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Figure 5: Quality control in the secretory and endocytic pathways. Cartoon representation of 
the secretory and endocytic pathways and their quality control branches in a generalized 
eukaryotic cell. Note that in S. cerevisiae, the Golgi cisternae do not form a cohesive stack as 
they do in mammalian cells. Also, yeast and other fungi have vacuoles in place of lysosomes.  
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Abbreviations: CCP—Clathrin Coated Pit, CME—Clathrin Mediated Endocytosis, COP—Coat 
Protein, ERAD—ER Associated Degradation, ESCRT—EndoSomal Complexes Required for 
Trafficking, GQC—Golgi Quality Control, ILV—IntraLumenal Vesicle, MVB—Multi-
Vesicular Body, RiboQC—Ribosomal Quality Control, SNX—Sorting NeXin, TGN—trans 
Golgi Network. 
 
 
 
The endocytic pathway retrieves proteins and membrane components from the plasma 
membrane and is broadly divided into clathrin-mediated (CME) (Pearse, 2000; McMahon and 
Boucrot, 2011) and clathrin-independent (CIE) endocytosis. Clathrin assembles spontaneously 
into a proteinaceous cage on the cytosolic side of a vesicle. Sites of endocytosis are readily 
visible in electron micrographs as electron-dense clathrin-coated pits (CCPs) (Ungewickell and 
Branton, 1981; Smith et al., 1998) and a variety of scaffolding proteins will recruit 
transmembrane cargo to CCPs as a prelude to endocytosis. Endocytic vesicles eventually 
coalesce to form early endosomes. Proteins in these structures have three possible fates: 
recycling to the Golgi apparatus through sorting into SNX-BAR-sculped membrane tubules that 
branch off from early endosomes (Burd and Cullen, 2014; McNally et al., 2017), direct recycling 
to the plasma membrane through specialized recycling endosomes (Grant and Donaldson, 2009; 
van Weering and Cullen, 2014), or degradation in the lysosome/vacuole (see below). 
Although the diversity of factors which control protein trafficking may seem dizzying, all 
intramembrane trafficking follows a tidy set of principles that are conserved among pathways 
and among organisms: 
1. Sites of vesicle budding are highly selective for particular substrates. Cargo selection 
machinery can recognize genetically encoded consensus sorting motifs as well as post-
translational modifications such as ubiquitination or glycosylation. 
2. Processes which bend membranes into pits or tubules occur through spontaneous protein 
oligomerization. However, membrane scission and vesicle uncoating require energy input 
in the form of ATP or GTP hydrolysis. 
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3. The membranes of various organelles are distinct and can be readily discriminated from 
each other by trafficking machinery to ensure that cargo is delivered to the correct 
destination. The Rab family of small GTPases plays a central role in this process. 
4. Vesicle fusion to destination organelles is a two-step process. First, vesicles are loosely 
bound to their target membrane by multi-protein complexes known as tethers. Once the 
vesicle and target membrane are in close proximity, membrane fusion is mediated by the 
spontaneous multimerization of SNARE proteins, one on the vesicle membrane and three 
on the target (Ungar and Hughson, 2003). 
Eukaryotes utilize three major quality control pathways: the ubiquitin-proteasome system (UPS), 
delivery to membrane-bound proteolytic organelles, such as the fungal vacuole or metazoan 
lysosome, and autophagy. All quality control pathways must select certain substrates for 
degradation and spare others. This enables cells to modulate their proteome in response to stress 
or stimuli and to eliminate misfolded proteins before they can damage the cell. Quality control 
pathways must also keep proteases sequestered from bulk cellular proteins and shuttle substrates 
destined for degradation to these sites of proteolysis. The common thread uniting all degradative 
pathways is ubiquitin. With very few exceptions, protein quality control pathways utilize 
ubiquitin as a tag for substrates destined for degradation (Kraft et al., 2010; Shields and Piper, 
2011; MacGurn et al., 2012; Preston and Brodsky, 2017).  
Proteins that transit the secretory pathway encounter quality control pathways at various 
stages in their maturation. Quality control begins with translation as nascent polypeptides can be 
co-translationally ubiquitinated in response to cellular stress, defective mRNA, or stalled 
translocation into the ER (Bengtson and Joazeiro, 2010; Brandman et al., 2012; von der 
Malsburg et al., 2015). Similarly, defective translocation into the ER can trigger cleavage of 
partially translocated proteins by the ER-resident protease Ste24 (Ast et al., 2015).  
ER quality control (ERQC) is built on the twin pillars of retaining incompletely folded 
substrates and degrading those that cannot achieve their native fold. The ER lumen is rich in 
chaperones and lectins that help newly synthesized proteins fold. Chaperone-bound proteins that 
have not assumed their native fold are excluded from COPII export vesicles (Ellgaard et al., 
1999). The ER lectins calnexin and calreticulin act as a kinetic brake by preventing ER export 
until the process of trimming and modifying core glycans is complete. Chaperone binding is also 
required to initiate ERAD. Therefore, secretory proteins that spend more time bound to 
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chaperones are more likely to be targeted for degradation (Vembar and Brodsky, 2008). ERAD is 
the preeminent quality control pathway in the early secretory pathway and the last opportunity to 
engage the UPS. ERAD is capable of degrading substrates that are misfolded (Xie et al., 2009), 
that are improperly glycosylated (Bhamidipati et al., 2005; Szathmary et al., 2005) or lipidated 
(Fisher et al., 2011), or that have not assembled into a functional complex (Mueller et al., 2015). 
A number of metabolically controlled “wild type” proteins are also targeted for ERAD including 
proteins with broad relevance to human health such as HMG-CoA reductase—the rate-limiting 
enzyme in cholesterol biosynsthesis and the target of statin drugs—and apolipoprotein B 
(ApoB): the principal proteinaceous component of low-density lipoproteins and chylomicrons 
(Hampton and Rine, 1994; Zhou et al., 1998). 
While ribosomal QC and ERAD converge on the cytosolic proteasome, post-ER quality 
control converges on proteolytic compartments: the lysosome in animals and the vacuole in 
plants and fungi. Substrates that escape ERQC in COPII can be retrieved to the ER via Golgi-
derived COPI-coated vesicles (Geva and Schuldiner, 2014; Briant et al., 2017). In addition, the 
Golgi can reroute defective or unneeded plasma membrane-destined cargo to the 
lysosome/vacuole for degradation (Arvan et al., 2002; Dobzinski et al., 2015). As a means of 
disposing of misfolded proteins, Golgi quality control (GQC) is far more prominent in yeast than 
in metazoans, as the mechanisms of ER-retention are less stringent in yeast. Indeed, improperly 
folded proteins can “leak” into the Golgi, particularly under conditions of ER stress (Spear and 
Ng, 2003). Rerouting from the Golgi to the lysosome/vacuole also allows cells to respond to 
environmental stimuli by degrading plasma membrane proteins, such as nutrient transporters, 
that are no longer needed (Scott et al., 2004). 
 Quality control at the plasma membrane depends on endocytosis to deliver substrates for 
lysosomal/vacuolar degradation. Endocytosis is often stimulated by substrate ubiquitination 
(Bonifacino and Weissman, 1998; Hicke and Dunn, 2003) that may result from direct interaction 
between E3 ligases with client proteins or may involve an intermediate scaffolding protein (Lin 
et al., 2008). There is some evidence that the endocytic machinery is able to detect plasma 
membrane protein misfolding or aggregation and therefore constitutes a bona fide quality control 
mechanism (Arvan et al., 2002; MacGurn, 2014). For example, a disease-associated misfolding 
mutation in CFTR causes rapid ubiquitin-dependent endocytosis of the channel when cells are 
shifted to a non-permissive temperature (Okiyoneda et al., 2010).  
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 Endocytic vesicles fuse to form organelles called early endosomes or sorting endosomes. 
Substrate ubiquitination can occur at endosomes and both E3 ligases and adaptor proteins are 
known to be localized to endosomes (Shin et al., 2001; Kim et al., 2006; Mund and Pelham, 
2009; Evangelinos et al., 2016). Early endosomes have both vacuolar and tubular subdomains. In 
general, tubular endosomal domains are associated with cargo recycling while vacuolar 
subdomains are associated with degradation (van Weering and Cullen, 2014). It is believed that 
recycling from early endosomes is the default pathway for most cargo proteins and that only 
ubiquitinated cargo is sorted for degradation (Grant and Donaldson, 2009).  
Delivery of cargo from early endosomes to late endosomes proceeds via a process of 
homotypic fusion mediated by the class-C vacuole-endosome transport (CORVET) complex. 
This transition is marked by increased acidification of the endosomal lumen, increased size due 
to homotypic fusion, and an exchange of Rab5 for Rab7. Late endosomes are also called multi-
vesicular bodies due to the intralumenal budding of vesicles containing cargo destined for 
vacuolar/lysosomal degradation. The budding of these intralumenal vesicles (ILVs) is directed 
by the endosomal sorting complexes required for trafficking (ESCRTs). ESCRT differs from all 
other vesiculation and tubulation machinery discussed thus far as it induces concave rather than 
convex membrane curvature, however it follows a similar set of principles. ESCRT-0 is a soluble 
recognition factor that binds ubiquitinated substrates and directs assembly of the downstream 
complexes. ESCRT-I and ESCRT-II sequentially assemble on the late endosomal membrane by 
binding endosome-enriched phospholipid phosphatidylinositol-3-phosphate (PI3P). This leads to 
the recruitment of additional ubiquitinated substrates as well as ESCRT-III. The ESCRT-III 
subunits then oligomerize and bind membranes, inducing negative curvature and ILV 
invagination. Finally, an ATPase, Vps4, constricts the inward-budding vesicle and eventually 
directs membrane scission (Babst, 2005; Henne et al., 2013). Vps4-mediated ILV scission is the 
final nail in the coffin for an ESCRT client as MVBs eventually fuse with the lysosome/vacuole 
through the action of the homotypic fusion and protein transport complex (HOPS) (Plemel et al., 
2011). 
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1.2.4 Goals of dissertation research 
Unlike gated ion channels such as GIRK2 (Kir3.2), which have a low Po until activation by their 
effector (Yi et al., 2001), ROMK has an invariably high Po of ~0.9 under normal physiological 
conditions (Choe et al., 1999). Therefore, as is the case for Kir2.1 (Section 1.1.6), cells must rely 
on the protein trafficking pathways described above in order to fine tune gross potassium 
currents mediated by ROMK. At the onset of this work, no studies had attempted to identify and 
rank genetic factors that regulate ROMK in a systemic and genome-wide manner. In addition to 
providing a comprehensive picture of the ROMK genetic interaction network, this study aimed to 
identify key ROMK regulators that may be potential targets for novel therapeutics for Type II 
Bartter syndrome or hypertension. 
Given the ability to perform genome-wide screens for Kir channel effectors in yeast, I 
decided to perform a yeast SGA screen (Kolb et al., 2014) (Section 1.1.6) in order to better 
define the ROMK trafficking pathway. I then conducted follow-up experiments in the yeast 
system as most major protein quality control and membrane trafficking pathways in human cells 
were first discovered in yeast (Robinson et al., 1988; Kaiser and Schekman, 1990; Tsukada and 
Ohsumi, 1993; McCracken et al., 1996; Xie and Varshavsky, 1999). In order to confirm the 
relevance of key findings in a more physiologically relevant system, I ultimately recapitulated 
select experiments in mammalian cells in culture. Based on these efforts, I discovered that the 
endosomal sorting pathways regulate ROMK residence at the plasma membrane in both yeast 
and mammalian cells. 
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2.0  THE ENDOSOMAL SORTING FACTORS ESCRT AND CORVET SUPPRESS 
PLASMA MEMBRANE RESIDENCE OF THE RENAL OUTER MEDULLARY 
POTASSIUM CHANNEL (ROMK) 
The contents of this chapter are adapted from two recently published articles appearing in the 
Journal of Biological Chemistry (O’Donnell et al., 2017b; Mackie et al., 2018). The figures and 
text have been edited for clarity and flow. 
2.1 INTRODUCTION 
Protein quality control allows cells in all organisms to survive proteotoxic stresses and fine-tune 
their proteome in response to environmental changes (Balchin et al., 2016). Significant recent 
work has elucidated in great detail how protein quality control pathways operate in the cytoplasm 
and in the endoplasmic reticulum (ER) (Ellgaard et al., 2016; Gottschling and Nyström, 2017; 
Preston and Brodsky, 2017). Common to both pathways is the delivery of substrates to the 
cytoplasmic proteasome, which selectively degrades ubiquitinated and misfolded protein 
substrates (Schmidt and Finley, 2014). In addition, proteins that reside in the ER or in the ER 
membrane must be removed from this compartment and delivered to the proteasome. The 
selection, delivery, and degradation of misfolded proteins in this compartment proceeds through 
the ER associated degradation (ERAD) pathway. Quality control “decisions” that operate at later 
steps in the secretory pathway, such as in the Golgi apparatus, the endosome, and the plasma 
membrane, have also been identified in eukaryotic cells (Arvan et al., 2002; Geva and 
Schuldiner, 2014; MacGurn, 2014). However, the relative influence of each system on specific 
client proteins is rarely investigated.  
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One critical class of proteins that transit the secretory pathway—and that might be 
subject to more than one quality control checkpoint—are ion channels. Even under ideal 
circumstances, ion channels may possess unfavorable folding kinetics or are thermodynamically 
unstable because of dynamic structural transitions, and/or because charged and hydrophilic 
residues reside within their transmembrane domains (Gajewski et al., 2011). Long-range 
interactions between channel domains or even between channel subunits further compromise 
folding efficiency (Lukacs and Verkman, 2012). Perhaps not surprisingly, genetic mutations that 
exacerbate protein misfolding result in degradation by cellular protein quality control pathways, 
including ERAD and the late secretory quality control pathways, (section 1.2.3)  (Young, 2014). 
For example, the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) requires 
approximately 30 minutes from the onset of translation to reach its native conformation, during 
which ~70% of the wild-type channel is recognized as being misfolded and is targeted for ERAD 
(Lukacs et al., 1994; Ward and Kopito, 1994). The predominant cystic fibrosis-causing allele, 
ΔF508, interferes with the assembly of a soluble domain that engages a transmembrane domain-
containing segment (Mendoza et al., 2012; Rabeh et al., 2012) so essentially all of the mutant 
protein is degraded by ERAD. Moreover, even if the mutant is released to the plasma membrane, 
either through the application of chemical chaperones or by low temperature incubation, it is 
more rapidly endocytosed than the wild type protein and destroyed in the lysosome via plasma 
membrane quality control (Sharma et al., 2004; Okiyoneda et al., 2010, 2018). Furthermore, 
ΔF508-containing aggregates have been detected in cells, which may be selected for degradation 
in the lysosome via the autophagic pathway (Luciani et al., 2010). Studies of multimeric ion 
channels, such as the voltage-gated potassium channel human Ether-à-go-go Related Gene 
(hERG), have found that subunit assembly can also present an energetic barrier during ion 
channel maturation (Li et al., 2017). In addition, hERG mutants associated with long Q-T 
syndrome are degraded by ERAD in a chaperone- and proteasome-dependent manner (Gong et 
al., 2005; Anderson et al., 2006; Wang et al., 2012b). Together, these data emphasize the 
inefficient nature of ion channel biogenesis and indicate that genetic, disease-causing mutations 
can interfere with protein folding in the secretory pathway. 
In addition to CFTR and hERG, the impact of cellular quality control mechanisms in the 
regulation of other disease-associated ion channels has also been investigated (Anderson et al., 
2006; Hirota et al., 2008; Gao et al., 2012, 2013; Buck et al., 2013; Donnelly et al., 2013; Iwai et 
 37 
al., 2013; Kolb et al., 2014; Young, 2014; Seaayfan et al., 2016). However, the rules that govern 
the quality control of diverse ion channels remain poorly defined. I propose that a continued 
investigation into the mechanisms underlying the biogenesis and degradation of ion channels will 
help uncover these rules and define how associated “channelopathies” might be treated.  
To this end, I initiated studies on the homo-tetrameric Renal Outer Medullary Potassium 
(ROMK) channel, also known as Kir1.1. ROMK is the primary potassium efflux channel in the 
thick ascending limb and distal nephron (Zhou et al., 1994) and is expressed as two major 
isoforms with divergent physiological roles. ROMK2 is primarily expressed in the thick 
ascending limb of the loop of Henle and is responsible for potassium cycling coupled to sodium 
and chloride reabsorption through the sodium potassium chloride cotransporter, NKCC2. In 
contrast, bulk potassium secretion via ROMK1 occurs in the late distal convoluted tubule, 
connecting tubule, and cortical collecting duct, and ROMK1 expression is increased in response 
to dietary potassium intake (Wang et al., 1990; Frindt et al., 2009). Under physiological 
conditions, both ROMK isoforms have a high open probability (Po) of ~0.9 (Ho et al., 1993; 
Leung, 2000), so channel expression must be tightly regulated due to its vital role in regulating 
serum potassium levels. Indeed, ROMK function is thought to be regulated primarily through the 
homeostatic control of protein trafficking (Zeng et al., 2002; Fang et al., 2009; Lin et al., 2009; 
Welling and Ho, 2009). In addition, mutations that deplete ROMK from the plasma membrane 
cause an autosomal recessive salt-wasting disorder known as Type II Bartter syndrome (Simon et 
al., 1996b). Interestingly, individuals heterozygous for a Type II Bartter mutant allele exhibit 
resistance to hypertension, most likely because of decreased NKCC2-mediated reabsorption of 
sodium (Ji et al., 2008). Of the >50 identified Bartter syndrome-associated mutations in ROMK, 
many appear to affect ROMK trafficking or post translational modification when ectopically 
expressed in Xenopus laevis oocytes (Peters et al., 2003). To date, therapies for Bartter syndrome 
are not curative and patients require lifelong multi-drug treatments and potassium 
supplementation. Thus, a deeper understanding of the trafficking and degradative machineries 
that shepherd ROMK to and from the plasma membrane is necessary to devise effective 
treatments for type II Bartter syndrome.  
In this study, I used the trk1Δ trk2Δ yeast to define the relative contributions of protein 
trafficking and two distinct quality control pathways on ROMK stability and plasma membrane 
residence. I conducted an SGA screen to monitor growth on low potassium as a readout for 
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genes that increase ROMK function at the plasma membrane. By screening the yeast non-
essential deletion collection (Giaever et al., 2002), I identified two complexes with established 
roles in post-endocytic trafficking that regulate the plasma membrane levels of ROMK: the 
endosomal complexes required for trafficking (ESCRT) and the class-C core vacuole/endosome 
tethering (CORVET) complex. I then confirmed the biological relevance of these complexes by 
silencing select ESCRT and CORVET homologs in human cells. These data provided the first 
genome-wide analysis of factors that control ROMK biogenesis, and my work may lead to the 
identification of components that, in principle, could be therapeutically modulated to treat 
disorders associated with ROMK function.  
2.2 MATERIALS AND METHODS 
2.2.1 Yeast strain construction, growth conditions, and plasmid construction 
All strains were grown at 30°C unless indicated otherwise. Temperature sensitive strains were 
propagated at room temperature prior to temperature shift. Standard procedures were followed 
for propagation and transformation of yeast (Adams and Kaiser, 1998). Importantly, SC medium 
used in this study contained 1 g/L monosodium glutamate instead of ammonium sulfate as the 
primary nitrogen source as ammonium sulfate interferes with the efficacy of aminoglycoside 
antibiotics and was buffered with MES to a pH of ~4.5 (Kolb et al., 2014). For serial dilution 
growth assays, 200 µl cultures were grown overnight with agitation in 96-well dishes in selective 
liquid medium supplemented with 100 mM KCl and covered with a Breathe-Easy polyurethane 
membrane (Sigma-Aldrich, St. Louis, MO) to prevent evaporation. Once all cultures reached 
stationary phase, they were serially diluted 1:5 five times to fill a grid in a standard 96-well plate. 
Droplets from each dilution were then transferred to SC-Leu solid medium supplemented with 
100, 25, 10, and 0 mM KCl using a 48-pin manifold (Sigma-Aldrich, St. Louis, MO). These 
plates were incubated for 4 days and imaged on days two, three, and four using a BioRad 
(Hercules, CA) Image Station. Medium to which no potassium was added (“0 mM”) has been 
estimated to contain 7-10 mM potassium (Nakamura and Gaber, 1998). 
 39 
Table 2: Yeast strains used in this study 
 
 
Strain Relevant Phenotype Source 
trk1Δ trk2Δ 
(YAK01) 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
can1Δ::STE2pr-HIS3 
(Kolb et al., 
2014) 
trk1Δ trk2Δ 
vps23Δ 
MATa his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
can1Δ::STE2pr-HIS3 vps23Δ::KANMX 
(Kolb et al., 
2014) 
BY4742 (PEP4 or 
CDC48) 
MATα his3Δ leu2Δ ura3Δ Invitrogen 
pep4Δ MATα his3Δ leu2Δ ura3Δ  pep4Δ::KANMX Invitrogen 
cdc48-2 MATα his3Δ, leu2Δ, ura3Δ, cdc48-2::KANMX (Moir et al., 
1982) 
HRD1 DOA10 MATα ade2, his3, leu2, ura3, trp1 (Pagant et al., 
2007) 
hrd1Δ doa10Δ MATα ade2 his3 leu2 ura3 trp1 hrd1::KANMX 
DOA10::KANMX 
(Pagant et al., 
2007) 
SSA1 MATα his3-11,15 leu2-3,112, ura3-52 trp1- ∆1, lys2, 
ssa2- 1(LEU2), ssa3-1(TRP1), ssa4- 2(LYS2) 
(Becker et al., 
1996) 
ssa1-45 MATα, his3-11,15, leu2-3,112, ura3-52, trp1-Δ1, lys2, 
ssa1-45, ssa2-1(LEU), ssa3-1(TRP1), ssa4-2(LYS2) 
(Becker et al., 
1996) 
trk1Δ trk2Δ vps3Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps3Δ::KANMX 
This study 
trk1Δ trk2Δ vps8Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps8Δ::KANMX 
This study 
trk1Δ trk2Δ 
vps27Δ 
MATa his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps27Δ::KANMX 
(Kolb et al., 
2014) 
trk1Δ trk2Δ 
vps36Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps36Δ::KANMX 
This study 
trk1Δ trk2Δ 
vps20Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps20Δ::KANMX 
This study 
trk1Δ trk2Δ snf7Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
snf7Δ::KANMX 
This study 
trk1Δ trk2Δ end3Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
end3Δ::KANMX 
This study 
trk1Δ trk2Δ 
pep12Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
pep12Δ::KANMX 
This study 
trk1Δ trk2Δ gos1Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
can1Δ::STE2pr-HIS3 gos1Δ::KANMX 
This study 
trk1Δ trk2Δ bsd2Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
bsd2Δ::KANMX 
This study 
trk1Δ trk2Δ vps5Δ MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps5Δ::KANMX 
This study 
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Table 2 (continued) 
trk1Δ trk2Δ 
vps35Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps35Δ::KANMX 
(Kolb et al., 
2014) 
RSP5 MATa his3 lys2 trp1 ura3 prc1::TRP1 rsp5::HIS3 
leu2::RSP5:LEU2 bar1::HIS3 
(Dunn and Hicke, 
2001) 
rsp5-2 MATa his3 lys2 trp1 ura3 prc1::TRP1 rsp5::HIS3 
leu2::rsp5-2:LEU2 bar1::HIS3 
(Dunn and Hicke, 
2001) 
trk1Δ trk2Δ vps23 
Δnhx1Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX 
vps23Δ::KANMX  nhx1Δ::KANMX 
This study 
trk1Δ trk2Δ 
vps23Δ vps5Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX  
vps23Δ::KANMX  vps5Δ::KANMX 
This study 
trk1Δ trk2Δ 
vps23Δ rcy1Δ 
MATα his3Δ leu2Δ ura3Δ trk1Δ::URA3 trk2Δ::NATMX  
vps23Δ::KANMX  rcy1Δ::KANMX 
This study 
Snf7-RFP MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 Snf7-
RFP::KANMX 
(Huh et al., 2003) 
 
Rat ROMK1 was tagged with an HA epitope in the extracellular loop as previously 
reported (Yoo et al., 2003), and the S44D and K80M mutations were introduced as recently 
described (O’Donnell et al., 2017b). All yeast ROMK expression in this study utilized the strong 
constitutive TEF1 promoter and the CYC1 terminator (Mumberg et al., 1995). The manually 
curated trk1Δ trk2Δ xxxΔ strains originating from this study were made using standard mating, 
sporulation, and tetrad dissection techniques (Adams and Kaiser, 1998). The genotypes of all 
parental strains originating from the Yeast Knockout Collection were confirmed by colony PCR 
prior to mating with YAK01 using the primers indicated in Table 3.  
The Venus-ROMKK80M expression vector was made by subcloning the gene encoding 
ROMK2 into the mVenusC1 (Koushik et al., 2006) expression vector with the restriction 
enzymes Kpn1 and Acc1. PCR amplification and site-directed mutagenesis were then used to 
make the LysMet mutation analogous to K80M in ROMK1 and to flank Vn-ROMK with 
XmaI and XhoI restriction sites. These enzymes were then used to subclone Vn-ROMK into the 
yeast expression vector pRS415. 
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Table 3: Oligonucleotides used in this study 
 
 
Name Purpose Sequence (5’-3’) 
KanB Confirm all strains deleted 
with KANMX 
ctgcagcgaggagccgtaat 
Vps3_Ext_Fwd Confirm deletion of VPS3 gacagagaatctaggctgtc 
Vps3_Int_Rev Confirm deletion of VPS3 tgaggtgaggattcgctatc 
Vps8_Ext_Fwd Confirm deletion of VPS8 ggtgtagggagttatggtgg 
Vps8_Int_Rev Confirm deletion of VPS8 aagttgtccatgagactacgg 
Vps36_Ext_Fwd Confirm deletion of VPS36 ggcgtagcgacatattaagaag 
Vps36_Int_Rev Confirm deletion of VPS36 cgcacttttaccaagttcatc 
Vps20_Ext_Fwd Confirm deletion of VPS20 gacttggaataacctgtggg 
Vps20_Int_Rev Confirm deletion of VPS20 acttctaggatcgccctatc 
Snf7_Ext_Fwd Confirm deletion of SNF7 gacaacgatggagttccgtaac 
Snf7_Int_Rev Confirm deletion of SNF7 cgccattactttattgcccttcg 
Pep12_Ext_Fwd Confirm deletion of PEP12 ccctttctcacacagtggcatc 
Pep12_Int_Rev Confirm deletion of PEP12 ctatctttgccacagatctc 
Gos1_Ext_Fwd Confirm deletion of GOS1 gctccgaatgtgcatttcacag 
Gos1_Int_Rev Confirm deletion of GOS1 gattacatcctgtctctggcc 
Bsd2_Ext_Fwd Confirm deletion of BSD2 ccggagatgtaaataaccgtgg 
Bsd2_Int_Rev Confirm deletion of BSD2 tgcttccctcgtcctctatg 
Vps5_Ext_Fwd Confirm deletion of VPS5 cggaagttgtccgctaagaac 
Vps5_Int_Rev Confirm deletion of VPS5 gtctttccattctggcgcac 
Nhx1_Ext_Fwd Confirm deletion of NXH1 ctagctactctaagataaagggc 
Nhx1_Int_Rev Confirm deletion of NHX1 cttgattcaactcgtacccac 
Vps23_Ext_Fwd Confirm deletion of VPS23 ggacgcgcagagagttagta 
Vps23_Int_Rev Confirm deletion of VPS23 gtcagagtgcgtaaataccc 
Venus_BamHI_Fwd Construction of pRS415 
Vn-ROMKK80M plasmid 
catcatggatccatggtgagcaagggcgagga 
ROMK_SmaI_Rev Construction of pRS415 
Vn-ROMKK80M plasmid 
catcatcccgggttacattttggtgtcatctgtttca 
YangP1 Construction of pRS415-
Vn-ROMKK80M plasmid 
gctggacctgaaatggaggtacatgatgaccgtgttcatcac 
YangP2 Construction of pRS415-
Vn-ROMKK80M plasmid 
gaaggctgtgatgaacacggtcatcatgtacctccatttcag 
TSG101 siRNA 1 Silencing TSG101transcript CCAAAUACUUCCUACAUGCdtdt 
TSG101 siRNA 2 Silencing TSG101transcript CCGUUUAGAUCAAGAAGUAdtdt 
HGS siRNA 1 Silencing HGS transcript GAACCCACACGUCGCCUUGdtdt 
HGS siRNA 2 Silencing HGS transcript GAGGUAAACGUCCGUAACAdtdt 
VPS8 siRNA 1 Silencing VPS8 transcript GCAUCUUCACCUAUACUAUdtdt 
VPS8 siRNA 2 Silencing VPS8 transcript GCACUUUGGUUUCCGUUAUdtdt 
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2.2.2 Synthetic genetic array screening conditions 
All screening procedures and media recipes were adapted from protocols published by the Boone 
lab (Tong and Boone, 2006), utilized the trk1Δ trk2Δ strain, and contained a plasmid designed 
for ROMK1S44D+K80M expression (see above). All yeast manipulations utilized a metal 96-pin 
manifold (V&P Scientific, San Diego, CA) except for the final transfer onto permissive and 
selective medium, which used a disposable plastic 96-pin manifold. Briefly, the query strain 
(YAK01) transformed with the ROMK1S44D+K80M expression vector was mated with the MATa 
deletion collection (Invitrogen) on YPD plates grown overnight at room temperature. Diploids 
were selected with SC-Leu containing 200 µg/L G418 (Research Products International, Mount 
Prospect, IL), 100 µg/L clonNAT (Werner BioAgents, Jena, Germany), and 100 mM KCl to 
maintain potassium sensitivity and hinder the appearance of suppressor mutations. These plates 
were incubated for 2 days. The diploids were then sporulated onto nitrogen-deficient medium for 
5 days at room temperature, and the tetrads were transferred onto SC medium lacking leucine, 
arginine, histidine, and uracil but containing 200 µg/L G418, 100 µg/L clonNAT, and 50 µg/L L-
canavanine (Sigma-Aldrich) in order to select for desired spores and against unsporulated 
diploids and undesired spores. Cells on this selective medium were incubated for 2 days, and this 
step was repeated two times but with 1 day incubations. Finally, the array of triple mutant 
haploid MATa cells lacking TRK1, TRK2, and one other unique non-essential gene were 
transferred to SC-Leu supplemented with 100 mM KCl and SC-Leu with no additional KCl (“0 
mM” potassium). Growth on these plates was assessed by imaging them after 12, 24, and 36 hr 
using the white light setting on a BioRad image station. Rescreening of hits was performed as 
described above, but with the additional step of transferring the array of triple mutant haploids 
into 100 µl of liquid SC-Leu medium supplemented with 100 mM KCl in a 96-well dish after the 
third selection step. These cultures were grown to saturation overnight, then droplets of liquid 
culture were transferred onto 0 mM and 100 mM KCl SC-Leu solid medium with the 96-pin 
manifold.  
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2.2.3 Cycloheximide chase analysis 
Yeast cultures transformed with human potassium channels expressed under the control of the 
TEF1 were grown overnight to saturation, diluted into 5 ml of SC-Leu at an OD600 of 0.25, and 
grown to mid-log phase, which I define as an OD600 of 0.7-1.3. Cultures were treated with 150 
µg/mL of cycloheximide (Sigma-Aldrich) and incubated with agitation in a 37°C waterbath 
unless otherwise specified. A total of 1 ml aliquots of culture were withdrawn at the indicated 
times and immediately harvested and flash frozen in liquid nitrogen. Aliquots were processed 
and analyzed for Western blot analysis as described below. For cycloheximide chase analyses of 
the temperature-sensitive cdc48-2 strain, all cultures were incubated at 39°C for 120 min prior to 
cycloheximide addition. For cycloheximide chase analyses of the temperature-sensitive ssa1-45 
and rsp5-2 strains, all cultures were incubated at 37°C for 60 min or 39°C for 75 min respectively 
prior to cycloheximide addition.  
Cycloheximide chase studies in HEK cells were performed 20-24 hrs after induction with 
doxycycline. Cells were pretreated with either 10 µM leupeptin (Sigma-Aldrich), 5 μM MG-132 
(EMD Millipore, Billerica, MA) or vehicle for 1 hr before the addition of cycloheximide (50 
µg/ml), and then cells were chased in the presence or absence of the protein degradation 
inhibitors for 1- 3 hrs. Cell lysates, collected every hour after addition of cycloheximide, were 
resolved by SDS-PAGE and probed in Western blots with ROMK antibodies (R79 Serum (Wade 
et al., 2011)). 
2.2.4 Analysis of ROMK residence 
To perform a sucrose gradient analysis of ROMK residence, yeast cultures transformed with 
plasmids encoding the indicated channels were grown overnight to saturation, diluted into 200 
mL of SC-Leu to an initial OD600 of 0.25, and then allowed to grow to mid-log phase. A total of 
150 OD600 of cells were harvested and lysed with glass beads in a solution containing 10% 
sucrose, 10 mM Tris pH 7.6, 1 mM DTT, 1 mM PMSF) (Sigma), 1 μg/mL leupeptin (Sigma), 
0.5 μg/mL pepstatin A (Sigma), and 10 mM EDTA (Roberg et al., 1997). The entire volume of 
the clarified lysate was then layered on top of a sucrose gradient with 1.5 ml of 30% sucrose, 1.5 
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ml of 40% sucrose, 2.5 ml of 50% sucrose, 1.5 ml of 60% sucrose, 1.5 ml of 65% sucrose, and 
2.5 ml of 70% sucrose in the same buffer. The gradients were centrifuged in a Beckman L8-70M 
ultracentrifuge (Beckman-Coulter, Pasadena, CA) at 28,500g for 18.5 hrs. The gradient was then 
divided into 24 fractions, which were analyzed by SDS-PAGE and Western blot (see below).  
 Prior to microscopy, all strains were grown to mid-log phase in SC-Leu media or in SC-
Leu-His for strains co-transformed with Scs2-mCh. Cells were placed on a 35 mm, poly-D-
lysine-coated dish (MatTek, Ashland, MA) and imaged with a Nikon (Tokyo) Eclipse Ti 
inverted microscope equipped with epifluorescence, an Apo100 x objective (NA 1.45) and an 
Orca Flash 4.0 cMOS (Hamamatsu, Bridgewater, NJ) camera. NIS-Elements software (Nikon) 
was used to control the imaging parameters, and all images within an experiment were captured 
used identical acquisition settings. Post-acquisition processing was conducted using ImageJ 
(National Institutes of Health). To stain the vacuolar membrane, cells were incubated with 300 
μM of the FM4-64 dye (Thermo Fisher) for at least 30 min, which allows for FM4-64 bound to 
lipid at the cell surface to traffic to the vacuolar-limiting membrane (Vida and Emr, 1995), and 
were washed prior to imaging. All images were acquired at room temperature. 
2.2.5 Inductively Coupled Plasma Mass Spectrometry (ICP-MS) 
Yeast cultures transformed with a vector control or a vector engineered for the expression of 
distinct human potassium channels were grown overnight to saturation, diluted into 7 ml of SC-
Leu medium containing either 100 mM or 10 mM KCl at an OD600 of 0.2, and allowed to grow 
for 8 hrs. Approximately 3.0 OD600 of cells were harvested by vacuum filtration onto 1.2 µm 
pore glass fiber membrane filters (EMD Millipore). Next, the cells were washed with 1 µM 
EDTA and with double distilled water before they were dissolved in 30% trace metal grade 
HNO3 (Fisher) at 65oC overnight. Solutions were clarified by centrifugation at 20,000g for 10 
min to remove any solid debris and diluted with 2% sub-boil distilled HNO3 prior to analysis on 
a Perkin Elmer (Waltham, MA) NexION 300x ICP-MS. All elemental concentrations were 
determined using a 5-point calibration curve. An internal standard of beryllium, germanium, and 
thallium was added to all samples to assess signal strength and instrument drift. A 2% nitric acid 
blank was run every seven samples to assess signal memory effects. All biological replicates 
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were run in technical duplicate and the technical replicates are the average of 3 replicate 
measurements from the ICP-MS. 
2.2.6 HEK293 cell culture and siRNA knockdown 
All cells were propagated at 37°C in a 5% CO2 humidified incubator. Cells were passaged every 
3-4 days using standard methods. All experiments were conducted after seven or fewer passages. 
T-REx-HEK-293 ROMK cells were a generous gift from the laboratory of Dr. Jerod Denton 
(Fallen et al., 2009), and the original T-REx-HEK 293 cells were purchased from Invitrogen. 
Upon receipt, they were tested for mycoplasma using a PCR-based kit (ATCC, Manassas, VA) 
and found to be negative. T-REx-HEK-293 ROMK cells were propagated in high-glucose 
DMEM (Sigma Life Sciences) supplemented with 10% Fetal Bovine Serum, 5 µg/ml Blasticidin 
S, and 250 µg/ml Hygromycin B to maintain selection for the integrated tetracycline-inducible 
ROMK cassette (Raphemot et al., 2013). To induce ROMK expression, cells were treated with 2 
µg/ml tetracycline for at least 24 hrs. siRNA silencing was achieved with 1.5 μg/ml 
Lipofectamine RNAiMax (ThermoFisher) transfection reagent and 10 nM RNA duplex (GE Life 
Sciences, Marlborough MA) (sequences are indicated in Supplementary Table 3). Lipofectamine 
and RNA were incubated separately in 0.25 ml pre-warmed OptiMEM (ThermoFisher) for 5 
min, mixed at a 1:1 volumetric ratio, incubated for another 5 min, and then added to cells. After 
24 hrs, culture media was changed and the transfection protocol was repeated a second time. 
 
2.2.7 HEK293 cell surface biotinylation 
Prior to biotinylation, cells at 80-90% confluency were treated with 125 μg/ml cycloheximide for 
2 hrs to increase the cell surface concentration of ROMK. The cells were washed 3 times with 
Dulbecco’s Phosphate Buffered Saline (DPBS), then treated with 0.3 mg/ml EZ-Link Sulfo-NHS 
Biotin (Thermo-Fisher) for 1 hr. Excess biotin was quenched by washing the cells with 100 mM 
glycine in DPBS 3 times, the cells were lysed in HEENG buffer (20 mM HEPES pH=7.6, 1 mM 
EDTA, 1 mM EGTA, 25 mM NaCl, 10% glycerol) containing 1% Triton TX-100 and cOmplete, 
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Mini, EDTA free protease inhibitors (Roche Diagnostics, Mannheim, Germany) for 1 hr, and the 
mixture was centrifuged for 5 min at maximum speed to remove any insoluble material. Soluble 
protein concentrations were assessed with a Pierce BCA Protein Assay Kit (Thermo-Fisher) per 
the manufacturer’s instructions. For each condition, 300 µg of protein was added to 30 µl of 
Pierce NeutrAvidin Agarose (Thermo-Fisher) beads, brought to a total volume of 1 ml, and 
incubated overnight. Beads were then triple washed with DPBS and treated with 1X SDS-PAGE 
sample buffer for 1 hr at room temperature prior to SDS-PAGE and Western blot analysis (see 
below). All steps of this protocol were conducted at 4°C. 
2.2.8 Western blot analysis 
To assay protein expression in yeast, equivalent OD600 cultures at mid-log growth phase were 
lysed in 300 mM NaOH, 1 mM 2-mercaptoethanol, 1 mM PMSF (Sigma), 1 μg/mL leupeptin 
(Sigma), and 0.5 μg/mL pepstatin A (Sigma). Total protein was precipitated from lysate with 5% 
trichloroacetic acid (TCA), resuspended in SDS-PAGE sample buffer, incubated for at least 1 hr 
at room temperature, and analyzed by SDS-PAGE (Zhang et al., 2001). Steady-state levels of 
protein in HEK293 cells were analyzed by dissolving 30 μg of protein from clarified lysate in 
SDS-PAGE sample buffer, incubating for at least 1 hr, and analyzing by SDS-PAGE. 
All Western blots were developed with the SuperSignal West enhanced 
chemiluminescence kit (Thermo-Fisher) per the manufacturer’s instructions. Chemiluminescence 
images were obtained on a BioRad image station. Quantitation of signal intensity was performed 
by measuring integrated pixel density in ImageJ (National Institutes of Health). Relevant 
antibody information is supplied in Table 4. 
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Table 4: Antibodies used in this study 
 
 
Target Species of 
Origin 
Source Catalog # Lot # 
(If Available) 
Hemagglutinin 
(HA) HRP-
conjugated 
Donkey Roche  12013819001 23551600 
G6PD Rabbit Sigma-Aldrich A9521 n/a 
Sec61 Rabbit (Stirling et al., 1992) n/a n/a 
Pma1 Mouse Abcam (Cambridge, 
UK) 
ab4645 40B7 
GFP Mouse Roche  11814460001 14442000 
ROMK Rabbit (Wade et al., 2011) n/a n/a 
Hsp90 Mouse Enzo Life Sciences, 
Farmingdale, NY 
ADI-SPA-830-D 01101340 
ATP1A Mouse Santa Cruz 
Biotechnology, Dallas, 
TX 
C464.6 sc-21712 
TSG101 Mouse GeneTex, Irvine, CA GTX70255 4A10 
HGS Mouse Abcam ab56468 n/a 
VPS8 Rabbit Proteintech, Rosemont, 
IL 
15079-1-AP n/a 
β-actin Mouse Abcam, ab6276 n/a 
Rabbit IgG 
(HRP-
conjugated) 
Goat Cell Signaling 
Technology, Beverly, 
MA 
7074S 26 
Mouse IgG 
(HRP-
conjugated) 
Goat Cell Signaling 
Technology, Beverly, 
MA 
7076S 29 
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2.3 RESULTS 
2.3.1 Identification of a ROMK variant suitable for SGA 
Initial attempts to express ROMK1 in trk1Δ trk2Δ yeast failed to reveal growth rescue on low 
potassium media (Figure 6A). This contrasts with the strong rescue phenotype observed in yeast 
expressing the inwardly rectifying channel Kir2.1, which shares 42% sequence identity with 
ROMK1. To remedy this problem, I modified ROMK1 with two point mutations which I 
hypothesized would potentiate it in yeast. First, ROMK1 contains an intracellular acid-sensitive 
gate, which keeps the channel closed under conditions of cellular acidification (Rapedius et al., 
2007a). All Kir channels are acid-gated to some degree, but only in ROMK, Kir4.x, and Kir5.1 
does the IC50 fall within a physiologically relevant range (Paynter et al., 2010). . I hypothesized 
that this pH gate closes ROMK because the yeast cytosol is acidic (pH 5.5–6.8), particularly in 
stationary phase cultures growing on solid agar medium (Paynter et al., 2010). Therefore, Lys-
80, which is crucial for pH gating (Rapedius et al., 2007a)  was mutated to Met (K80M). Second, 
ROMK1 is retained in the ER of mammalian cells due to the presence of multiple RXR motifs at 
both the N- and C-terminal domains. Aldosterone-regulated phosphorylation at Ser-44 by SGK-1 
overrides ER retention, promoting anterograde traffic (Yoo et al., 2005). To favor ER exit in 
yeast, Ser-44 was mutated to Asp (S44D).  
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Figure 6: The S44D and K80M mutations in ROMK improve its function and stability. A. 
Yeast containing an empty expression vector or plasmids engineered for the expression of 
Kir2.1, wild-type ROMK, or the S44D and K80M mutations alone or in combination were 
spotted onto SC medium containing the indicated added concentration of KCl. B. Yeast 
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expressing wild-type ROMK or ROMK1S44D+K80M were treated with either 100 µM MG132 
(closed circles) or with an equal volume of DMSO (open circles) for 30 min before the addition 
of cycloheximide. ROMK expression was assessed by Western Blot and data were normalized to 
the initial timepoint. Representative blots are shown and all blots were stripped and reprobed for 
glucose-6-phosphate dehydrogenase (G6PD) as a loading control. Data represent the means of 
six independent experiments from two independent yeast transformations. C. ER-enriched 
microsomes prepared from wild-type yeast expressing wild-type ROMK1 or ROMK1S44D+K80M 
were treated with 10 µg/ml Proteinase K for the indicated times. Representative blots are shown, 
and protein disulfide isomerase (PDI) was used as a loading control. Data represent the means of 
four independent experiments. Error bars show standard errors of the mean, *indicates a 
significant (p<0.05) difference as assessed by Student’s t-test.   
 
 
 
Vectors engineered for the constitutive expression of ROMK1, each of the single 
mutants, and the double mutant were constructed and introduced into trk1Δ trk2Δ yeast as well as 
into a strain that Dr. Alexander Kolb had previously identified as deficient in a negative regulator 
of Kir2.1, trk1Δ trk2Δ vps23Δ (Kolb et al., 2014) (section 1.1.6). As shown in Figure 6A, 
ROMK1S44D+K80M rescued the growth of cells on low potassium almost as well as Kir2.1. 
Although the ROMK1S44D species displayed only minimal growth rescue, this mutation 
augmented growth when combined with the K80M mutation. Importantly, the expression of any 
of these species did not retard the growth of trk1Δ trk2Δ yeast (data not shown). Therefore, I 
chose to use the double mutant (ROMK1S44D+K80M) for subsequent experiments. All Kir channels 
in this study were expressed under the control of the TEF1 promoter on a low-copy plasmid as 
prior research with Kir2.1 has found that this expression scheme produces optimal low potassium 
growth rescue in trk1Δ trk2Δ yeast (Kolb et al., 2014). 
Cycloheximide chase analysis revealed that ROMK1S44D+K80M was more resistant to 
proteasomal degradation than ROMK1, as the degradation rate was affected less when 
ROMK1S44D+K80M expressing cells versus ROMK1-expressing cells were treated with the 
proteasome inhibitor MG132 (Fig. 4B). Based on its effects on channel gating, I reasoned that 
the K80M mutation might stabilize the channel by favoring its open conformation. To test this 
 51 
hypothesis, ER-derived microsomes were prepared from yeast expressing wild type ROMK1 and 
ROMK1S44D+K80M. As proposed, I discovered that ROMK1S44D+K80M was more resistant to in 
vitro degradation by ProteinaseK as compared to the wild type channel (Figure 6C). Dr. Brighid 
O’Donnell, a University of Pittsburgh Medical Center (UPMC) neonatology fellow, would take 
advantage of the fact that ROMK1S44D+K80M is refractory to proteasomal degradation. 
Specifically, she was able to use this construct as a control for investigating the role of select 
Type II Bartter syndrome mutations in targeting ROMK for ERAD (O’Donnell et al., 2017a, 
2017b) (section 1.2.2). 
I next tested the two alternatively spliced isoforms in the kidney, ROMK1 and ROMK2, 
which are identical except for a 19-amino acid residue N-terminal extension in ROMK1. To date, 
no biophysical differences between the channels have been identified, though they have 
divergent physiological roles (Welling and Ho, 2009) (section 1.2.1). Curiously, 
ROMK2S44D+K80M did not rescue the growth of trk1Δ trk2Δ vps23Δ yeast on low potassium 
media as effectively as ROMK1S44D+K80M (Figure 7A), despite somewhat higher steady-state 
expression levels of ROMK2S44D+K80M compared to ROMK1S44D+K80M (Figure 8). Notably, the 
degree of rescue mediated by ROMK1S44D+K80M was similar to that of Kir2.1, which was used in a 
previous screen from the lab (Kolb et al., 2014). Hence, ROMK1S44D+K80M was used for the 
remainder of the work outlined in this chapter. Furthermore, I predicted that the 
ROMK1S44D+K80M protein could be used to conduct an SGA analysis, which could provide for the 
first time a whole genomic profile of the factors that negatively regulate ROMK trafficking. 
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Figure 7: ROMK1S44D+K80M increases potassium uptake. A. Yeast strains with the indicated 
genotypes transformed with an empty expression vector control or vectors engineered to express 
Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially diluted onto medium 
supplemented with the indicated amounts of KCl. B. Intracellular potassium levels, as measured 
by ICP-MS, were assessed using equivalent amounts of yeast containing an empty vector or 
expressing Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M. Cells were cultured for 8 hrs in 
liquid media containing either 100 mM or 10 mM KCl. Data show the means of 3 biological 
replicates. Error bars show standard deviations, *indicates p<0.05 (Student’s t-test). C. Western 
blots of sucrose gradient fractions showing migration of HA-tagged ROMK1S44D+K80M containing 
microsomes in wild-type yeast. Pma1 marks the plasma membrane-derived fractions while Sec61 
marks ER-derived fractions. 
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In order to confirm that Kir2.1 and ROMK1S44D+K80M directly increase the amount of 
intracellular potassium in trk1Δ trk2Δ yeast, I prepared extracts from yeast cells expressing these 
proteins, as well as from those containing a vector control, and subjected the extracts to 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) with the assistance of Dr. Daniel 
Bain of the University of Pittsburgh Department of Geology and Environmental Science. This 
method allows for precise measurement of the metallic elemental composition of a biological 
sample. I first noted that the level of intracellular potassium in trk1Δ trk2Δ yeast expressing 
ROMK1S44D+K80M was not statistically different from the vector control after approximately 8 hrs 
of culture in medium containing 10 mM potassium (Figure 7B, left graph). These data are 
consistent with the inability of this strain to grow better than the vector control in the same 
medium (Figure 7A). However, both Kir2.1 and ROMK1S44D+K80M expression increased 
intracellular potassium more than twofold compared to the vector control in trk1Δ trk2Δ vps23Δ 
cells (Figure 7B, right graph), consistent with Vps23 acting as a negative regulator of ROMK. 
 
 
Figure 8: Expression of the ROMK1 and ROMK2 variants in yeast. Western blots of lysate 
from yeast of the indicated genotype and expressing the indicated HA-tagged potassium channels 
or containing an empty vector control were probed with an anti-HA antibody. All blots were 
stripped and reprobed for glucose-6-phosphate dehydrogenase (G6PD) as a loading control. 
 
 
 
Prior studies established that trk1Δ trk2Δ yeast are sensitive to the toxic cations 
hygromycin B (an aminoglycoside antibiotic), spermine, and tetramethylammonium (Barreto et 
 54 
al., 2011). This phenotype arises from increased cellular uptake of the toxins in trk1Δ trk2Δ yeast 
because the membrane is hyperpolarized when potassium entry is limited. Therefore, I examined 
growth on medium containing hygromycin B. Consistent with data in Figure 7A, Kir2.1 or 
ROMK1S44D+K80M expression enhanced trk1Δ trk2Δ vps23Δ yeast growth on medium 
supplemented with hygromycin B (Figure 9). Together, these results indicate that 
ROMK1S44D+K80M functions as a potassium transporter in yeast, allowing for sufficient import of 
this cation to support growth on low potassium medium.  
 
 
Figure 9: ROMK1S44D+K80M expression increases resistance to the toxic cation Hygromycin 
B. Yeast strains with the indicated genotype transformed with an empty expression vector 
control or vectors engineered to express Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were 
serially diluted onto growth medium supplemented with the indicated amounts of Hygromycin B 
(Hygro). 
 
 
 
When examined under steady-state conditions in mammalian cells, ROMK primarily 
resides in the ER (Peters et al., 2003; Welling and Ho, 2009). Similarly, I found that the majority 
of ROMK1S44D+K80M co-migrated with the ER-resident protein Sec61 when lysates from a wild-
type yeast strain isogenic to trk1Δ trk2Δ and its derivatives (BY4742) were subjected to 
subcellular fractionation by sucrose gradient sedimentation analysis (Figure 7C). ROMK 
appeared to be absent in the Pma1-containing plasma membrane fractions. Based on the clear 
increase in intracellular potassium and the phenotypic data presented above, these results suggest 
that ROMK1S44D+K80M growth rescue on low potassium medium requires only small amounts of 
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protein at the plasma membrane that are undetectable using this approach. This conclusion is 
consistent with data from Dr. Alexander Kolb, indicating that very low levels of Kir2.1 plasma 
membrane residence are sufficient for growth rescue under these steady-state conditions (Kolb et 
al., 2014).  
2.3.2 ROMK1S44D+K80M is primarily degraded by the vacuole and not by ERAD in yeast 
ER-associated degradation (ERAD) is one of the first lines of defense against the accumulation 
of misfolded proteins in the secretory pathway (section 1.2.2). As neither ROMK1 nor 
ROMK1S44D+K80M was completely stable when the proteasome was inhibited with the proteasome 
inhibitor MG132 (Figure 6B), I hypothesized that a sub-population of ROMK is degraded in the 
vacuole, which serves as the degradative compartment for post-ER quality control in yeast 
(MacGurn et al., 2012).  To determine whether the vacuole contributes directly to ROMK 
degradation, both wild-type ROMK1 and ROMK1S44D+K80M were expressed in a yeast strain 
lacking Pep4, which activates proteases in the vacuole by cleaving their immature forms 
(Woolford et al., 1986), as well as in an isogenic wild-type strain. I then analyzed their relative 
degradation profiles in a cycloheximide chase assay. As shown in Figure 10, both ROMK 
variants were significantly stabilized in pep4Δ yeast. However, while ROMK1 was only partially 
stabilized (Figure 10A), consistent with targeting to the ERAD pathway, ROMK1S44D+K80M was 
almost completely stable within the 90-minute timescale of the chase (Figure 10B). These data 
also emphasized the overall heightened stability of the ROMK1S44D+K80M protein as compared to 
wild type ROMK1 (O’Donnell et al., 2017b).  
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Figure 10: ROMK1 and ROMK1S44D+K80M are degraded to varying degrees by the vacuole 
in yeast. Yeast cultures expressing HA-tagged versions of either (A) ROMK1 or (B) 
ROMK1S44D+K80M grown to mid-logarithmic phase were dosed with cycloheximide and aliquots 
were withdrawn at 0, 30, 60, and 90 min. A yeast strain lacking the master vacuolar protease 
(pep4Δ, filled circles) or an isogenic wild-type (PEP4, open circles) expressing the proteins were 
shifted from room temperature to 37OC 30 min before addition of cycloheximide. ROMK 
expression was assessed by Western Blot and data were normalized to the initial timepoint. 
Representative blots are shown and all blots were stripped and reprobed for glucose-6-phosphate 
dehydrogenase (G6PD) as a loading control. Data represent the means of six independent 
experiments from two independent yeast transformations. Error bars show standard errors of the 
mean, *indicates a significant (p<0.05) difference as assessed by Student’s t-test. 
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I next examined the relative efficiencies with which wild-type ROMK1 and the 
ROMK1S44D+K80M isoform are degraded by ERAD. During ERAD, misfolded protein substrates 
are recognized by molecular chaperones such as Hsp70 and ubiquitinated by E3 ubiquitin ligases 
that are ER associated (Ellgaard et al., 2016; Gottschling and Nyström, 2017). After the 
acquisition of a polyubiquitin tag, the ERAD substrate is retrotranslocated from the ER in an 
ATP-dependent process that utilizes the AAA-ATPase, Cdc48 (in yeast) or p97 (in mammals). I 
found that wild-type ROMK1 behaves like a canonical yeast ERAD substrate as it was 
significantly stabilized when Cdc48 was inactivated, when the genes encoding two ER-localized 
E3 ubiquitin ligases in yeast, Hrd1 and Doa10, were deleted, or when the cytosolic Hsp70 Ssa1 
was disabled (Figure 11A,C,E). However, ROMK1S44D+K80M is consistently more stable, and the 
relative amount of degradation is affected less or not at all by ablation of these ERAD 
components (Figure 11B,D,F). Therefore, I propose that the degradation of wild-type ROMK1 is 
dominated by ERAD whereas the degradation of ROMK1S44D+K80M is dominated by post-ER 
quality control. Therefore, ROMK1S44D+K80M represents a novel “tool” with which to decipher 
how the post-ER quality control machinery regulates channel levels. 
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Figure 11: ROMK1 is degraded by the ERAD pathway to a greater extent than 
ROMK1S44D+K80M in yeast. Yeast cultures expressing HA-tagged versions of either (A,C,E) 
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ROMK1 or (B,D,F) ROMK1S44D+K80M grown to mid-logarithmic phase were dosed with 
cycloheximide and aliquots were withdrawn at 0, 30, 60, and 90 minutes. Yeast strains 
containing either a temperature sensitive mutation in the gene encoding Cdc48 (cdc48-2, filled 
circles) or lacking the mutant allele (CDC48, open circles) expressing (A) wild-type ROMK1 or 
(B) ROMK1S44D+K80M were shifted from room temperature to 39°C for 60 min before addition of 
cycloheximide. A yeast strain lacking the ER-resident E3 ubiquitin ligases (hrd1Δ doa10Δ, filled 
circles) or an isogenic wild-type strain (HRD1 DOA10, open circles) expressing (C) wild-type 
ROMK1 or (D) ROMK1S44D+K80M were shifted from room temperature to 37°C 30 min before 
addition of cycloheximide. Yeast strains lacking four cytosolic isoforms of Hsp70 (Ssa1, Ssa2, 
Ssa3, and Ssa4) and containing either a temperature sensitive mutation of Ssa1 (ssa1-45, filled 
circles) or an isogenic wild-type allele (SSA1, open circles) and expressing (E) wild-type 
ROMK1 or (F) ROMK1S44D+K80M were shifted from room temperature to 37°C 30 min before 
addition of cycloheximide. For all experiments, ROMK expression was assessed by Western 
Blot and normalized to the initial timepoint. Representative images are shown and all blots were 
stripped and reprobed for glucose-6-phosphate dehydrogenase (G6PD) as a loading control. Data 
represent the means of six independent experiments from two independent yeast transformations. 
Error bars show standard errors of the mean and *indicates a significant (p<0.05) difference as 
assessed by Student’s t-test. 
 
 
2.3.3 SGA for ROMK1 effectors implicates late secretory pathway protein degradation 
Since ROMK1S44D+K80M rescues potassium sensitivity in trk1Δ trk2Δ vps23Δ yeast and appears to 
do so by increasing intracellular potassium (Figure 7A,B), I next conducted a whole-genome 
screen for other factors that negatively regulate ROMK residence and activity at the plasma 
membrane. To this end, ROMK1S44D+K80M-expressing trk1Δ trk2Δ yeast were mated with the 
non-essential yeast deletion collection and arrays of triple mutant progeny (i.e., those that were 
deleted for TRK1, TRK2, and a non-essential gene; see Experimental Procedures) were generated 
(Figure 3). Potential negative effectors were identified by comparing growth on high (100 mM) 
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versus low (“0” mM) potassium medium, in which the only available potassium derives from 
trace amounts in the media components (Nakamura and Gaber, 1998). Strain growth was ranked 
by z-score (number of standard deviations from the plate mean) to correct for variance among 
agar plates. The initial screen revealed 40 very strong hits (z-score >3), 228 strong hits (z-score 
>2), and 519 weak hits (z-score >1) from the nearly 5,000 strains screened (Appendix D). The 
confirmed negative regulator of ROMK, VPS23 (Figures 5A,6A), was among the very strong hits 
from the screen. I then re-arrayed select parental strains representing the 228 strong and very 
strong hits into fresh 96-well plates and performed the screen a second time to eliminate false 
positives. For the purposes of this study, I also eliminated from consideration genes known to 
sensitize yeast to toxic cations, such as members of the RSC chromatin remodeling complex 
(Barreto et al., 2011). GO-term analysis of the 40 confirmed strongest hits indicated a positive 
(p<0.05) enrichment for the terms “endosomal transport”, “late endosome to vacuole transport”, 
and “vacuolar transport”, each of which are components of the late secretory trafficking and 
quality control machineries (Table 5). Other genes associated with these pathways were also 
represented among the strong (z-score >2) and weak (z-score >1) hits. 
 
Table 5: Gene ontology (GO) term analysis of very strong hits (z-score >3) isolated from 
initial screen. Gene ontology (GO) term analysis of very strong hits (z-score >3) isolated from 
initial screen listed in increasing order of p-value from most significant (<0.001) to least 
significant (<0.05). 
 
 
GO Term Genes 
ATP-dependent chromatin remodeling SWC5, SWR1, RSC1, RSC2, BDF1, NPL6 
Nucleosome organization SWC5, SWR1, RSC1, RSC2, BDF1, NPL6 
Chromatin remodeling SWC5, SWR1, RSC1, RSC2, BDF1, NPL6 
Histone Exchange SWC5, SWR1, BDF2 
DNA-templated transcription, elongation RSC1, RSC2, NPL6, NPL3, RPA49 
Protein-DNA complex subunit organization SWC5, SWR1, RSC1, RSC2, BDF1, NPL6 
Chromatin disassembly RSC1, RSC2, NPL6 
Protein-DNA complex disassembly RSC1, RSC2, NPL6 
Endosomal transport VPS8, VPS23, YPT7, VPS20, VPS21 
Late endosome to vacuole transport VPS8, VPS23, VPS20, VPS21 
Vacuolar transport VPS8, VPS23, VPS64, YPT7, VPS20, VPS21 
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Next, to further increase my confidence in select hits, I reconstructed several of the triple 
mutant strains de novo by manually mating trk1Δ trk2Δ with the appropriate strain from the 
deletion collection, inducing sporulation, micro-dissecting the resultant tetrads, and selecting 
triple knock-out progeny (Table 6, underlined). This step was necessary to correct for false 
positives from the original list of screen hits and to build a trustworthy set of strains for 
subsequent experiments. Select strains that were absent from the original screen were included in 
this curated list as they are well-characterized components of the endosome-to-vacuole sorting 
pathway and genetically interact with the isolated hits (Table 6). The parental strains from the 
deletion collection corresponding to those in this curated list were also confirmed by PCR (see 
Table 3 for oligonucleotides used for this experiment). The reconstructed strains were then 
transformed with a vector control or the Kir2.1, ROMK1, or ROMK1S44D+K80M expression 
vectors. Transformants were serially diluted onto a range of potassium supplemented media, and 
yeast expressing ROMK1S44D+K80M that grew better on low (“0” or 10 mM) concentrations of 
potassium relative to the vector control were considered to be verified negative regulators of 
ROMK (Figures 12,13). Importantly, the relative amounts of Kir2.1, ROMK1, and 
ROMK1S44D+K80M in these strains did not reflect the degree to which growth was rescued (Figure 
14), suggesting that the primary effect of the mutants was on protein residence at the plasma 
membrane and not only on changes in global protein levels. 
 
Table 6: Endosomal transport genes considered for further investigation in this study. 
Genes are arranged by functional classification. Genes in boldface were identified in the screen, 
while those in normal type were selected as known interactors with identified genes. Underlined 
genes were selected for de novo strain reconstruction. 
 
 
Family Function Genes 
CORVET Tether Early Endosomes VPS3, VPS8, VPS18, VAM6, VPS11, 
VPS16 
HOPS Tether Late Endosomes VPS39, VPS41, VPS18, VAM6, 
VPS11, VPS16 
Table 6 (continued) 
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ESCRT-0 Bind Ubiquitinated Cargo VPS27, HSE1 
ESCRT-I Recruit Cargo to ILVs VPS23, VPS28, VPS37, MVB12 
ESCRT-II Recruit Cargo to ILVs VPS22, VPS25, VPS36 
ESCRT-III Invaginate ILVs VPS2, VPS20, VPS24, SNF7 
Vps4C Sever ILVs VPS4, VPS60, VTA1 
Retromer Return Cargo to Golgi VPS5, VPS17, VPS26, VPS29, 
VPS35 
Rsp5 Adaptors Promote Ubiquitination SSH4, BSD2, EAR1 
SNAREs Fuse Membranes TVP15, TVP23, TGL6, VAM7, 
PEP12, GOS1 
Rab GTPases and cofactors Identify Endosomal Sub-
Populations 
VPS21, YPT7, YPT10, MSB3, 
MSB4, VPS9, BTS2 
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Figure 12: The deletion of genes encoding select ESCRT and CORVET components 
improves the growth of potassium sensitive yeast expressing ROMK1S44D+K80M. Yeast strains 
with the indicated genotypes transformed with an empty expression vector control or vectors 
engineered to express Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially diluted onto 
medium supplemented with the indicated amounts of KCl. All strains in this figure were 
identified in the high-throughput SGA screen and then reconstructed de novo. All experiments 
were performed in duplicate, and representative serial dilutions are shown. 
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Figure 13: Deletion of genes encoding other endosomal sorting components improves the 
growth of potassium sensitive yeast expressing ROMK1S44D+K80M. Yeast strains with the 
indicated genotypes transformed with an empty expression vector control or vectors engineered 
to express Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially diluted onto medium 
supplemented with the indicated amounts of KCl. All strains in this figure were identified in the 
high-throughput SGA screen and then reconstructed de novo. All experiments were performed in 
duplicate, and representative assays are shown. 
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Figure 14: Expression of human potassium channels in the indicated hits from the SGA 
screen. Western blots were performed with lysates from yeast with the indicated genotypes and 
expressing the indicated potassium channels. Both Kir2.1 and the ROMK variants are HA-
tagged. All blots were stripped and reprobed for glucose-6-phosphate dehydrogenase (G6PD) as 
a loading control. 
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To bolster my confidence that the rescue of growth on low potassium medium correlates 
with an increase in ROMK plasma membrane residency, I next conducted sucrose gradient 
analysis on fractionated membranes derived from end3Δ potassium sensitive yeast and an 
isogenic wild-type strain.  In the end3Δ background, which is endocytosis deficient, a small 
amount of ROMK1S44D+K80M appears to comigrate with the plasma membrane marker Pma1 
(Figure 15B “long exposure”).  A signal corresponding to the plasma membrane was not evident 
when lysates from wild-type cells were examined (Figure 15A). Thus, even though the amount 
of the protein at the plasma membrane is quite low, ROMK1S44D+K80M promotes robust rescue of 
potassium sensitive growth in end3Δ yeast (Figure 15C,D). This phenomenon most likely arises 
from the high Po reported for ROMK (Ho et al., 1993; Leung, 2000) coupled with the 
presumably high transmembrane voltage in S. cerevisiae. 
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Figure 15: Deletion of endocytosis component End3 allows for ROMK plasma membrane 
residency. Western blots of sucrose gradient fractions showing migration of HA-tagged 
ROMK1S44D+K80M in trk1Δ trk2Δ (A) and trk1Δ trk2Δ end3Δ (B) yeast. Two exposures of the HA 
immunoblot are shown.  * indicates an uncharacterized band that is likely a degradation product. 
Pma1 marks the plasma membrane-derived fractions while Sec61 marks ER-derived fractions.  
Note the population of ROMK that resides in fractions 13-17 that comigrates with Pma1.  (C,D) 
Yeast strains with the indicated genotypes transformed with an empty expression vector control 
or vectors engineered to express Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially 
diluted onto medium supplemented with the indicated amounts of KCl. All strains in this figure 
were identified in the high-throughput SGA screen and then reconstructed de novo. All 
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experiments were performed in duplicate, and representative assays are shown. Note: panel C is 
identical to Figure 12A.   
 
 
 
Vps8, a subunit of the CORVET complex, was identified as one of the strongest hits from 
the initial screen (Table 6, Figure 12). The CORVET complex is a heterohexamer involved in 
tethering vesicles containing Vps21, which is the yeast Rab5 homolog, prior to early endosome 
biogenesis (Balderhaar et al., 2013). CORVET shares four out of six subunits with the HOPS 
complex, which performs a similar role as CORVET. However, HOPS instead functions with 
vesicles containing Ypt7, which is the yeast Rab7 homolog, to promote fusion of multi-vesicular 
bodies (MVBs) with the vacuole (Plemel et al., 2011; Kingsbury et al., 2014). Components of 
both complexes are conserved from yeast to man (Pols et al., 2013; Lachmann et al., 2014; 
Perini et al., 2014). Therefore, to determine whether CORVET and/or HOPS functioned as 
novel, negative regulators of ROMK, both unique and shared CORVET and HOPS knockout 
strains were generated in the trk1Δ trk2Δ background. I discovered that only deletion of the 
CORVET-specific subunits Vps3 and Vps8 improved the growth of in trk1Δ trk2Δ yeast 
expressing ROMK1S44D+K80M (Figure 12B-C). In contrast, deletion of the HOPS-specific subunits 
Vps39 and Vps41 and shared subunits Vps11, Vps16, Vps18, and Vps33 had no or little effect 
on growth (data not shown). A model to explain these data is provided in the section 2.4. 
Several other strong hits, as measured by the degree of growth rescue on low potassium, 
included strains lacking the ubiquitin-binding subunits of the four ESCRT complexes:  Vps27 
(ESCRT-0), Vps23 (ESCRT-I), Vps36 (ESCRT-II), and Vps20 (ESCRT-III) (Figure 7D-H). The 
ESCRT subcomplexes act sequentially to recruit ubiquitinated endocytic and Golgi-derived 
cargo into the MVB degradation pathway (Babst, 2005) (section 1.2.3). ESCRT targeting is 
primarily mediated by the cytoplasmic E3 ubiquitin ligase Rsp5 in yeast and the homologous 
Nedd4 ligases in mammals (Stringer and Piper, 2011; Henne et al., 2013). Therefore, I 
hypothesized that disabling Rsp5 would stabilize ROMK1S44D+K80M to a greater degree than 
ROMK1 since the degradation of ROMK1S44D+K80M was exclusively Pep4-dependent (Figure 
10). As anticipated, ROMK1S44D+K80M was completely stable in yeast containing the temperature-
sensitive rsp5-2 allele (Figure 16Figure 16B). The lack of any Rsp5-dependence on wild-type 
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ROMK1 degradation (Figure 16A) likely reflects the predominant contribution of ERAD to the 
disposal of this channel (Figures 6B, 11A,C,E). 
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Figure 16: Rsp5 promotes the degradation of ROMK1S44D+K80M and Nhx1 promotes 
recycling of ROMK. Yeast cultures expressing HA-tagged versions of either (A) ROMK1 or 
(B) ROMK1S44D+K80M grown to mid-logarithmic phase were dosed with cycloheximide and 
aliquots were withdrawn at 0, 30, 60, and 90 minutes. Yeast strains containing either a 
temperature sensitive mutation in the gene encoding Rsp5 (rsp5-2, filled circles) or wild-type 
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yeast (RSP5, open circles) expressing ROMK were shifted from room temperature to 39°C 75 
min before addition of cycloheximide. ROMK expression was assessed by Western Blot and 
normalized to the initial timepoint. Representative blots are shown and all blots were stripped 
and reprobed for glucose-6-phosphate dehydrogenase (G6PD) as a loading control. Data 
represent the means of four independent experiments. Error bars show standard errors of the 
mean and *indicates a significant (p<0.05) difference as assessed by Student’s t-test. (C). Yeast 
strains with the indicated genotypes transformed with an empty expression vector control or 
vectors engineered to express Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially 
diluted onto medium supplemented with the indicated amounts of KCl. All experiments were 
performed in duplicate, and a representative assay is shown. 
 
 
 
How is ROMK activity enhanced in yeast lacking ESCRT, CORVET, or other endosomal 
sorting genes?  Early endosomes are crucial branch points from which cargo may be trafficked in 
a retrograde fashion to the Golgi apparatus through the action of the Retromer and GARP 
complexes, sorted into intralumenal vesicles by ESCRT, or recycled directly to the plasma 
membrane. Direct recycling is known to occur in yeast, though the precise mechanisms are not 
completely understood (MacDonald and Piper, 2016). I hypothesized that perturbations in 
ESCRT and other pro-degradation factors shift the dynamic equilibrium of the endosomal 
population of ROMK toward increased recycling. To test this hypothesis, I crossed my 
reconstructed trk1Δ trk2Δ vps23Δ strain with nhx1Δ yeast, which lack a sodium-proton 
exchanger involved in endosome acidification and cargo recycling (Kojima et al., 2012). As 
expected, the NHX1 deletion ablated ROMK-mediated growth on low potassium medium in the 
trk1Δtrk2Δvps23Δ background (Figure 16Figure 16C), suggesting that the increase in ROMK 
activity when ESCRT is perturbed arises from increased recycling.   
 As the contribution of Nhx1 during cargo recycling is indirect, I sought to replicate this 
analysis with components of known protein recycling pathways in the cell. I chose Vps5, a BAR-
domain containing subunit of the Retromer subcomplex that induces the formation of tubular 
structures for endosome-to-Golgi recycling (Burd and Cullen, 2014), and Rcy1, a factor 
presumed to act upstream of most Vps proteins (Wiederkehr et al., 2000). Surprisingly, deletion 
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of neither VPS5 (Figure 17A) nor RCY1 (Figure 17B) in the trk1Δ trk2Δ vps23Δ background 
ablated ROMK1S44D+K80M activity. These data suggest that ROMK recycling occurs through 
redundant pathways. 
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Figure 17: Deletion of Vps5 or Rcy1 does not abrogate enhanced growth of ESCRT-
deficient potassium sensitive yeast expressing ROMK1S44D+K80M. Yeast strains with the 
indicated genotypes transformed with an empty expression vector control or vectors engineered 
to express Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially diluted onto medium 
supplemented with the indicated amounts of KCl.  Images were captured after three days of 
growth at 30°C All experiments were performed in duplicate, and representative assays are 
shown. 
 
2.3.4 ROMK vacuolar targeting is impeded in yeast deficient in ESCRT components 
Having shown that ROMK1S44D+K80M is ERAD-resistant and is regulated by ESCRT and 
CORVET, I next asked whether ROMK subcellular localization is altered in strains lacking 
genes encoding select members of these complexes. To this end, I expressed Venus-tagged 
ROMKK80M (Vn-ROMK) in an ESCRT (snf7Δ) and CORVET (vps8Δ) deficient yeast strain, in 
the pep4Δ mutant, and in an isogenic wild -type strain (BY4742). In wild-type yeast, Vn-ROMK 
partially colocalized with both an mCherry-tagged ER-resident marker, Scs2-mCh (Zhou et al., 
2014), and the dye FM4-64 (Vida and Emr, 1995), which binds lipids on the cell surface, passes 
through the endocytic pathway, and accumulates on the vacuolar limiting membrane (Figure 
18A,B). These results are consistent with passage of the protein through the secretory pathway 
and into a pre-degradative compartment. In agreement with dual localization, an immunoblot of 
lysate from wild-type yeast with an antibody that detects GFP derivatives, such as Venus, shows 
both full-length Vn-ROMK (predicted molecular mass of ~70 kDa) and the free Venus species 
(predicted molecular mass of ~28 kDa) (Figure 18C). The free Venus species arises from the fact 
that the fluorescent protein tag is refractory to vacuolar proteolysis (Guiney et al., 2016), so once 
the Vn-ROMK channel enters a proteolytic compartment the fusion protein is only partially 
digested. Consistent with this view, Vn-ROMK-derived fluorescence accumulated primarily in 
the vacuole in pep4Δ yeast (Figure 18A,B), and the free Venus species was absent when vacuolar 
proteases were inactivated (Figure 18C). These data are also consistent with my observation that 
ROMK1S44D+K80M degradation is primarily vacuolar (Figure 10B). 
 75 
In the snf7Δ ESCRT mutant, Vn-ROMK fluorescence shifts from the ER and vacuole to a 
large punctum that is adjacent to, but not contiguous with, the vacuolar limiting membrane 
(Figure 18A,B, see white arrows). This localization pattern is consistent with a substrate that is 
unable to enter intraluminal vesicles and therefore accumulates on the surface of the prevacuolar 
compartment due to the loss of ESCRT activity in this background (Stringer and Piper, 2011). 
Furthermore, the free Venus species is again absent in immunoblot analyses of snf7Δ lysates 
(Figure 18C). Interestingly, a species of ~36 kDa is instead present in this background and not in 
the isogenic wild-type. The appearance of this band, only in ESCRT mutants, could be due to 
proteolytic clipping by proteases within the prevacuolar compartment, as its observed molecular 
weight coincides with a predicted cleavage site between the first and second transmembrane 
domains of ROMK (data not shown). The fluorescence of Vn-ROMK in other ESCRT mutants 
(e.g., vps23Δ and vps36Δ) showed a nearly identical phenotype to snf7Δ (data not shown). 
Finally, to confirm that the Vn-ROMK-enriched puncta in snf7Δ cells represents the prevacuolar 
compartment, I expressed Vn-ROMK in a strain expressing an mCherry-tagged version of the 
Snf7 protein and found that Vn-ROMK and Snf7-RFP colocalize (Figure 18D, white arrows). It 
was previously observed that the RFP tag interferes with Snf7 function (Huh et al., 2003), 
causing a dominant negative phenotype similar to the genetic null (Figure 18C, compare lanes 7 
and 10). Therefore, the expression of Snf7-RFP serves both as a marker of the prevacuolar 
compartment and as an inhibitor of trafficking beyond this compartment.  
I also examined localization and Vn-ROMK processing in the vps8Δ CORVET mutant. 
In this strain, Vn-ROMK is primarily present in the ER with little to no vacuolar signal (Figure 
18A,B). Furthermore, although the free Venus species accumulates in this background, its levels 
are reduced relative to the isogenic wild-type strain (Figure 18C). In some vps8Δ cells, I 
observed Vn-ROMK accumulating in small puncta near the outer margin of the cell (Figure 18B, 
white arrows). These results are in accordance with reduced vacuolar delivery in the vps8Δ strain 
and are in line with localization patterns observed for native yeast substrates in this genetic 
background (Luo and Chang, 2000). 
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Figure 18: Venus-tagged ROMKK80M (Vn-ROMK) vacuolar trafficking is arrested in 
ESCRT-deficient yeast and reduced in CORVET-deficient yeast. Epifluorescence live cell 
images of the indicated yeast strains co-expressing Venus-ROMKK80M (Vn-ROMK) and the ER-
resident protein Scs2-mCherry (Scs2-mCh). B. Epifluorescence live cell images of the indicated 
yeast strains expressing Vn-ROMK are shown and were treated with the styryl dye FM4-64 for 
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at least 30 min prior to imaging in order to stain the endosomal and vacuolar membranes. C. 
Western blot analysis of lysates from yeast of the indicated genetic backgrounds expressing Vn-
ROMK or untagged ROMK1K80M, or containing an empty expression vector was performed 
using the indicated antibodies. The Venus epitope migrates as three bands: full length Vn-
ROMK (whole), a partially degraded species (clipped), and free Venus (free-Vn). The blot was 
stripped and reprobed with an antibody against the ROMK C-terminus to show the relative 
expression of untagged ROMK1K80M (ROMK) and Vn-ROMK. All unlabeled bands are due to 
non-specific antibody binding (compare to lane 1 “vec”). G6PD is also shown as a loading 
control. D. Epifluorescence live cell images of yeast co-expressing Vn-ROMK and Snf7-RFP. 
For all images, a direct interference contrast (DIC) image is shown at right. The white scale bar 
measures 5 µm. White arrows indicate features of interest as described in the text. 
2.3.5 ESCRT and CORVET deplete ROMK from the plasma membrane in HEK293 cells 
Given that components in the trafficking and degradation machineries in the late secretory 
pathway are conserved between yeast and humans, I next asked whether depleting the levels of 
select components that function in this pathway increases the steady-state distribution of ROMK 
at the plasma membrane in human cells. To answer this question, I reduced the levels of HGS 
(sole homologue of yeast Vps27), TSG101 (sole homologue of Vps23), and VPS8 (sole 
homologue of Vps8) in HEK293 cells that stably express wild-type ROMK1 under the control of 
an inducible promoter. Next, ROMK at the plasma membrane was biotinylated, captured on 
beads, and quantified via Western blot with anti-ROMK antibodies. Robust suppression of 
TSG101, HGS, and VPS8 protein levels was achieved by siRNAs-mediated knockdown. 
Moreover, silencing each of these components increased the steady-state levels of ROMK1 at the 
plasma membrane (Figure 19A). I noted that both immature and mature glycosylated ROMK 
were biotinylated, as previously reported (Fallen et al., 2009), and that is likely a consequence of 
ROMK overexpression in these cells. As controls for this experiment, I found that the Na+/K+ 
ATPase α-subunit, ATP1A, was also biotinylated, but its cell surface expression was unchanged 
upon knockdown of the ESCRT or CORVET subunits (Figure 19A). In turn, the abundant 
cytosolic protein, Hsp90, was not biotinylated. Similar results were obtained when this 
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experiment was repeated with a second set of siRNA oligonucleotides (data not shown). As in 
yeast, ROMK1 residence in this cell line is primarily intracellular with only a small 
subpopulation resident at the plasma membrane. This is evidenced by the low ratio of 
biotinylated protein to total relative to that of ATP1A (Figure 19A). Accordingly, I was unable to 
visualize a plasma membrane population of ROMK via immunofluorescence microscopy as the 
protein appeared primarily confined to the ER (data not shown). 
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Figure 19: Depletion of select ESCRT and CORVET components increases ROMK surface 
expression in HEK293 cells. A. Lysates from HEK293 cells expressing ROMK under the 
control of the doxycycline-inducible “T-REx” promoter were examined by anti-ROMK 
immunoblot in toto (left) or were surface biotinylated and precipitated with NeutAvidin beads 
(right). ROMK migrates as two bands: an (i) immature ER-glycosylated band at ~45 kDa and 
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(m) a larger maturely glycosylated species of ~55-65 kDa (75). All blots were stripped and 
reprobed for cytosolic Hsp90 and plasma membrane-enriched ATP1A to show accurate loading 
and selective biotinylation of only cell surface proteins. An empty lane between the total and 
biotinylated samples was cropped out as indicated by the line. Quantitation of change in cell 
surface ROMK normalized to total protein for each replicate is shown below. Cell lysates from 
all siRNA-targeted factors were blotted on separate membranes to show efficient knockdown. 
Silencing for nine experimental replicates led to a decrease of 63 ± 4.7% for TSG101, 71 ± 4.3% 
for HGS, and 55 ± 5.1% for VPS8. *indicates p<0.05 (Student’s t-test). B,C. HEK293 cells 
expressing ROMK under the control of the doxycycline-inducible “T-REx” promoter were 
pretreated with the lysosomal protease inhibitor Leupeptin (B) or MG132 (C) (closed circles), or 
vehicle (open circles) for 1 hour prior to cycloheximide addition. Samples were harvested at the 
indicated times. ROMK expression was assessed by Western Blot and normalized to the initial 
timepoint. For this figure, only the upper mature band (m) was quantitated. Representative blots 
are shown and all blots were stripped and reprobed for actin as a loading control. Data represent 
the means of three independent experiments. Error bars show standard errors of the mean and 
*indicates a significant (p<0.05) difference as assessed by Student’s t-test. 
 
 
 
To examine if ROMK1 was primarily degraded in the lysosome in HEK293 cells, I then 
performed a cycloheximide chase analysis in the presence or absence of the lysosomal protease 
inhibitor, leupeptin in collaboration with Dr. Paul Welling and Bo-Young Kim of the University 
of Maryland Medical School, Baltimore. As shown in Figure 19B, the addition of leupeptin 
reduced the rate of ROMK1 degradation relative to the vehicle control. However, treatment with 
MG132 had no observable effect on ROMK stability (Figure 19C), indicating that ERAD played 
a minimal role in degrading ROMK1 in HEK293 cells. These effects were observed for both the 
mature (m) and immature (i) ROMK species (data not shown). It is important to emphasize that 
wild type ROMK1 was used in these experiments since the ROMK1S44D+K80M derivative was 
only needed in yeast to overcome defects in its trafficking/regulation (also see Section 2.4, 
below). Nevertheless, these data indicate that ROMK1 degradation in mammalian cells is 
primarily lysosomal and also utilizes the ESCRT and CORVET complexes to deplete ROMK 
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from the cell surface. Thus, the yeast-based expression system identified evolutionarily 
conserved trafficking components that influence the biogenesis of human potassium channels in 
a human kidney-derived cell line. 
2.4 DISCUSSION 
Surface expression of the ROMK channel in the distal nephron is physiologically downregulated 
in states of dietary potassium deprivation by clathrin-dependent endocytosis to safeguard against 
deleterious potassium loss and to maintain potassium homeostasis (Zeng et al., 2002; Al-Qusairi 
et al., 2017). My studies identify components of the trafficking machinery that may underlie a 
highly regulated pathway that determines whether internalized channels recycle to the surface or 
are targeted for degradation in the lysosome. Indeed, my genetic screen in yeast revealed that 
trafficking components involved in endosomal sorting and trafficking act as negative regulators 
of ROMK. Particularly noteworthy ROMK regulators included the CORVET subunits Vps3 and 
Vps8, the ESCRT subunits Vps27, Vps23, Vps36, Vps20, and Snf7. Knockdown of the sole 
human homologues of Vps23, Vps27, and Vps8 increased density of ROMK at the plasma 
membrane of HEK293 cells, indicating that negative regulators identified in the yeast screen are 
also relevant in human cells (Figure 19A).  
To explain how inhibition of ESCRT and CORVET genetic components increases 
ROMK plasma membrane residency, I propose the following model (Figure 20). Deletion or 
silencing of ESCRT, CORVET, and other endosomal sorting factors shifts the equilibrium of 
cargo sorting at early endosomes to favor increased recycling of ROMK to the plasma 
membrane. Evidence for this model is provided by the abrogation of ROMK function in a yeast 
strain lacking both an ESCRT component and a recycling component (Figure 16Figure 16C). It 
is likely that deletion or silencing of different components produces the same phenotype through 
different mechanisms, as divergent recycling pathways originate from different endosomal 
populations (van Weering and Cullen, 2014; MacDonald and Piper, 2016). Indeed, the 
subcellular localization of Venus-tagged ROMK differs dramatically between yeast strains 
lacking ESCRT and CORVET components (Figure 18), despite similar ROMK function in these 
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strains (Figure 12). With the exception of the end3Δ strain, increased ROMK activity is unlikely 
due to non-specific inhibition of endocytosis, as deletion of ESCRT and CORVET components 
do not perturb the rate of endocytosis (Luo and Chang, 2000; Wiederkehr et al., 2001). 
 
 
Figure 20: Model of proposed roles for ESCRT and CORVET in ROMK post-endocytic 
regulation. After endocytosis, ROMK (grey cylinders) accumulates in early endosomes. The 
hexameric CORVET complex (dotted circles, “Vps” gene numbers indicated) tethers post-
endocytic Rab5-positive vesicles to promote their fusion and maturation into early endosomes. 
ESCRT proteins (dashed circles, complexes 0, I, II, and III) recognize ubiquitinated ROMK and 
sequester the channel into intra-lumenal vesicles in late endosomes/multi-vesicular bodies. These 
late endosomes eventually mature and fuse with lysosomes in mammalian cells or vacuoles in 
yeast, where ROMK is degraded. 
 
 
 
The initial screen of the yeast knockout collection uncovered hits in diverse biological 
pathways, such as endosomal trafficking, mitochondrial function, and translational regulation. I 
chose to exclude several factors from further analysis as they had been previously identified to 
act independently of any exogenous potassium channel by altering sensitivity to toxic cations 
(Barreto et al., 2011). It is possible that the disruption of chromatin remodeling factors such as 
the RSC complex may phenocopy endosomal trafficking mutants by reducing transcription of 
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key trafficking components or by affecting cytoskeletal organization (Chai et al., 2002). As 
endosomal trafficking is an important determinant of a protein’s plasma membrane residency, I 
chose to focus on trafficking factors. Notably, at least one member each of the four ESCRT 
complexes—ESCRT-0, ESCRT-I, ESCRT-II, and ESCRT-III—was identified as a hit in the 
initial screen and confirmed by de novo strain construction. The first three ESCRTs act 
sequentially to identify ubiquitinated cargo for recruitment to inwardly-budding membrane 
invaginations, while ESCRT-III acts as the primary membrane deforming complex that drives 
intra-lumenal vesicle (ILV) formation (Henne et al., 2013). The ESCRT-0 subunit Vps27 binds 
ubiquitinated cargo, as does the ESCRT-I subunit Vps23 (Babst, 2005). The ubiquitin-binding 
subunit of ESCRT-II, Vps36, was also identified in my screen, but as a weaker hit. Since these 
ubiquitin binding subunits are themselves ubiquitinated, ESCRT is able to recognize both mono- 
and polyubiquitinated cargoes (Stringer and Piper, 2011). Most ESCRT substrates in yeast are 
ubiquitinated by the Nedd4 homologue Rsp5 (Erpapazoglou et al., 2012) (Guiney et al., 2016), 
which I also found contributes to ROMK1S44D+K80M degradation (Figure 16Figure 16B) in 
accordance with the well-characterized role of Nedd4 in regulating ROMK in the kidney in 
response to fluctuations in dietary potassium (Ronzaud et al., 2013; Al-Qusairi et al., 2017). 
Another E3 ligase that acts in the late secretory pathway in yeast, Pib1, can complement Rsp5 
activity for some substrates (Shin et al., 2001; Nikko and Pelham, 2009; Kampmeyer et al., 
2017). Further study is needed to determine how these respective ligases affect ROMK1 
ubiquitination and degradation in the yeast system. 
CORVET is a hexameric Rab5-positive vesicle tethering complex consisting of six 
distinct subunits. Four of these subunits, Vps11, Vps16, Vps18, and Vps33, are also components 
of the HOPS complex found on Rab7-positive vesicles (Balderhaar et al., 2013). Recent 
structural studies have shown that these tethering complexes adopt a disordered and highly 
flexible conformation that coalesces into a tightly ordered structure upon Rab GTPase binding 
(Bröcker et al., 2012; Chou et al., 2016; Murray et al., 2016). Both of the Rab5-binding subunits 
that are unique to CORVET, Vps8 and Vps3, were identified in this study as negative regulators 
of ROMK plasma membrane residence in yeast. Consistent with these data, Vps8 knockdown in 
mammalian cells increased cell surface expression of ROMK (Figure 12). Strikingly, neither the 
CORVET/HOPS shared subunits nor the HOPS Rab7-binding subunits were identified as hits in 
my screen. One model for these data is that CORVET acts upstream of a critical and as yet 
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uncharacterized sorting step for ROMK (Figure 20). It is also possible that blocking HOPS-
mediated tethering arrests ROMK trafficking after it has been packaged into intra-lumenal 
vesicles by ESCRT and Vps4, at which point its degradative fate is sealed. Trivially, HOPS 
function may simply be more tolerant of the loss of individual subunits than CORVET. In 
addition to binding Rab5, Vps8 also contains a RING E3 ubiquitin ligase domain, which is 
necessary for tethering (Horazdovsky et al., 1996). However, no specific clients for Vps8-
ubiquitination have been found. Therefore, Vps8 ubiquitination may be redundant with other E3 
ligases acting at endosomes, notably Rsp5 and Pib1 (see above), yet the CORVET-interacting 
early endosomal SNARE, Pep12, was also identified as a negative regulator of ROMK. These 
results lead me to hypothesize that CORVET negatively regulates ROMK by promoting 
endosome maturation and fusion with lysosomes. To my knowledge, my work represents the 
first study to genetically link CORVET to the regulation of a specific, clinically relevant cargo, 
as most mechanistic studies of CORVET have utilized synthetic substrates (Galmes et al., 2015).  
Other trafficking related genes identified as negative regulators of ROMK include the 
Golgi-localized SNARE GOS1, and the Retromer encoding factors VPS5 and VPS35. The genes 
were also identified as negative regulators of Kir2.1 (Kolb et al., 2014). Retromer is a membrane 
remodeling complex that facilitates cargo retrieval from endosomes either to the plasma 
membrane or the trans-Golgi network and is generally conceived of as being a “pro-recycling” 
component, thereby acting in opposition to ESCRT-mediated MVB sorting (Burd and Cullen, 
2014). Based on this activity, it is difficult to envision how Retromer functions as a negative 
regulator of ROMK. However, it is possible that Retromer promotes futile cycling between 
endosomes and the Golgi, and that a sub population of ROMK is freed and recycled to the 
plasma membrane through alternative pathways in Retromer mutants. In fact, select cargo have 
been found in multiple model systems to be enriched at the plasma membrane upon Retromer 
inhibition (Dang et al., 2011; Xia et al., 2013; Choy et al., 2014). 
ROMK may follow a similar trafficking itinerary to that described for the Jen1 lactate 
permease (Becuwe and Léon, 2014). In this study, the authors demonstrated that endocytosed 
Jen1 traffics from endosomes back to the Golgi in a Retromer-dependent fashion before 
transiting back to the endosome and entering the MVB pathway. In this way, Retromer 
ultimately stimulates protein degradation by promoting the MVB-vacuolar trafficking of cargo 
proteins. If ROMK follows a similar route, then internalized ROMK would migrate from 
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endosomes back to the Golgi in a Retromer dependent fashion, but only as a prequel to ROMK 
trafficking to the MVB-vacuole for degradation. 
The results from this study expand upon previous work from the lab with another inward-
rectifying potassium channel, Kir2.1 (Kolb et al., 2014). Surface expression of both channels was 
suppressed by many of the same components, identifying the late secretory pathway as a key 
inhibitory trafficking step for inward rectifying potassium channels. Notably, both channels were 
primarily ER-localized, with only very small sub-populations detectible at the plasma membrane 
via sucrose gradient analysis (Kolb et al., 2014) (Figure 15A,B). ROMK and Kir2.1 share 42% 
sequence identity, though neither protein has predicted homology with any endogenous yeast 
protein (data not shown). Therefore, the yeast trafficking and post-ER degradation machineries 
may be largely unable to distinguish between the two channels. Nevertheless, I observed some 
subtle differences. In particular, I found that Kir2.1 increased growth rescue better than ROMK1 
in all examined cases. I speculate that this is most likely due to stronger inward rectification of 
Kir2.1 (Choe et al., 1999; Hibino et al., 2010), allowing more potassium influx for growth. In 
contrast, the fact that select genes identified in this study were absent in the prior screen with 
Kir2.1 may have resulted from a higher signal to noise ratio due to differences in conductance 
properties between ROMK and Kir2.1. 
The genetic screen described in this report required the use of a non-physiological variant 
of ROMK1, ROMK1S44D+K80M, which contains the phosphomimetic S44D mutation to override 
an ER-localization signal (Yoo et al., 2005) as well as the K80M mutation to allow ROMK to 
access its open conformation in the acidic yeast cytosol (Rapedius et al., 2007a; Paynter et al., 
2010). My work indicates that the K80M mutation is more important than the S44D mutation in 
promoting ROMK-mediated rescue on low potassium medium when expressed in the trk1Δ 
trk2Δ strain (Figure 6A). Although I was initially unable to detect a plasma membrane 
population of ROMK1S44D+K80M by either sucrose density gradient fractionation (Figure 7C) or 
epifluorescence microscopy (data not shown), a minor fraction of plasma membrane 
ROMK1S44D+K80M was found in end3Δ yeast in which endocytosis is impaired (Figure 14B). 
Furthermore, rescue of growth on low potassium media correlates directly with increased 
intracellular potassium (Figure 7B). This result indicates that ROMK1S44D+K80M–mediated 
growth rescue is due to increased potassium influx. Together, it is likely that yeast require only 
small amounts of ROMK1S44D+K80M at the plasma membrane to achieve sufficient potassium 
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influx to both increase intracellular potassium and allow growth on low potassium media. These 
data are consistent with the reported high Po for ROMK (Choe et al., 1999). 
An unforeseen but advantageous consequence of the K80M mutation was that the 
channel was more ERAD resistant than wild-type ROMK1 in yeast (Figures 6B, 11B,D,F). The 
Lys-80 side chain is predicted by homology modeling to face the intrasubunit interface of the 
two transmembrane α-helices and acts as a pH-sensitive gate by hydrogen-bonding with the 
backbone carbonyl of A177 (Rapedius et al., 2007a).. K80M causes a pronounced acidic shift in 
ROMK gating, while the reciprocal mutation in Kir2.1 (M84K) introduces an alkaline shift in pH 
gating (Fakler et al., 1996). While K80 is necessary for acid-sensitivity, occurring at a 
paralogous position in the other acid-sensitive channels Kir4.x and Kir5.1 but not in the other 
human Kir channels, it is not sufficient as ROMKK80M still exhibits some low pH gating 
(Rapedius et al., 2006). A current model to explain pH sensitivity in Kir channels holds that pH-
titratable residues are critical for stabilization of the open channel conformation and that pH 
sensitivity cannot be wholly divorced from channel opening. Accordingly, single mutations that 
cause an acidic shift in ROMK gating are rare, while those that cause an alkaline shift are quite 
common (Rapedius et al., 2006). In addition, Kir4.1 homotetramers and Kir4.1/5.1 
heterotetramers exhibit different degrees of acid sensitivity, indicating that the “pH sensor” is 
likely composed of multiple residues (Rapedius et al., 2007b).  
It is possible that wild-type ROMK1 residing in the low pH cytosol in yeast is in a closed 
state that is prone to misfolding, which targets the protein for ERAD. In contrast, the 
ROMK1S44D+K80M derivative may be more stable in this environment as the K80M mutation 
destabilizes the closed state of the channel (Rapedius et al., 2007a). Indeed, Dr. Brighid 
O’Donnell and I recently reported that ROMK1S44D+K80M is less susceptible to in vitro proteolysis 
than wild-type ROMK1 (Figure 6C), and that trafficking-incompetent mutations in ROMK 
associated with Type II Bartter syndrome destabilize the channel and restore ERAD targeting of 
ROMK1S44D+K80M (O’Donnell et al., 2017b). It is also noteworthy that neither wild-type ROMK1 
nor ROMK1S44D+K80M could rescue growth of potassium-sensitive yeast lacking the ER-resident 
E3 ubiquitin ligase Doa10 (Figure 21), indicating that inhibiting ERAD is insufficient to promote 
the forward trafficking of ROMK in yeast. Future studies may wish to examine if the other two 
mutations known to cause an acidic shift in ROMK gating—I63R and S172T—also decrease 
ERAD of ROMK in yeast (Schulze et al., 2003; Paynter et al., 2010). 
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Figure 21: Deletion of ERAD E3 ubiquitin ligase Doa10 does not enhance growth of 
potassium sensitive yeast expressing ROMK1S44D+K80M. Yeast strains with the indicated 
genotypes transformed with an empty expression vector control or vectors engineered to express 
Kir2.1, wild-type ROMK1, or ROMK1S44D+K80M were serially diluted onto medium 
supplemented with the indicated amounts of KCl.  Images were captured after two days of 
growth at 30°C.  All experiments were performed in duplicate, and representative assays are 
shown. 
 
 
 
The properties of ROMK1S44D+K80M in yeast are analogous to those of wild-type ROMK1 
in mammalian cells, as both are primarily substrates for vacuolar/lysosomal degradation 
(compare Figure 10B to Figure 19B). Future studies of ROMK in budding yeast should at 
minimum include the K80M mutation to ensure that the results will be translatable into 
mammalian systems. 
In mammalian cells engineered to inducibly express ROMK1, only a small quantity of 
the channel resides at the plasma membrane. This necessitated the use of cell surface 
biotinylation to reproducibly detect it (Figure 19A) as indirect immunofluorescence could only 
detect an intracellular—primarily ER—ROMK signal (data not shown). The increased cell 
surface population observed upon silencing of ESCRT and CORVET components might be 
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further clarified by more efficient knockdown using an siRNA SmartPool or by construction of 
dedicated gene knockout cell lines via CRISPR. Furthermore, visualization of the plasma 
membrane ROMK population might be accomplished by immunofluorescence conducted 
without plasma membrane permeabilization or by total internal reflection fluorescence (TIRF) 
microscopy. Neither method was pursued in this study as the former would require an 
extracellular epitope that the R79 anti-ROMK antibody would not recognize (Wade et al., 2011) 
while the latter requires a fluorescent protein-tagged variant of ROMK.  
In conclusion, I have identified key machinery involved in post-endocytic quality control 
of ROMK. My findings build upon related work on the inwardly-rectifying potassium channel 
Kir2.1 (Kolb et al., 2014), the calcium-gated potassium channel KCa3.1 (Balut et al., 2012), and 
the voltage-gated potassium channel hERG (Guo et al., 2009; Apaja et al., 2013), adding ROMK 
to a growing list of channels and transporters regulated by post-endocytic transport (Apaja and 
Lukacs, 2014). Previous studies of ROMK in yeast focused instead on the identification of 
ROMK-interaction partners from human cDNA libraries via the yeast two-hybrid method 
(Bundis et al., 2006; Renigunta et al., 2011a). My report instead represents the first attempt to 
use a genome-wide screen for negative regulators of ROMK by directly assessing ROMK 
function in trk1Δ trk2Δ yeast.  
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3.0  CONCLUSIONS AND FUTURE DIRECTIONS 
In this section, I will describe how my work advances scientific understanding of ROMK 
regulation as well as how it fits into the fields of protein trafficking and quality control. I will 
also propose experiments stemming from my work that might guide future research in the 
Brodsky lab. 
3.1 SIGNIFICANCE OF THIS STUDY 
Prior work on the role of protein trafficking in regulating ROMK has focused on ER export and 
endocytosis. My work is the first to establish post-endocytic trafficking as a mechanism for 
ROMK degradation.  
3.1.1 Known roles of trafficking in ROMK regulation 
ROMK is a classic example of an ion channel that must be activated or deactivated through 
protein trafficking, as gating mechanisms for ROMK are only applicable under conditions of 
cellular stress. As noted throughout chapter 2, ROMK is steeply gated by low intracellular pH, 
which may be an adaptation to preserve potassium upon metabolic acidosis. pH gating appears to 
be tied to its PKA phosphorylation state, and may simply be a mechanism for keeping the 
dephosphorylated channel closed (Leipziger et al., 2000). Conversely, ROMK channels in the 
TAL are gated by high intracellular ATP, though this appears to be due to their association with 
CFTR (an ABC transporter) as ROMK expressed in the absence of CFTR is not ATP-gated (Yoo 
et al., 2004). This may reflect an adaptation to open the channel under conditions of Na+/K+ 
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ATPase stimulation, as occurs following a high potassium meal because the activity of the 
sodium-potassium pump is a major determinant of intracellular ATP concentration (Welling and 
Ho, 2009). It is unknown to what extent these gating mechanisms regulate ROMK in vivo. In 
contrast, protein trafficking is widely accepted as the primary means to regulate ROMK (Figure 
22). 
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Figure 22: Visual summary of known regulatory mechanisms for ROMK in the distal 
nephron. Increases in bloodstream potassium cause depolarization of the basolateral membrane 
in the distal nephron, setting off a WNK-mediated signaling cascade that activates NCC in the 
distal convoluted tubule (DCT) and ROMK in the cortical collecting duct (CCD). Other known 
regulatory mechanisms are shown as applicable. Abbreviations not described in text: 
Nuc=nucleus, EE=early endosome, Ls=lysosome. 
 
 
 
ROMK contains a C-terminal RXR motif and is thus largely retained within the ER. ER 
export of ROMK is stimulated by channel phosphorylation at one N-terminal and two C-terminal 
serines. Two kinases are known to be involved in regulating ER retention: protein kinase A 
(PKA) and serine glucocorticoid kinase-1 (SGK1) (McNicholas et al., 1998; Yoo et al., 2003). 
SGK1 is transcriptionally upregulated by the mineralocorticoid hormone aldosterone, which is 
known to stimulate potassium excretion from the distal nephron. For a time, aldosterone 
signaling was believed to be the primary driver of ROMK apical expression, however recent 
evidence suggests that ROMK is not directly regulated by aldosterone and that upregulation of 
ROMK can occur in animals completely insensitive to aldosterone signaling (Todkar et al., 
2015). Therefore, the currently favored model is that the distal nephron is capable of directly 
sensing dietary potassium and stimulating or repressing ROMK endocytosis accordingly (Boyd-
Shiwarski and Subramanya, 2017). 
Cells in the distal nephron tubule also express potassium channels at their basolateral 
surface. These channels, Kir4.1/5.l, allow for electroneutral chloride reabsorption into the blood 
via the chloride channel ClC-KB (Hennings et al., 2017). As these channels are also inward 
rectifiers, they are exquisitely sensitive to small changes in plasma potassium. A spike in plasma 
potassium will depolarize the basolateral membrane, thereby inhibiting chloride reabsorption 
(Cuevas et al., 2017). An increase in intracellular chloride represses the “with-no-lysine” (WNK) 
kinases, which serve as master regulators of renal sodium/potassium balance (Kahle et al., 2008; 
Shekarabi et al., 2017).  
With-no-lysine is a misnomer, as the lysine in the kinase domain of the WNKs is simply 
in an unconventional orientation that inactivates the kinase domain upon binding intracellular 
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chloride (Piala et al., 2014). This unique regulatory mechanism allows WNK activation by 
changes in membrane voltage, allowing cells to mount a rapid response to changes in electrolyte 
balance. WNK1 and WNK4 are both expressed in the distal nephron and regulate ROMK 
function through a two-pronged mechanism. First, in the distal convoluted tubule (DCT), which 
expresses the sodium-chloride cotransporter (NCC)—but neither ROMK nor the epithelial 
sodium channel (ENaC)—WNK kinases phosphorylate SPAK, which in turn phosphorylates and 
activates NCC (Figure 22). Increased sodium reabsorption in the DCT results in less sodium 
delivery to the downstream CCD, thus hyperpolarizing the CCD apical membrane and 
stimulating ROMK (Terker et al., 2015). Second, both WNK1 and WNK4 promote ROMK 
endocytosis in the CCD.  
ROMK residence at the plasma membrane is known to be regulated by clathrin-mediated 
endocytosis (CME) (Zeng et al., 2002). Apical membrane ROMK is recruited to clathrin-coated 
pits (CCPs) by the scaffold protein ARH, which binds both ROMK and the clathrin adaptor 
complex AP-2 (Fang et al., 2009). ARH is polyubiquitinated by the E3 ligase complex 
CUL3/KLHL3, targeting it for proteasomal degradation; however, ARH phosphorylation by 
WNK1 or WNK4 antagonizes ARH ubiquitination (Paul Welling, personal communication). 
CUL3/KLHL3 also polyubiquitinate WNKs, promoting their turnover by the proteasome 
(Shibata et al., 2013). Finding the upstream regulators of this E3 ligase complex is an active area 
of investigation.  
Both WNK1 and WNK4 are downregulated in response to dietary potassium loading. 
WNK4 is inactivated by SGK1 phosphorylation (Ring et al., 2007), which in turn is inactivated 
by the known osmoregulatory kinase c-Src (Lin et al., 2015). WNK1 is expressed as two 
isoforms: the full-length or “long” isoform (L-WNK1) expressed throughout the kidney and in 
other tissues, and the shorter “kidney-specific” isoform, which is unique to the distal nephron. 
KS-WNK1 lacks a kinase domain, but inhibits L-WNK1 function by mediating reversible 
sequestration of WNK1 and related kinases into liquid-liquid phase-separated “WNK bodies” 
(Boyd-Shiwarski et al., 2018).  
 Ubiquitination has long been known to negatively regulate ROMK surface abundance 
(Lin et al., 2005), though the identity of the E3 ligases responsible is not entirely clear. Nedd4-2 
(a homologue of yeast Rsp5) is an abundant E3 ligase in the distal nephron with well-established 
roles in promoting endocytosis and lysosomal degradation of various substrates (Tardiff et al., 
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2013). While Nedd4-2 promotes degradation of ENaC, NCC, and WNK1 (Rotin and Staub, 
2011; Al-Qusairi et al., 2016, 2017), thus affecting renal salt handling, it is uncertain whether 
Nedd4-2 directly ubiquitinates ROMK. Nedd4-2 recognizes (L/P)PXY motifs, which are present 
in ENaC, NCC, and WNK1, but not in ROMK. Therefore, if Nedd4-2 ubiquitinates ROMK, it 
will require an intervening adaptor protein, such as an α-arrestin (Becuwe et al., 2012) (also see 
Appendix B).  However, POSH, a RING-domain E3 ligase, has been shown to directly 
ubiquitinate and promote the lysosomal degradation of ROMK in the CCD (Lin et al., 2009), yet 
it is uncertain whether POSH acts at the plasma membrane or in endosomes. 
3.1.2 Endosomal sorting as a previously uncharacterized mechanism of ROMK 
regulation 
The vast majority of ROMK studies have examined the channel in its native context of the 
mammalian nephron or more commonly in heterologous expression systems. Yeast are neither 
kidneys nor kidney-derived cells and therefore lack much of the signaling machinery described 
in the previous section, but consequently the yeast model provides an opportunity to answer 
specific questions about the default pathways that regulate ROMK protein trafficking and quality 
control. Apart from the experimental pliability mentioned in Chapter I, the yeast system affords 
us the opportunity to ask which mechanisms dominate ROMK regulation in a minimal cellular 
system. Specifically, my research has implicated the protein trafficking pathway as a major 
regulator of ROMK. Silencing of ESCRT and CORVET components in mammalian cells also 
increases ROMK surface expression, suggesting that a key regulatory decision for this channel 
occurs in endosomes, rather than in the ER or at the plasma membrane. 
An endocytosed protein is by no means doomed to degradation, as various mechanisms 
alter the kinetics of recycling endocytosed material to the plasma membrane or degrading a 
substrate via the ESCRT/MVB pathway. For example, some plasma membrane proteins contain 
sorting motifs that target them to specific sorting pathways after endocytosis, but the default 
pathway for most endocytosed proteins is recycling (van Weering and Cullen, 2014). However, 
ubiquitination strongly shifts the sorting equilibrium towards degradation as specific components 
in ESCRT recognize this modification (Shields and Piper, 2011). Post-endocytic sorting is well-
established as a regulatory mechanism for many other membrane proteins, including ion 
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channels such as CFTR (Sharma et al., 2004; Okiyoneda et al., 2018), hERG (Apaja et al., 
2013), KCa2.3 (Gao et al., 2010), and Kv1.1 (Seebohm et al., 2007). My work represents the first 
demonstration of ESCRT-mediated regulation of ROMK.  
While ubiquitination promotes ROMK lysosomal degradation (Lin et al., 2005), it is 
unclear whether ubiquitination occurs at the plasma membrane to promote endocytosis or in the 
endosome to promote sorting into MVBs. I hypothesize that ROMK ubiquitination occurs after 
endocytosis due to the following lines of evidence: 1) The non-enzymatic scaffolding protein 
ARH is sufficient to promote CME of ROMK as it binds directly to both clathrin and to an 
NPXY internalization motif in the C-terminal domain of ROMK (Fang et al., 2009); 2) POSH, 
the only E3 ligase known to ubiquitinate ROMK in the distal nephron (see above), appears to act 
downstream of dynamin scission (i.e. the final step in CME) (Lin et al., 2009); 3) POSH is 
localized primarily at early endosomes rather than the plasma membrane (Kim et al., 2006). 
Similarly, another endosome-localized E3 ligase, RFFL, was recently shown to promote 
ubiquitination and degradation of endocytosed ΔF508-CFTR (Okiyoneda et al., 2018); 4) The 
Welling and Staub groups have gathered evidence that an endosome-localized transmembrane 
Nedd4 adaptor, NDFIP1, promotes lysosomal degradation of ROMK (Paul Welling, personal 
communication). In accordance with these unpublished data, I found that the yeast NDFIP1 
homologue, Bsd2, negatively regulates ROMK function in trk1Δ trk2Δ yeast (Figure 13B) and 
that the Nedd4-2 homologue Rsp5 facilitates ROMK1S44D+K80M degradation (Figure 16B).  
3.1.3 Limitations of this study 
It is important to highlight several limitations of this work, which are important to consider in 
light of my discoveries. Such considerations may also direct future efforts in which the yeast 
system is used to screen for effectors of potassium channel biogenesis. 
First, which factors control the balance of ROMK recycling and degradation from 
endosomes? Is the process stochastic or is it under regulatory selection? This study falls short of 
answering such questions as the major findings implicate only the machinery of endosomal 
sorting rather than a high-level regulator such as an E3 ligase. The heterology between yeast and 
mammals is significant, and many proteins known to regulate ROMK in the kidney—such as 
ARH or the WNK kinases—lack obvious yeast homologues. Additional research is needed to 
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determine how cellular signaling pathways might alter the kinetics of ROMK recycling and 
degradation. As mentioned above, the role of ubiquitin in determining this equilibrium should be 
pursued. 
Second, although the SGA screen conducted in this study ultimately produced verifiable 
results that were reproducible in mammalian cells (chapter 2), there are several caveats to this 
technique that bear mention. The raw data from the study were measurements of yeast growth on 
solid media, which are readily saturable and not necessarily linear. I have shown that increased 
growth positively correlates with increased cellular potassium through ICP-MS (Figure 6B), but 
this approach is hardly adaptable to high-throughput analysis. An alternative approach that lends 
itself better to precise quantitation would be to devise a colorimetric intracellular potassium 
sensor that would allow precise measurement of ROMK-mediated potassium uptake via a plate 
reader or FACS sorter. Dr. Jerod Denton’s group has devised such a scheme for use with 
mammalian cells that utilizes a thallium-sensitive dye (Tl+ is known to readily transit potassium 
channels) (Raphemot et al., 2013). In addition, a genetically encoded fluorescent protein-based 
intracellular potassium sensor that is active over a wide range of potassium concentrations and is 
non-toxic was recently described (Bischof et al., 2017). 
Third, the use of trk1Δ trk2Δ yeast for the screen precluded any two-tail analysis of hits 
as this system—at least under the conditions in which I performed my screen—cannot detect 
mutants which cause decreased growth on low potassium media. Given that ROMK function is 
linked to hypertension and there is strong interest by academic and industrial research groups to 
identify ROMK inhibitors (see Section 1.2.1), a yeast screen to identify novel positive regulators 
of ROMK could yield valuable insight. Such a screen might be feasible using ena1-4Δ nha1Δ as 
a query strain (Bañuelos et al., 1998) (section 1.1.2). 
Fourth, although many gene networks in multicellular eukaryotes are generally simpler in 
yeast (for example, yeast have 11 Rab GTPase genes while humans have over 60 (Stenmark and 
Olkkonen, 2001)), the yeast genome is rife with paralogues due to an ancestral genome 
duplication (Kellis et al., 2004). This can make single gene analysis problematic as one 
paralogue is often able to completely functionally substitute when its counterpart is deleted. 
Consequently, screens in which single mutants are analyzed will—by definition—miss 
functionally redundant genes 
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Fifth, the lore among researchers who have utilized the yeast knockout collection is that 
about 10-20% of the genes are incorrectly annotated. I certainly found this to be the case in my 
own endeavors to confirm the genotype of strains of interest (data not shown). In addition, due to 
the highly compact genome of S. cerevisiae, the knockout collection suffers from the 
“neighboring gene effect” whereby a phenotype ostensibly attributable to an annotated deletion 
is in fact due to a loss of function of another gene nearby on the chromosome (Ben-Shitrit et al., 
2012). It is also worth noting that some gene deletions give rise to profound compensatory 
effects at the chromosomal level. In a recent example, deletion of a gene that plays a role in 
ERAD led to a duplication of a functionally similar but non-homologous gene in another region 
of the genome, resulting in dosage-dependent suppression of the desired mutant phenotype (Neal 
et al., 2018).  
Finally, the decision to recreate hits from the initial SGA screen via mating and tetrad 
dissection was a response to difficulties in reproducing many initial hits from the screen (data not 
shown). This vexing phenomenon led to eventual abandonment of several initially exciting hits 
(see Appendix C). Poor screen reproducibility is a recognized problem in the SGA community 
(Giaever and Nislow, 2014), but in my case, I believe that the use of trk1Δ trk2Δ as a query strain 
may have exacerbated the problem. This strain exhibits well-characterized growth defects even 
on high potassium medium (Navarrete et al., 2010) and the long growth times involved in SGA 
methods may have driven a rate of phenotypic suppression higher than otherwise expected. Ideas 
to resolve some of these known pitfalls in future genetic screens are described in the next 
section. 
3.2 FUTURE DIRECTIONS 
I am currently conducting a random mutagenesis screen to identify and characterize intragenic 
gain-of-function mutations in ROMK, which is being assessed by increased growth of trk1Δ 
trk2Δ yeast on low potassium medium. This project is described in detail in Appendix A of this 
document. If I were advising an incoming graduate student on potentially exciting research 
opportunities related to my work, I would recommend the following lines of inquiry. 
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3.2.1 Short term future directions 
A lingering question from my work is the specific role played by ubiquitination and individual 
E3 ligases in the regulation of ROMK degradation. Monoubiquitination is established as a 
mechanism for negative regulation of ROMK in mammalian kidneys (Lin et al., 2005) My work 
has implicated the ER-localized E3 ligases Hrd1 and Doa10 in degradation of wild-type 
ROMK1, but not of ROMK1S44D+K80M, in yeast (Figure 11C,D). In contrast, ROMK1S44D+K80M 
degradation is dependent on the post-ER quality control E3 ligase Rsp5, while wild-type 
ROMK1 is not (Figure 16Figure 16A,B). I also tested the degradation of wild-type ROMK1 and 
ROMK1S44D+K80M in yeast deleted for the Golgi-localized E3 ligase Tul1 and the endosome-
localized E3 Pib1, which have been shown to regulate the residence and degradation of select 
membrane proteins in yeast (Shin et al., 2001; Reggiori and Pelham, 2002), but found no 
evidence for altered degradation (data not shown). 
It would be fairly simple to test whether or not ROMK variants are ubiquitinated in yeast 
by immunoprecipitating ROMK from yeast lysate and immunoblotting for ubiquitin (for recent 
examples from our group, see (Kolb et al., 2014; Ye et al., 2017). However, analysis of these 
assays can be difficult as yeast have over 60 predicted E3 ligases (as a point of contrast, humans 
encode ~600), many of which have redundant client sets (Finley et al., 2012). In principle, one 
might expect to detect an E3 ligase bound to ROMK through co-immunoprecipitation, however 
such E3-client associations are often transient and low-affinity. Some groups have approached 
this problem by making ubiquitination-proof substrates that lack all lysines, however this method 
is laborious and very likely to deleteriously affect protein folding and/or function. An alternate 
approach is to inactivate the active site in an E3, which may facilitate substrate capture. In 
contrast, the Piper lab has devised a method for connecting E3 ligases with clients that does not 
rely on gene deletions or genetic ablation. Fusing a protein of interest to a non-specific 
deubiquitinating peptidase (DUb) from herpes virus renders that protein effectively 
nonubiquitinable (Stringer and Piper, 2011). They have also constructed a library of dominant 
negative DUb-E3 fusion proteins that not only abrogate the ubiqutinating activity of their wild-
type counterpart, but also of any other E3 ligases with overlapping client sets (MacDonald et al., 
2017). Screening this library for dominant negative E3-ligases that alter ROMK ubiquitination as 
assayed by immunoprecipitation would likely isolate functionally dominant ligases. The effect of 
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these ligases on ROMK degradation kinetics could then be assessed by cycloheximide chase. If 
endosomal sorting is, in fact, the predominant mechanism of ROMK1S44D+K80M regulation in 
yeast, I would expect that DUb-E3 fusions that abrogate ROMK degradation would also have a 
phenotype similar to ESCRT mutant strains: increased potassium uptake and defective sorting 
into the vacuolar lumen (Figures 6,12,18). 
If Rsp5 is shown to be a predominant factor in ROMK endosomal sorting and 
degradation, it will require an adaptor protein as an intermediate. Rsp5 has a very particular 
client set defined by the (L/P)PXY consensus motif (Belgareh-Touzé et al., 2008), which ROMK 
lacks. The transmembrane endosomal Rsp5 adapter Bsd2 seems like a promising candidate as 
deleting it causes increased growth on low potassium (Figure 13) and work from the Staub and 
Welling labs has shown that a human homologue of Bsd2, NDFIP1, also negatively regulates 
ROMK. It would be interesting to test whether ROMK ubiquitination is decreased in bsd2Δ yeast 
or in yeast expressing a Bsd2-DUb fusion. 
Other Rsp5 adaptors that could conceivably regulate ROMK are the α-arrestins. These 
cytosolic adaptor proteins regulate a variety of yeast nutrient permeases in response to 
environmental changes (Lin et al., 2008; O’Donnell, 2012; O’Donnell et al., 2013). There are 
nine α-arrestins expressed in yeast, many with overlapping client sets, and most with an obvious 
paralogue resulting from whole genome duplication (Nikko and Pelham, 2009). Despite their 
highly specialized role in controlling the yeast plasma membrane proteome, Dr. Allyson 
O’Donnell has shown that overexpression of specific α-arrestins increases Kir2.1 function and 
plasma membrane residence in yeast (Appendix B, O’Donnell et al., JBC, in revision). This is a 
remarkable result given that yeast do not express any inward-rectifying potassium channels. Key 
experiments from Dr. O’Donnell’s study could be easily replicated with ROMK1S44D+K80M given 
that ROMK and Kir2.1 share 42% primary structure identity. In addition, α-arrestins are 
expressed in mammalian cells and it would be worthwhile to test whether knockdown or 
overexpression of mammalian α-arrestins affects ROMK surface expression using the ROMK-
inducible HEK 293 cell line (Figure 19). 
While the trk1Δ trk2Δ and ena1-4Δ nha1Δ strains have been traditionally used to study 
potassium channel function, there is in principle no reason why they could not be adapted to 
study other families of exogenous disease-related ion channels. The ena1-4Δ nha1Δ strain seems 
particularly amenable to this as it exhibits high sensitivity to all alkali metals (Bañuelos et al., 
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1998). My colleague Dr. Teresa Buck has published several papers on using yeast to identify 
pro-degradative factors for the epithelial sodium channel (ENaC) (Buck et al., 2013, 2017; 
Kashlan et al., 2018), however our group has been unable to devise a phenotypic assay for ENaC 
function. In principle, such an assay would test for decreased growth on high sodium of ENaC-
expressing ena1-4Δ nha1Δ yeast. This would enable a number of studies using yeast to screen for 
novel regulators of an ion channel functionally and structurally unrelated to any potassium 
channel. Current efforts toward this goal are underway in collaboration with Dr. Buck. 
3.2.2 Long term future directions 
As previously mentioned, there are 15 inward-rectifying potassium channels expressed in 
humans, and thus far only two, ROMK and Kir2.1, have been analyzed in yeast SGA screens. 
Other Kir channels that might benefit from such an analysis include Kir3.2 (GIRK2), which has 
been tied to epilepsy and intellectual disability in Down’s syndrome (Rachidi and Lopes, 2007), 
and Kir4.1, a renal Kir channel expressed on the basolateral surface of distal nephron epithelium 
that senses changes in blood potassium (Cuevas et al., 2017). Kir4.1 in the kidney forms mixed 
channels in a 2:2 stoichiometric ratio with Kir5.1 (Paulais et al., 2011), distinguishing it from the 
homomeric Kir channels described thus far. 
 Recent advances in yeast genetic technology may allow future SGA screens to avoid 
issues of low reproducibility when working with a “sick” query strain such as trk1Δ trk2Δ. 
“Traditional” SGA screens on solid medium are now routinely performed by specialized robotic 
manipulators, which analyze each library strain in quadruplicate. This helps correct for 
suppressor mutations and experimental artifacts as it is unlikely that such random events would 
affect all four replicates equally. Data analysis for automated manipulations is also greatly 
streamlined (Wagih et al., 2013). In addition, advances in DNA sequencing technology enabled 
SGA screens to be conducted in liquid medium. For example, a version of the yeast knockout 
collection in which each deletion cassette is marked with a unique DNA barcode is pooled and 
mated with a query strain to generate a library containing every possible gene deletion. This 
strain collection is then transferred into permissive and selective liquid growth medium, aliquots 
are withdrawn periodically, and the relative growth rates of the deletion strains in the pool are 
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determined by quantitative PCR targeting the deletion barcodes (Pierce et al., 2007). This 
approach allows for more quantitative ranking of growth rates than analysis of images from solid 
growth media, which instead relies on image processing that is inexact and easily saturable.  
 Another approach to deal with growth defects in the trk1Δ trk2Δ SGA query strain would 
be to redesign it to have inducible rather than constitutive knockout of one or both TRK genes. In 
this experimental design, expression of the native potassium transporters would be normal during 
the process of array construction and then suppressed just before the final transfer onto 
permissive and selective media. This approach is common in multicellular eukaryotes in which 
constitutive knockouts are often lethal or induce compensatory effects that confound analysis. 
There are a number of techniques for controlled repression of a protein in yeast, including 
repressible promoters such as GAL4 or the Tet-off system as well as directly targeting mature 
proteins via the auxin-inducible degron system (Nishimura et al., 2009).  
 Whether protein multimerization is rate limiting for transport from the ER is an important 
and generally open question in both the ion channel biology and the ER proteostasis fields. Ion 
channels are known to vary greatly in their propensity to multimerize. Some channels 
multimerize co-translationally, as evidenced by fully assembled Kv1.3 channels associated with 
ribosomes (Lu et al., 2001), while others appear to multimerize only after translation and 
translocation is complete, as evidenced by specialized C-terminal domains that mediate 
multimerization in retinal rod cells (Zhong et al., 2003). Multimeric ion channels assemble 
inefficiently upon in vitro translation, suggesting that multimerization requires a distinct set of 
extrinsic factors (Papazian, 1999). Indeed, hERG and its paralogues require specialized 
transmembrane chaperones that are conserved from nematodes to humans to mediate channel 
multimerization (Li et al., 2017). Furthermore, post-translational assembly of heterogenous 
subunits has been proposed as a regulatory mechanism for the functionally heterotrimeric 
channel ENaC (Butterworth et al., 2008).  
 Multiprotein complexes must correctly and completely assemble prior to ER exit. ERAD 
has been shown to degrade “orphaned” subunits of large ER protein complexes such as the 
oligosaccharyl-transferase (OST) complex (Mueller et al., 2015). When mutations in a functional 
multimeric protein increase targeting for ERAD, they may do so by affecting either monomer 
folding or multimer assembly. ROMK tetramerization appears to involves several sites of 
intersubunit contact involving the N- and C- termini as well as the transmembrane helices 
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(Koster et al., 1998). A few functionally important residues that mediate intersubunit contact 
have been identified (Leng et al., 2006), and it is currently unknown if any Bartter syndrome-
associated mutations interfere with tetramerization. To test whether or not a residue is involved 
in tetramerization, a mutant subunit and a wild-type subunit tagged with different epitopes could 
be co-expressed and co-immunoprecipitated under non-denaturing conditions. In addition, 
multimerization could be directly observed by immunoprecipitation followed by native PAGE or 
by resolution of tetramers and monomers on a size exclusion column (see for example (Preston 
et al., 2018)). In addition to ROMK, the renal Kir4.1/5.1 channel would be a good candidate for 
studying multimerization as it forms an obligate heterotetramer  
 The ER chaperones that mediate hERG tetramerization, DNAJB12 and DNAJB14, are 
transmembrane proteins containing a cytosolic J-domain (Li et al., 2017). It is currently 
unknown whether these or other J-proteins promote tetramerization of any Kir channels. J-
domains are known to act as Hsp70 cochaperones by increasing Hsp70’s substrate specificity 
and kinetics of substrate binding and release. There are 41 J-proteins in the human genome, 
exhibiting great functional and structural divergence (Kampinga and Craig, 2010). A small scale 
siRNA screen targeting these J-proteins in ROMK-expressing HEK 293 cells using the 
colorimetric thallium uptake assay developed by the Denton lab as a functional readout 
(Raphemot et al., 2013) would determine whether or not any of them had a role in ROMK 
tetramerization.  
 Ultimately, renal ion channels and transporters are best understood in the context of the 
mammalian kidney. The use of the Tet-on Cre-Lox recombinase system expressed only in 
specific nephron segments has enabled inducible knockout or modification of many components 
of the ROMK regulatory pathway (e.g. (Todkar et al., 2015; Grimm et al., 2017)). Using such a 
system to knockdown a component of CORVET and ESCRT in the distal nephron of adult mice 
would likely induce hypokalemia due to ROMK overactivation at the apical membrane. While 
laborious, such a system would undoubtedly serve as an ultimate proof-of-principle implicating 
endosomal sorting in ROMK regulation. 
 The work presented herein focuses almost exclusively on ROMK1, however future 
studies should validate whether endosomal sorting also regulates ROMK2. Aside from their 
different tissue expression patterns (section 1.2.1 and Figure 4), the two isoforms display 
different subcellular localization patterns in their respective cell types. In rodent kidneys, 
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ROMK2 is invariantly localized to the apical plasma membrane of TAL cells while ROMK1 is 
confined to the ER of CCD cells unless the animal is challenged with a high potassium diet (Yoo 
et al., 2005; Renigunta et al., 2011b). This disparity between the two isoforms puzzles 
researchers as the two isoforms differ by only a 19 amino acid N-terminal extension present in 
ROMK1 but absent in ROMK2. These 19 amino acids do not contain any obvious linear sorting 
motifs nor do they alter electrophysiological properties. Two hypotheses spring to mind: either 
the extra 19 amino acids in ROMK1 promote its ER retention through an as yet uncharacterized 
mechanism, or the different cellular itineraries of the two isoforms arise from trans-acting 
regulatory factors that may be active in the TAL but not the CCD or vice versa. To distinguish 
between these two possibilities, future studies should attempt to disrupt only the exon of KCNJ1 
encoding the ROMK1 N-terminal extension while leaving the rest of the gene intact, effectively 
forcing expression of ROMK2 in the CCD. If the 19 additional amino acids of ROMK1 are a cis-
acting factor that promotes ER retention, I would hypothesize that replacing ROMK1 with 
ROMK2 in the CCD would cause strong apical surface expression of ROMK leading to 
potassium wasting and hypokalemia.   
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APPENDIX A 
A SCREEN FOR ROMK GAIN-OF-FUNCTION MUTATIONS 
This project was developed in collaboration with undergraduate researcher Jackson Parr and 
graduate rotation student Nga (Katie) Nguyen, both with my supervision and mentorship. This 
project is ongoing and this appendix represents its status as of March 2018.  
A.1 INTRODUCTION 
Hypertension is the greatest single cause of human mortality worldwide (Murray and Lopez, 
2013). While many environmental and lifestyle factors have been linked to hypertension, the 
condition is commonly known to run in families and its heritable contribution is estimated at 30-
60% (Kupper et al., 2006). Due to the diversity and complexity of signaling pathways and organ 
systems that modulate blood pressure, heritable hypertension is presumably highly polygenic. 
The salt-handling channels and transporters of the distal nephron are prime regulators of 
extracellular fluid volume and blood pressure. Loss of function mutations known to cause Bartter 
syndrome and Gitelman syndrome in the genes encoding NKCC2, NCC, and ROMK are 
associated with a mild decrease in blood pressure in heterozygous individuals (Ji et al., 2008). 
This is likely due to decreased distal nephron sodium reabsorption via NKCC2 and ENaC in 
these individuals, leading to a reduction in blood volume and pressure that nevertheless falls 
within the healthy range. 
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If a loss-of-function mutation in ROMK lowers blood pressure, it follows that a gain-of-
function mutation in ROMK will increase blood pressure. These mutations might be part of a 
cadre of polymorphisms that synergize to increase the risk of hypertension; however, when the 
effects of each mutation are considered in isolation they may lie below threshold of detection. 
Due to this presumed uncertainty, there is no reliable way to predict whether a polymorphism in 
ROMK identified by genome-wide association studies (GWAS) causes gain-of-function. 
Conversely, we know which polymorphisms cause loss-of-function because they have been 
identified in patients with the monogenic trait Type II Bartter Syndrome. Therefore, an 
experimental approach to identify gain-of-function mutations in ROMK would be a great asset in 
identifying the genetic factors responsible for heritable hypertension.  
Random mutagenesis screens in trk1Δ trk2Δ yeast offer a straightforward approach to 
identifying gain-of-function mutations in ROMK or other Kir channels (see section 1.1.5). In 
collaboration with two junior researchers, I designed and implemented such a screen for 
ROMK1K80M. I decided to perform the screen in the presence of the K80M mutation as a prior 
random mutagenesis screen had been frustrated by an overwhelming bias for that particular 
amino acid substitution (Paynter et al., 2010). This is undoubtedly due to the salubrious effect of 
deleting the pH gate on ROMK function in yeast (see section 2.3.1, Figure 6, 7). 
A.2 MATERIALS AND METHODS 
All yeast were propagated at 30oC as previously described (section 2.2.1). ROMK1K80M in the 
yeast expression vector pRS415 (O’Donnell et al., 2017b; Mackie et al., 2018) under the control 
of the TEF1 promoter and the CYC1 terminator (Mumberg et al., 1995) was amplified by PCR 
with Go-Taq DNA polymerase (Promega, Madison, WI) for 35 cycles according to the 
manufacturer’s instructions. The oligonucleotides were used to guarantee ~100 bp of homology 
to the pRS415 backbone upstream and downstream of the ROMK ORF to facilitate yeast gap 
repair. Taq (Thermophilus aquaticus) DNA polymerase has an estimated error rate of 1 in 
2.28x10-5. Therefore, the number of cycles was chosen to favor an average of one error per 1.4 
kbp amplicon. After PCR, the amplicons were purified from an agarose gel to remove any 
 106 
template DNA. In parallel, the pRS415 vector containing the TEF1 promoter and the CYC1 
terminator, but lacking an ORF, was restriction digested with Fast Digest BamHI and XhoI 
(Thermo) per the manufacturer’s instructions. Linearized vector and mutagenized cassette were 
transformed into trk1Δ trk2Δ yeast using a slightly modified lithium acetate transformation 
protocol (Ito et al., 1983) in which the yeast were rotated overnight at room temperature after the 
addition of PEG and the cells were treated with 10% ethanol during the last 5 min of heat shock. 
Transformed yeast were grown for three days at 30oC on SC-leu medium supplemented with 100 
mM KCl. They were then replica plated onto SC-leu medium supplemented with 100, 25, 10, 
and 0 mM KCl. After two days of incubation at 30oC, any colonies observed to be growing 
robustly on both the 10 and 0 mM plates were restruck for further analysis. Plasmids were 
isolated from these cell by lysing them with glass beads followed by a Qiagen mini-prep. The 
plasmids were then transformed into chemically competent E. coli, re-isolated, and transformed 
into naïve trk1Δ trk2Δ yeast. These yeast were then arrayed in a serial dilution assay as 
previously described (section 2.2.1). Clones able to reproducibly rescue trk1Δ trk2Δ growth on 
low potassium medium were analyzed by Sanger sequencing (GENEWIZ, South Plainfield, NJ).  
A.3 RESULTS AND DISCUSSION 
To generate a library of gain-of-function ROMK mutants, ROMK1K80M was amplified with 
error-prone PCR and transformed into trk1Δ trk2Δ yeast along with a linearized expression 
vector to facilitate gap repair (Weir and Keeney, 2014). Putative gain-of-function clones were 
confirmed by purification and retransformation of trk1Δ trk2Δ yeast (Figure 23C).  
After four independent iterations of the mutagenesis protocol, we identified identical 
mutations in multiple independent clones, indicating that the screen is nearly saturated. We 
estimate the incidence of gain-of-function clones at 0.92%, assuming an average error rate of one 
per amplicon. These data indicate that the acquisition of a gain-of-function mutation is a rare 
event and likely confined to select amino acids. However, it is possible that the GoTaq PCR error 
rate is higher than the published value. Further study is needed to determine whether or not we 
have achieved our targeted error rate.  
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The mutations identified thus far are summarized in Table 7 and Figure 23A, including 
several in the HA tag. Although the tag does not appear to interfere with channel conductance in 
Xenopus oocytes (Yoo et al., 2003), it is possible that the tag interferes with channel function in 
yeast, and that the mutations suppress this activity. In the future, the mutations will be introduced 
in untagged ROMK1K80M in yeast. It is also possible that the tag inhibits transport to the plasma 
membrane, and the mutations similarly suppress this activity. These future experiments should 
be straightforward as I have validated that the ROMK R79 antibody is competent for Western 
analysis of yeast lysate (Figure 18C). 
 
Table 7: Gain-of-function mutations in ROMK. Nucleotide and amino acid level changes in 
ROMK1K80M leading to increased growth on low potassium medium. All numberings are given 
for untagged ROMK1. Mutations in the HA tag are numbered separately starting from the N-
terminal diglycine linker. “Linkage” indicates that the mutation was identified in the context of 
another mutation. * indicates also identified in Paynter et al. 2010.  † indicates found in human 
populations via GWAS. 
 
 
Nucleotide 
Change 
Amino Acid 
Change 
Domain # of 
Clones 
Linkage 
T35C L12P N-terminal 1 S305G 
T302C V101A Extracellular Pore 1  
a1g g1r HA-tag 1  
a8g y3c HA-tag 6  
t13c y5h HA-tag 3  
A338G Y113C* Extracellular Pore 4  
C352T R118C Extracellular Pore 2  
G367A E123K Extracellular Pore 1  
T405C S135P Extracellular Pore 1 Y113C 
G419A V140M* Extracellular Pore 1  
T725C I242T IgLD 1 D245G 
A734G D245G IgLD 1 I242T 
T831C F278L IgLD 1  
A913G S305G IgLD 1 T35C 
T983C I328T C-terminal† 3  
A1027G N343D C-terminal 3  
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Given that the HA tag is inserted between residues F112 and Y113 in the native sequence, it is 
likely that the HA y3c and native Y113C mutations have equivalent effects. Along with the 
nearby R118C alteration, the extracellular gain-of-function mutations may possess novel 
disulfide bonds which increase channel activity. Analysis of a ROMK homology model indicates 
that these substituted cysteines are most likely to form an intramolecular disulfide with C121 
(Figure 23B). To test this hypothesis, we will substitute C121 to alanine in the context of Y113C 
and R118C and analyze whether or not the gain-of-function phenotype reverts.  
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Figure 23: ROMK gain-of-function mutations and relative phenotypes. A. Homology model 
of ROMK based on KirBac3.1 from Magnetospirillum magnetotaceticum showing a single 
 110 
monomer with residues mutated in gain-of-function alleles rendered in orange. L12P and N343D 
are not pictured as the template protein lacks homology to the corresponding ROMK sequence. 
B. Close-up of external pore domain showing a potential novel disulfide bridge between Y113C 
or R118C and native C121 (green). Renderings created in PyMol (v.1.8.6). C. Yeast strains with 
the indicated genotypes transformed with an empty expression vector control or vectors 
engineered to express Kir2.1, wild-type ROMK1, ROMK1K80M, or the indicated gain-of-function 
mutations in the context of K80M were serially diluted onto medium supplemented with the 
indicated amounts of KCl.  Images were captured after two days of growth at 30OC. 
 
 
 
The N343D mutation in the unstructured C-terminal region of ROMK is in a region 
known to harbor several trafficking motifs, including the RxR ER-retention motif (residues 379-
381) and the NPxΦ endocytosis motif (residues 388-391). It is possible that this mutation 
increases the plasma membrane expression of the channel by inhibiting ER retention and/or 
endocytosis from the plasma membrane.  
A previous screen for ROMK gain-of-function mutations was only able to identify the 
well-studied acid desensitizing mutation K80V (Paynter et al., 2010). In this published study, the 
authors performed a similar screen using a ROMK1-Kir4.1 chimera consisting of the N-terminus 
and transmembrane-pore domains of ROMK1K80M fused to the C-terminal domains of Kir4.1. 
Two of the gain-of-function mutations we identified—Y113C and V140M—were also found in 
this previous screen, however the authors of this study did not perform any subsequent 
experiments other than testing their effect on pH gating. Only one of their isolated mutants—the 
conservative S172T—was found to measurably decrease pH gating. It is also likely that these 
authors were unable to screen full-length ROMK as their growth medium was buffered to a near 
neutral pH of 6.5, whereas the medium used in our study is considerably more acidic (pH~4.5). 
Acidic media increase the sensitivity of trk1Δ trk2Δ yeast to low potassium, providing the 
necessary signal-to-noise ratio to perform genetic screens. Paynter and colleagues observed near 
complete growth rescue of trk1Δ trk2Δ growth with ROMK1K80(M/V) and Kir2.1 on limiting 
potassium (Paynter et al., 2010), which we do not observe on our acidic medium (Figure 6). 
These seemingly trivial technical differences have provided us with an advantage over this 
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previous work. This has allowed us to identify novel mutations, including several in the C-
terminal domain that were excluded from the previous study.  
Analysis of the Trans-Omics for Precision Medicine (TOPMed) database—a repository 
of known human genetic variation collated from numerous GWAS—indicates that the I328T 
mutation has been identified in at least one individual. The absence of the other mutations could 
be due to purifying selection if they are extremely deleterious, or more trivially due to the limited 
subset of the human population that has been captured by whole exome sequencing. 
A.4 FUTURE DIRECTIONS 
In principle, a gain-of-function mutation may affect one of three broad channel attributes: open 
probability, conductance, and plasma membrane residence. To test gain-of-function mutation 
effects on protein stability, the mutations will be recreated in wild-type ROMK1 by site-directed 
mutagenesis and stability will be assessed by cycloheximide chase analysis. Addition of MG132 
will determine if gain-of-function ROMK is degraded by the proteasome. To test the effect of 
gain-of-function mutations on plasma membrane residency, yeast expressing these mutants will 
be analyzed by indirect immunofluorescence microscopy.  
As several of the mutations cluster near the selectivity filter, it is possible that they alter 
the permeability of ROMK to monovalent cations other than potassium. Indeed, mutations in the 
sequence flanking the selectivity filter of KAT1 have been shown to alter conductance of sodium 
and cesium (section 1.1.5) (Nakamura et al., 1997). To test this effect in budding yeast, relevant 
gain-of-function mutants will be expressed in ena1-4Δ nha1Δ yeast and growth will be assessed 
on medium supplemented with several concentrations of lithium, sodium, potassium, and 
cesium.  
Taq-polymerase has a strong bias for transition over transversion mutations, and indeed 
all of the mutations identified in this study are transitions. PCR kits optimized for unbiased 
mutagenesis are available and repeating this screen with such a kit may reveal previously 
undiscovered gain-of-function mutations. Transversion polymorphisms are less common in the 
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human genome, particularly in protein-coding regions, but are often more consequential due to 
the degeneracy of the genetic code.  
To determine the effects of these mutations on channel conductance, selectivity, and 
rectification, we have partnered with Drs. Thomas Kleyman and Shaohu Sheng of the University 
of Pittsburgh School of Medicine to perform two-electrode voltage clamp (TEVC) on Xenopus 
oocytes expressing these mutants. Briefly, in vitro transcribed ROMK mRNA will be injected 
into oocytes. ROMK activity is determined by measuring barium-sensitive whole-cell 
transmembrane conductance. 
If a gain-of-function mutation is found to consistently increase ROMK function in 
multiple heterologous expression systems, it would seem prudent to make a knock-in mouse 
expressing gain-of-function ROMK in their distal nephron. I hypothesize that these mice would 
be at minimum hypertensive and hypokalemic and they may also exhibit hypernatremia that 
responds to amiloride treatment due to ENaC overactivity. 
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APPENDIX B 
DETECTING INWARD RECTIFYING POTASSIUM CHANNELS AT THE PLASMA 
MEMBRANE 
This project was spearheaded by Dr. Allyson O’Donnell of Duquesne University: an expert in 
yeast α-arrestins. As of this writing, a report on the major findings is in revision at the Journal of 
Biological Chemistry. 
B.1 INTRODUCTION 
The proteins of the plasma membrane are the primary means by which a living cell interfaces 
with its environment. Cells endocytose plasma membrane proteins in response to signaling, 
misfolding, environmental changes, or changes in cellular needs. α-arrestins are trafficking 
adaptors conserved throughout eukaryotes. They are the base of a clade that includes β-arrestins, 
which are best known for their roles in GPCR trafficking (Kang et al., 2013). In contrast, yeast 
α-arrestins couple substrates destined for endocytosis with the E3 ubiquitin ligase Rsp5 (Lin et 
al., 2008; Nikko and Pelham, 2009; O’Donnell, 2012; Becuwe and Léon, 2014).  
α-arrestins client selection is both promiscuous and redundant. As Kir channel plasma 
membrane residency has a clear phenotypic profile (i.e. increased growth of trk1Δ trk2Δ yeast on 
low potassium medium), we sought to determine if yeast α-arrestins can recognize and regulate 
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mammalian Kir channels. Initially, this project encompassed both ROMK1S44D+K80M and Kir2.1, 
but came to focus exclusively on Kir2.1. 
In most of the α-arrestin literature, fluorescent protein-tagged amino acid permeases have 
been used as model substrates. These proteins have a clear plasma membrane distribution when 
α-arrestin activity is suppressed and a clear vacuolar distribution when α-arrestins are actively 
mediating their endocytosis (e.g. (Guiney et al., 2016)). Mammalian Kir channels, however, are 
primarily observed to colocalize with ER markers when expressed in yeast (Figure 18A) (Kolb et 
al., 2014; O’Donnell et al., 2017b; Mackie et al., 2018). The yeast cortical ER is tethered to the 
plasma membrane, making quantitative assessment of the relative ER and PM populations of a 
protein by fluorescent microscopy a dubious prospect (Manford et al., 2012). Fortunately, the 
research groups of Drs. Christopher Szent-Gyorgyi, Marcel Bruchez, and Alan Waggoner at 
Carnegie Mellon University have designed a fluorescence protein tagging technology that is 
rapidly inducible, non-toxic, and can discriminate surface-exposed and intracellular populations 
of membrane proteins. Briefly, the tag was developed by fusing a single-chain antibody (SCA) 
cDNA library to the yeast plasma membrane protein Aga2 and expressing this library in yeast 
(Feldhaus et al., 2003). Clones were selected by FACS for their affinity for the fluorescent dyes 
malachite green (MG) and thiazole orange (TO). Next, the dye molecules were chemically 
modified to render them cell permeant or impermeant. The final product was a fluorogen-
activated peptide (FAP) that may be appended to a protein of interest. Cells expressing FAP-
tagged proteins are then treated with permeant or impermeant variants of the dyes, which 
increase in fluorescent intensity several thousand-fold upon FAP binding (Szent-Gyorgyi et al., 
2008).  
As both termini of Kir channel proteins are cytosolic, an additional transmembrane 
domain derived from platelet-derived growth factor receptor (PGFR) was added to the N-
terminus of Kir2.1 to ensure that the FAP would face the extracellular surface. To ensure that 
FAP-Kir2.1 would be also inserted into the membrane in the correct orientation, an N-terminal 
signal sequence derived from the yeast ER-lumenal chaperone Kar2 was also added. My primary 
contribution to the project was to validate that the activity and stability of FAP-Kir2.1 was 
comparable to the untagged channel. To this end, I measured the ability of FAP-Kir2.1 to support 
the growth of trk1Δ trk2Δ yeast grown on low potassium medium. I also determined the stability 
and aggregation propensity of FAP-Kir2.1 relative to its untagged counterpart. These studies 
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have validated FAP technology as a novel method for detecting very small cell surface 
populations of a protein of interest. 
B.2 MATERIALS AND METHODS 
All serial dilution assays, cycloheximide chases, and Western blots were performed as previously 
described (section 2.2.1).  
ER-enriched microsomes were prepared from yeast expressing either Kir2.1 or SCA-
Kir2.1 using the previously described “small scale” protocol (Nakatsukasa and Brodsky, 2010).  
A total of 1.5 μL of microsomes at an OD600 of approximately 0.2 was added to 30 μL of PBS 
containing 250 mM sorbitol along with the indicated concentrations of n-dodecyl-β-D-maltoside 
(DDM; EMD Millipore, Billerica, MA) or SDS.  Samples were agitated on a Vortex mixer for 5 
seconds, incubated on ice for 30 min, and centrifuged at 18,000 g for 10 min at 4oC.  The soluble 
fraction was transferred to a new tube and the supernatant and pellet (insoluble) samples were 
incubated with SDS-PAGE sample buffer prior at room temperature for one hour prior to SDS-
PAGE and Western Blot analysis. 
B.3 RESULTS AND DISCUSSION 
Dr. O’Donnell found that the subcellular distribution of FAP-Kir2.1 matches what has been 
previously reported for the wild-type protein (Kolb et al., 2014). To test if FAP-Kir2.1 could 
form a functional potassium channel after expression in yeast. I introduced the expression vector 
into trk1Δ trk2Δ vps35Δ yeast as Vps35 had been previously identified as a negative regulator of 
Kir2.1 (Kolb et al., 2014). Compared to wild-type Kir2.1, FAP-Kir2.1 mediates poorer growth 
rescue on low potassium medium, though it is still well above the vector control (i.e., the 
background) (Figure 24A). I hypothesized that the addition of the exogenous SCA and TMD 
might destabilize the protein and cause increased targeted for protein quality control. Indeed, 
FAP-Kir2.1 was aggressively degraded in a proteasome-dependent manner, while its wild-type 
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counterpart was minimally degraded over the course of a 90 min cycloheximide chase (Figure 
24B,C). Furthermore, I showed that this decreased stability correlates with an increased 
propensity of FAP-Kir2.1 to aggregate into detergent (DDM)-resistant inclusions relative to wild-
type Kir2.1 (Figure 24D,E). Taken together, these data indicate that the FAP tag combined with 
the exogenous TMD from PGFR are not benign and destabilize the protein when expressed in 
yeast. Nonetheless, enough protein is able to escape ER protein quality control to function at the 
plasma membrane as a potassium channel in yeast. Dr. O’Donnell further confirmed this 
conclusion by demonstrating via ICP-MS that FAP-Kir2.1 facilitates and increase in intracellular 
potassium in trk1Δ trk2Δ vps35Δ yeast (O’Donnell et al, 2018, In Revision).  Together, these 
results show that FAP-tagging represents a promising tool for resolving the dilemma of imaging 
small populations of a protein at the plasma membrane in yeast.  
I have also constructed a FAP-tagged version of ROMK1S44D+K80M that is analogous to 
FAP-Kir2.1. The function of FAP-Kir2.1 was validated with the same experiments described 
above. Like FAP-Kir2.1, FAP-ROMK1S44D+K80M is less stable than its untagged counterpart 
(Figure 25), but still forms a functional channel in potassium uptake-deficient yeast (data not 
shown). Future studies of ROMK in budding yeast may benefit from this sensitive and precise 
molecular tool. 
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Figure 24: FAP-tagging Kir2.1 reduces channel function and protein stability. A. Yeast 
strains with the indicated genotypes transformed with an empty expression vector control or 
vectors engineered to express Kir2.1 or FAP-Kir2.1were serially diluted onto medium 
supplemented with the indicated amounts of KCl.  Images were captured after two days of 
growth at 30OC. B,C. Yeast cultures expressing HA-tagged versions of either (B) Kir2.1 or (C) 
FAP-Kir2.1 grown to mid-logarithmic phase were treated with MG132 (closed circles) or DMSO 
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(open circles) for 30 min, dosed with cycloheximide, and aliquots were withdrawn at 0, 30, 60, 
and 90 minutes. Kir2.1 expression was assessed by Western Blot and normalized to the initial 
timepoint. Representative blots are shown and all blots were stripped and reprobed for glucose-6-
phosphate dehydrogenase (G6PD) as a loading control. Data represent the means of three 
independent experiments. Error bars show standard errors of the mean and *indicates a 
significant (p<0.05) difference as assessed by Student’s t-test. D,E. ER-enriched microsomes 
from yeast engineered to express Kir2.1 (D) or FAP-Kir2.1 (E) were treated with the indicated 
concentrations of DDM and then centrifuged to separate the soluble supernatant (S) from the 
insoluble pellet (P). The native yeast integral membrane protein Sec61 was used as a loading 
control. 
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Figure 25: Appending the FAP tag to ROMK1S44D+K80M increases ERAD of the protein. 
Yeast cultures expressing HA-tagged versions of either (A) ROMK1S44D+K80M or (B) FAP-
ROMK1S44D+K80M grown to mid-logarithmic phase were treated with MG132 (closed circles) or 
DMSO (open circles) for 30 min, dosed with cycloheximide, and aliquots were withdrawn at 0, 
30, 60, and 90 minutes. ROMK expression was assessed by Western Blot and normalized to the 
initial timepoint. Representative blots are shown and all blots were stripped and reprobed for 
glucose-6-phosphate dehydrogenase (G6PD) as a loading control. Data represent the means of 
three independent experiments. Error bars show standard errors of the mean and *indicates a 
significant (p<0.05) difference as assessed by Student’s t-test. Part A is identical to Figure 6B. 
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APPENDIX C 
HSP90 IS A POTENTIAL NEGATIVE REGULATOR OF ROMK 
The following work is neither published nor being considered for publication as of this writing. It 
is, however, potentially of interest to the research community, so I have briefly summarized it 
here. 
C.1 INTRODUCTION 
Hsp90s are a major molecular chaperone in eukaryotic cells that serves to buffer the disordered 
components of the eukaryotic proteome (Karras et al., 2017). The action of his conserved and 
abundant chaperone is coordinated with Hsp70s and Hsp90s are generally believed to function as 
“late-acting” chaperones, targeting proteins that have misfolded into states refractory to Hsp70 
activity (Taipale et al., 2010). In addition to their role in protein quality control, Hsp90s are also 
key regulators of protein kinases and steroid hormone receptors, and facilitate the assembly of 
large multi-protein complexes (McClellan et al., 2007; Makhnevych and Houry, 2012).  
I became interested in Hsp90s upon identifying the Hsp90 co-chaperone Sse1 as a strong 
hit in the SGA screen (see Appendix D). However, upon de novo recreation of the trk1Δ trk2Δ 
sse1Δ strain, there was no increased growth mediated by exogenous potassium channels in this 
strain background when propagated on low potassium medium (data not shown). Furthermore, 
ROMK degradation was unaffected in multiple verified sse1Δ strains when examined by 
cycloheximide chase analysis (data not shown). However, upon investigating ROMK 
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degradation kinetics in a yeast strain expressing a temperature-sensitive variant of Hsp90, I 
found that ROMK was modestly stabilized at the non-permissive temperature. This encouraged 
me to investigate whether Hsp90 played a role in regulating ROMK stability in mammalian cells. 
I found that inhibiting Hsp90 in HEK 293H cells transfected with a ROMK1 expression vector 
greatly increased steady-state protein levels.  
C.2 MATERIALS AND METHODS 
All cycloheximide chases and Western blots were performed as previously described (section 
2.2.3).   
 HEK293H cells cultured as previously described (2.2.6) were transformed with HA-
tagged ROMK1 in pcDNA3.1 (O’Donnell et al., 2017b) with Lipofectamine 2000 (Invitrogen) 
per the manufacturer’s instructions. The cells were then treated with the indicated quantities of 
Tanespimycin (17-allylamino-17-demethoxygeldanamycin) for 24 hours. The cells were washed 
twice with DPBS and then detached with PBS. They were lysed for 30 minutes with PBS 
containing 1% Triton X-100 and a protease inhibitor cocktail (Roche). Lysate protein 
concentrations were determined with a BCA colorimetric assay per the manufacturer’s 
instructions prior to SDS-PAGE and Western analysis. 
C.3 RESULTS AND DISCUSSION 
Yeast express two nearly identical isoforms of Hsp90: Hsp82 and Hsc82. To ascertain if Hsp90 
is a pro-degradative factor for ROMK in yeast, I performed cycloheximide chases in hsp82Δ 
hsc82Δ yeast expressing either wild-type Hsp82 or the temperature-sensitive G313N allele 
(Nathan and Lindquist, 1995). I observed a modest, but reproducible reduction in ROMK 
degradation in the Hsp90 mutant strain (Figure 26A). 
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Figure 26: Hsp90 inhibition increases ROMK expression in yeast and mammalian cells. A. 
Yeast strains containing either a temperature sensitive mutation in the gene encoding Hsp82 
(hsp82-G313N, filled circles) or lacking the mutant allele (HSP82) expressing wild-type 
ROMK1 were shifted from room temperature to 37OC for 30 min before addition of 
cycloheximide. For all experiments, ROMK expression was assessed by Western Blot and 
normalized to the initial timepoint. Representative images are shown and all blots were stripped 
and reprobed for glucose-6-phosphate dehydrogenase (G6PD) as a loading control. Data 
represent the means of three independent experiments. Error bars show standard errors of the 
mean and *indicates a significant (p<0.05) difference as assessed by Student’s t-test. B. 
HEK293H cells transfected with HA-tagged ROMK1 expression vector were treated with 17-
AAG at the indicated concentrations for 24 hours. Cells lysates were analyzed by Western blot. 
u=unglycosylated. i=immaturely glycosylated. A representative image is shown and the blots 
were stripped and reprobed for actin as a loading control. 
 
 
 
As Hsp90 is a prominent survival factor for many cancers (Whitesell and Lindquist, 
2005), Hsp90 inhibitors have been broadly investigated as chemotherapeutics. The synthetic 
Hsp90 inhibitor Tanespimycin (17-AAG) is currently undergoing phase-III clinical trials for its 
efficacy in multiple myeloma. Hsp90s are known to promote folding and maturation of several 
potassium channels, such as the cardiac channel hERG (Ficker et al., 2003; Peterson et al., 
2012), the cochlear channel KCNQ4 (Gao et al., 2013), and the pancreatic β-cell channel 
Kir6.1/SUR (Yan et al., 2010). However, different Hsp90 isoforms in mammalian cells can 
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promote degradation or maturation of the same client protein (Gao et al., 2013). To test if Hsp90 
promotes the folding or maturation of ROMK, I treated HEK 293H cells expressing ROMK with 
17-AAG and observed a dosage dependent increase in ROMK steady-state protein levels (Figure 
26B). Note that transiently transfected cells only express the unglycosylated (u) and immaturely 
glycosylated (i) forms of ROMK in contrast to the Tet-On cells which also express the maturely 
glycosylated form (Figure 19). This result was intriguing as our group in collaboration with the 
Subramanya lab at the University of Pittsburgh School of Medicine has shown that Hsp90 
inhibition is deleterious for the folding and expression of NCC (Donnelly et al., 2013), which 
reabsorbs sodium and chloride in the distal nephron and is regulated in tandem with ROMK in 
response to fluctuating extracellular potassium levels (Figure 23). Therefore, Hsp90 may 
constitute an as yet uncharacterized node in the distal nephron potassium response network. 
Further study is needed to determine if the effects of Hsp90 on ROMK expression are due to 
direct chaperone-client interaction or modulation of a cellular signaling pathway. 
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APPENDIX D 
FULL LIST OF HITS FROM SGA SCREEN 
Table 8: Full list of hits from SGA screen. All hits from SGA screen described in section 2.3.3 
arranged by z-score cutoff. For more information on genes not discussed in the text, refer to the 
Saccharomyces genome database (SGD).  
 
 
z-
score 
Systemic 
Name 
Stan-
dard 
Name 
z-
score 
Systemic 
Name 
Stan-
dard 
Name 
z-
score 
Systemic 
Name 
Stan-
dard 
Name 
3 YAL002W VPS8 2 
YER185
W PUG1 1 YLR069C MEF1 
3 YAL011W SWC3 2 YFL006W  1 YLR074C BUD20 
3 YAL051W OAF1 2 YFL007W 
BLM1
0 1 YLR083C EMP70 
3 YAL053W FLC2 2 YFL019C  1 YLR099C ICT1 
3 YAL068C PAU8 1 YFL020C PAU5 1 YLR108C  
3 
YAR002C-
A ERP1 1 YFL028C CAF16 1 YLR109W AHP1 
3 YBL006C LDB7 1 YFL031W HAC1 1 YLR110C CCW12 
3 YBL011W SCT1 1 YFL032W  1 YLR111W  
3 YBL049W MOH1 1 
YFL034C
-A 
RPL22
B 1 YLR118C  
3 YBL057C PTH2 1 YFL042C LAM5 1 YLR139C SLS1 
3 YBL064C PRX1 1 YFL055W AGP3 1 YLR184W  
3 YBL065W  1 
YFR010
W UBP6 1 YLR187W SKG3 
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3 YBL078C ATG8 1 
YFR024C
-A LSB3 1 YLR201C COQ9 
3 YBL091C MAP2 1 YFR026C ULI1 1 YLR205C HMX1 
3 YBL094C  1 YFR032C RRT5 1 YLR214W FRE1 
3 YBR018C GAL7 1 YFR043C IRC6 1 YLR217W  
3 YBR019C GAL10 1 YFR046C CNN1 1 YLR226W BUR2 
3 YBR020W GAL1 1 YGL013C PDR1 1 YLR234W TOP3 
3 YBR022W POA1 1 
YGL014
W PUF4 1 YLR236C  
3 YBR024W SCO2 1 YGL025C PGD1 1 YLR239C LIP2 
3 YBR025C OLA1 1 YGL027C 
CWH4
1 1 YLR254C NDL1 
3 YBR026C ETR1 1 YGL028C 
SCW1
1 1 YLR261C VPS63 
3 YBR033W EDS1 1 
YGL033
W HOP2 1 YLR352W  
3 YBR041W FAT1 1 YGL064C MRH4 1 YLR356W ATG33 
3 YBR051W  1 
YGL066
W SGF73 1 YLR357W RSC2 
3 YBR059C AKL1 1 
YGL071
W AFT1 1 YLR360W VPS38 
3 YBR106W PHO88 1 YGL072C  1 YLR364W GRX8 
3 YBR127C VMA2 1 
YGL080
W MPC1 1 YLR369W SSQ1 
3 YBR128C ATG14 1 YGL084C GUP1 1 YLR370C ARC18 
3 YBR130C SHE3 1 YGL087C MMS2 1 YLR371W ROM2 
3 YBR132C AGP2 1 
YGL105
W ARC1 1 YLR377C FBP1 
3 YBR134W  1 
YGL114
W  1 YLR381W CTF3 
3 YBR137W  1 
YGL117
W  1 YLR382C NAM2 
3 YBR150C TBS1 1 YGL118C  1 YLR387C REH1 
3 YBR151W APD1 1 YGL121C GPG1 1 YLR395C COX8 
3 YBR158W AMN1 1 
YGL125
W MET13 1 YLR399C BDF1 
3 YBR161W CSH1 1 
YGL126
W SCS3 1 YLR404W SEI1 
3 YBR169C SSE2 1 YGL167C PMR1 1 YLR412W BER1 
3 YBR175W SWD3 1 YGL170C SPO74 1 YLR413W INA1 
3 YBR176W 
ECM3
1 1 YGL173C XRN1 1 YLR417W VPS36 
2 YBR187W GDT1 1 
YGL195
W GCN1 1 YLR436C ECM30 
 126 
2 YBR189W RPS9B 1 
YGL244
W RTF1 1 YLR438W CAR2 
2 YBR191W 
RPL21
A 1 
YGL249
W ZIP2 1 YLR447C VMA6 
2 YBR197C  1 YGL261C PAU11 1 YLR454W FMP27 
2 YBR200W BEM1 1 
YGR010
W NMA2 1 YLR460C  
2 YBR206W  1 
YGR011
W  1 YLR461W PAU4 
2 YBR207W FTH1 1 
YGR012
W MCY1 1 YML001W YPT7 
2 YBR208C 
DUR1,
2 1 YGR015C  1 YML002W  
2 YBR220C  1 
YGR026
W  1 YML009C 
MRPL3
9 
2 YBR221C PDB1 1 YGR027C 
RPS25
A 1 
YML012C-
A  
2 YBR224W  1 YGR036C CAX4 1 YML014W TRM9 
2 YBR225W  1 
YGR041
W BUD9 1 YML041C VPS71 
2 YBR231C SWC5 1 
YGR056
W RSC1 1 YML061C PIF1 
2 YBR248C HIS7 1 YGR057C LST7 1 YML075C HMG1 
2 YBR249C ARO4 1 
YGR064
W  1 YML080W DUS1 
2 YBR262C MIC12 1 YGR071C ENV11 1 YML081W TDA9 
2 YBR264C YPT10 1 YGR084C MRP13 1 YML082W  
2 YBR266C SLM6 1 
YGR096
W TPC1 1 YML086C ALO1 
2 YBR267W REI1 1 
YGR097
W ASK10 1 YML087C AIM33 
2 YBR269C SDH8 1 
YGR100
W MDR1 1 YML089C  
2 YBR272C HSM3 1 YGR104C SRB5 1 YMR016C SOK2 
2 YBR276C PPS1 1 
YGR118
W 
RPS23
A 1 
YMR031W
-A  
2 YBR286W APE3 1 YGR121C MEP1 1 YMR032W HOF1 
2 YBR287W  1 
YGR122
W  1 
YMR052C
-A  
2 YBR291C CTP1 1 
YGR131
W FHN1 1 YMR062C ARG7 
2 
YCL001W
-A  1 
YGR136
W LSB1 1 YMR072W ABF2 
2 YCL005W LDB16 1 
YGR142
W BTN2 1 YMR073C IRC21 
 127 
2 YCL008C STP22 1 
YGR149
W GPC1 1 YMR077C VPS20 
2 YCL026C  1 
YGR153
W  1 YMR082C  
2 YCL030C HIS4 1 
YGR160
W  1 
YMR086C
-A  
2 YCL040W GLK1 1 
YGR164
W  1 YMR091C NPL6 
2 YCL061C MRC1 1 YGR169C PUS6 1 YMR142C RPL13B 
2 YCR002C CDC10 1 YGR174C CBP4 1 YMR155W  
2 YCR007C  1 YGR188C BUB1 1 YMR169C ALD3 
2 
YCR020W
-B HTL1 1 YGR189C CRH1 1 YMR179W SPT21 
2 YCR026C NPP1 1 YGR192C TDH3 1 YMR184W ADD37 
2 YCR032W BPH1 1 
YGR199
W PMT6 1 YMR230W RPS10B 
2 YCR036W RBK1 1 YGR207C CIR1 1 YMR232W FUS2 
2 YCR043C  1 
YGR208
W SER2 1 YMR243C ZRC1 
2 YCR045C RRT12 1 
YGR215
W RSM27 1 
YMR244C
-A COA6 
2 YCR053W THR4 1 
YGR224
W AZR1 1 YMR252C  
2 YCR069W CPR4 1 YGR240C PFK1 1 YMR253C  
2 YCR084C TUP1 1 YGR255C COQ6 1 YMR254C  
2 YCR087W  1 YHL003C LAG1 1 YMR257C PET111 
2 YCR089W FIG2 1 YHL014C YLF2 1 YMR264W CUE1 
2 YDL010W GRX6 1 YHL016C DUR3 1 YMR271C URA10 
2 YDL013W SLX5 1 
YHL028
W WSC4 1 YMR282C AEP2 
2 YDL021W GPM2 1 YHL029C OCA5 1 YMR286W 
MRPL3
3 
2 YDL048C STP4 1 
YHL030
W 
ECM2
9 1 YNL052W COX5A 
2 YDL069C CBS1 1 YHL031C GOS1 1 YNL057W  
2 YDL070W BDF2 1 YHL033C RPL8A 1 YNL066W SUN4 
2 YDL101C DUN1 1 
YHL042
W  1 YNL080C EOS1 
2 YDL121C  1 
YHL043
W 
ECM3
4 1 YNL085W MKT1 
2 
YDL130W
-A STF1 1 
YHL044
W  1 YNL086W SNN1 
2 YDL131W LYS21 1 
YHL045
W  1 YNL096C RPS7B 
 128 
2 
YDL133C-
A 
RPL41
B 1 
YHR010
W 
RPL27
A 1 YNL097C PHO23 
2 YDL151C BUD30 1 YHR013C ARD1 1 YNL117W MLS1 
2 YDL157C  1 
YHR015
W MIP6 1 YNL133C FYV6 
2 YDL161W ENT1 1 
YHR017
W YSC83 1 YNL144C  
2 YDL182W LYS20 1 YHR018C ARG4 1 YNL145W MFA2 
2 YDL233W MFG1 1 
YHR033
W  1 YNL160W YGP1 
2 YDR004W RAD57 1 
YHR037
W PUT2 1 YNL176C TDA7 
2 YDR006C SOK1 1 
YHR038
W RRF1 1 YNL179C  
2 YDR028C REG1 1 YHR044C DOG1 1 YNL187W SWT21 
2 YDR029W  1 YHR047C AAP1 1 YNL197C WHI3 
2 YDR030C RAD28 1 
YHR051
W COX6 1 YNL224C SQS1 
2 YDR046C BAP3 1 
YHR060
W 
VMA2
2 1 YNL227C JJJ1 
2 YDR059C UBC5 1 
YHR073
W OSH3 1 YNL234W  
2 YDR061W  1 
YHR081
W LRP1 1 YNL238W KEX2 
2 YDR063W AIM7 1 YHR082C KSP1 1 YNL239W LAP3 
2 YDR067C OCA6 1 YHR092C HXT4 1 YNL246W VPS75 
2 YDR069C DOA4 1 
YHR104
W GRE3 1 YNL248C RPA49 
2 YDR071C PAA1 1 
YHR111
W UBA4 1 YNL253W TEX1 
2 YDR084C TVP23 1 
YHR124
W NDT80 1 YNL266W  
2 YDR100W TVP15 1 
YHR125
W  1 YNL268W LYP1 
2 YDR101C ARX1 1 
YHR134
W WSS1 1 YNL270C ALP1 
2 YDR112W IRC2 1 YHR147C 
MRPL
6 1 YNL273W TOF1 
2 YDR114C  1 YHR151C MTC6 1 YNL275W BOR1 
2 YDR117C 
TMA6
4 1 
YHR154
W 
RTT10
7 1 YNL280C ERG24 
2 YDR120C TRM1 1 
YHR162
W MPC2 1 YNL293W MSB3 
2 YDR123C INO2 1 
YHR167
W THP2 1 YNL298W CLA4 
 129 
2 YDR129C SAC6 1 
YHR181
W SVP26 1 
YNR032C-
A HUB1 
2 YDR130C FIN1 1 
YHR183
W GND1 1 YNR070W PDR18 
2 YDR136C VPS61 1 YHR198C AIM18 1 YOL001W PHO80 
2 YDR138W HPR1 1 YIL012W  1 YOL003C PFA4 
2 YDR140W MTQ2 1 YIL014W MNT3 1 YOL008W COQ10 
2 YDR143C SAN1 1 YIL020C HIS6 1 YOL014W  
2 YDR195W REF2 1 YIL035C CKA1 1 YOL015W IRC10 
2 YDR199W  1 YIL043C CBR1 1 YOL018C TLG2 
2 YDR200C VPS64 1 YIL059C  1 YOL036W  
2 YDR204W COQ4 1 YIL067C  1 YOL037C  
2 YDR207C UME6 1 YIL090W ICE2 1 YOL049W GSH2 
2 YDR218C SPR28 1 YIL107C PFK26 1 YOL050C  
2 YDR220C  1 YIL116W HIS5 1 YOL053W AIM39 
2 YDR226W ADK1 1 YIL136W OM45 1 YOL054W PSH1 
2 YDR231C COX20 1 YIL145C PAN6 1 YOL058W ARG1 
2 YDR233C RTN1 1 YIL153W RRD1 1 YOL067C RTG1 
2 YDR237W 
MRPL
7 1 YIL154C IMP2' 1 YOL075C  
2 YDR252W BTT1 1 YIL157C COA1 1 YOL096C COQ3 
2 YDR261C EXG2 1 YIL160C POT1 1 YOL111C MDY2 
2 YDR270W CCC2 1 YIL161W  1 YOL112W MSB4 
2 YDR286C  1 YIL170W HXT12 1 YOL115W PAP2 
2 YDR290W  1 YIR032C DAL3 1 YOL151W GRE2 
2 YDR297W SUR2 1 YJL038C LOH1 1 YOR002W ALG6 
2 YDR305C HNT2 1 YJL088W ARG3 1 YOR011W AUS1 
2 YDR307W PMT7 1 YJL094C KHA1 1 YOR026W BUB3 
2 YDR315C IPK1 1 YJL101C GSH1 1 YOR065W CYT1 
2 YDR323C PEP7 1 YJL127C SPT10 1 YOR068C VAM10 
2 YDR326C YSP2 1 YJL128C PBS2 1 YOR069W VPS5 
2 YDR334W SWR1 1 YJL129C TRK1 1 YOR079C ATX2 
2 YDR347W MRP1 1 YJL130C URA2 1 YOR089C VPS21 
2 YDR348C PAL1 1 YJL131C AIM23 1 YOR096W RPS7A 
2 YDR349C YPS7 1 YJL132W  1 YOR130C ORT1 
2 YDR352W YPQ2 1 YJL135W  1 YOR141C ARP8 
2 YDR358W GGA1 1 YJL136C 
RPS21
B 1 YOR172W YRM1 
2 YDR363W ESC2 1 YJL140W RPB4 1 YOR187W TUF1 
2 
YDR363W
-A SEM1 1 YJL142C IRC9 1 YOR198C BFR1 
2 YDR374C PHO92 1 YJL146W IDS2 1 YOR199W  
2 YDR383C NKP1 1 YJL147C MRX5 1 YOR200W  
2 YDR384C ATO3 1 YJL159W 
HSP15
0 1 YOR215C AIM41 
 130 
2 YDR385W EFT2 1 YJL161W FMP33 1 YOR216C RUD3 
2 YDR392W SPT3 1 YJL163C  1 YOR219C STE13 
2 YDR399W HPT1 1 YJL166W QCR8 1 YOR221C MCT1 
2 YDR400W URH1 1 YJL168C SET2 1 YOR227W HER1 
2 YDR417C  1 YJL172W CPS1 1 YOR228C MCP1 
2 YDR419W RAD30 1 YJL176C SWI3 1 YOR233W KIN4 
2 YDR421W ARO80 1 YJL178C ATG27 1 YOR239W ABP140 
2 YDR422C SIP1 1 YJL179W PFD1 1 YOR241W MET7 
2 YDR431W  1 YJL182C  1 YOR245C DGA1 
2 YDR432W NPL3 1 YJL184W GON7 1 YOR258W HNT3 
2 YDR435C PPM1 1 YJL189W RPL39 1 YOR268C  
2 YDR465C RMT2 1 YJL191W 
RPS14
B 1 YOR274W MOD5 
2 YDR475C JIP4 1 YJL218W  1 YOR288C MPD1 
2 YDR482C 
CWC2
1 1 YJR018W  1 YOR355W GDS1 
2 YDR490C PKH1 1 YJR030C RBH2 1 YOR365C  
2 YDR516C EMI2 1 YJR031C GEA1 1 YPL002C SNF8 
2 YDR518W EUG1 1 YJR033C RAV1 1 YPL022W RAD1 
2 YDR533C HSP31 1 YJR049C UTR1 1 YPL027W SMA1 
2 YDR535C  1 YJR054W KCH1 1 YPL034W  
2 YDR540C IRC4 1 YJR055W HIT1 1 YPL036W PMA2 
2 YEL001C IRC22 1 YJR061W  1 YPL059W GRX5 
2 YEL009C GCN4 1 YJR066W TOR1 1 YPL069C BTS1 
2 
YEL017C-
A PMP2 1 YJR088C EMC2 1 YPL074W YTA6 
2 YEL017W GTT3 1 YJR122W IBA57 1 YPL079W RPL21B 
2 YEL024W RIP1 1 YKL003C MRP17 1 YPL084W BRO1 
2 YEL027W VMA3 1 
YKL009
W MRT4 1 YPL091W GLR1 
2 YEL040W UTR2 1 YKL011C CCE1 1 YPL097W MSY1 
2 YEL045C  1 YKL026C GPX1 1 YPL104W MSD1 
2 YEL046C GLY1 1 
YKL027
W TCD2 1 YPL105C SYH1 
2 YEL051W VMA8 1 
YKL038
W RGT1 1 YPL106C SSE1 
2 YEL054C 
RPL12
A 1 
YKL044
W MMO1 1 YPL144W POC4 
2 YEL063C CAN1 1 YKL054C DEF1 1 YPL152W RRD2 
2 YEL067C  1 
YKL070
W  1 YPL157W TGS1 
2 
YER019C-
A SBH2 1 
YKL080
W VMA5 1 YPL158C AIM44 
2 
YER038W
-A FMP49 1 
YKL081
W TEF4 1 YPL163C SVS1 
 131 
2 YER040W GLN3 1 YKL103C APE1 1 YPL167C REV3 
2 YER049W TPA1 1 
YKL109
W HAP4 1 YPL168W MRX4 
2 YER051W JHD1 1 
YKL117
W SBA1 1 YPL173W 
MRPL4
0 
2 YER052C HOM3 1 
YKL118
W  1 YPL174C NIP100 
2 
YER056C-
A 
RPL34
A 1 
YKL120
W OAC1 1 YPL180W TCO89 
2 YER061C CEM1 1 
YKL123
W  1 YPL182C  
2 YER065C ICL1 1 
YKL124
W SSH4 1 YPL188W POS5 
2 
YER068C-
A  1 
YKL127
W PGM1 1 YPL195W APL5 
2 YER068W MOT2 1 YKL130C SHE2 1 YPL196W OXR1 
2 YER069W 
ARG5,
6 1 YKL138C 
MRPL
31 1 YPL207W TYW1 
2 YER071C TDA2 1 
YKL139
W CTK1 1 YPL208W RKM1 
2 YER072W VTC1 1 
YKL142
W MRP8 1 YPL212C PUS1 
2 YER073W ALD5 1 
YKL143
W LTV1 1 YPL213W LEA1 
2 YER097W  1 
YKL146
W AVT3 1 YPL215W CBP3 
2 YER106W MAM1 1 YKL147C  1 YPL216W  
2 YER109C FLO8 1 YKL151C NNR2 1 YPL219W PCL8 
2 YER135C  1 
YKL156
W 
RPS27
A 1 YPL227C ALG5 
2 YER150W SPI1 1 
YKL157
W APE2 1 YPL230W USV1 
2 YER151C UBP3 1 
YKL162C
-A  1 YPL232W SSO1 
2 YER155C BEM2 1 
YKL170
W 
MRPL
38 1 YPL234C VMA11 
2 YER164W CHD1 1 
YKL184
W SPE1 1 YPL249C GYP5 
2 YER166W DNF1 1 
YKL185
W ASH1 1 YPL264C  
2 YER169W RPH1 1 YKL187C FAT3 1 YPR002W PDH1 
2 YER170W ADK2 1 YKL194C MST1 1 YPR011C  
2 YER173W RAD24 1 YKL200C  1 YPR043W 
RPL43
A 
2 YER174C GRX4 1 YKL201C MNN4 1 YPR044C OPI11 
 132 
2 YER176W 
ECM3
2 1 
YKL205
W LOS1 1 YPR045C THP3 
2 YER182W FMP10 1 
YKL216
W URA1 1 YPR101W SNT309 
2 YER183C FAU1 1 YKL218C SRY1 1 YPR120C CLB5 
1 YLL013C PUF3 1 YKR031C SPO14 1 YPR121W THI22 
1 YLL021W SPA2 1 
YKR041
W  1 YPR140W TAZ1 
1 YLL043W FPS1 1 YKR043C SHB17 1 YPR141C KAR3 
1 YLL044W  1 
YKR044
W UIP5 1 YPR159W KRE6 
1 YLR024C UBR2 1 YKR045C  1 YPR160W GPH1 
1 YLR027C AAT2 1 
YKR050
W TRK2 1 YPR163C TIF3 
1 YLR048W RPS0B 1 YKR054C DYN1 1 YPR166C MRP2 
1 YLR064W PER33 1 
YKR057
W 
RPS21
A 1 YPR173C VPS4 
1 YLR068W FYV7 1 
YKR059
W TIF1 1 YPR196W  
1 YLL005C SPO75 1 YPR200C ARR2    
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